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ABSTRACT
The aim of this study was to examine the mechanisms of transcription and replication 
of the paramyxovirus, simian virus type 5 (SV5). This was initially attempted using 
reverse genetics techniques and subsequently examining specific viral protein : protein 
interactions within the replication complex.
A cDNA clone encoding a synthetic negative-sense RNA genome analogue was 
constructed. Reverse genetics techniques were used to attempt to characterise 
conditions which supported the transcription and replication of this genome analogue, 
with or without the use of wild-type helper virus but were unsuccessful.
During the course of these studies, a number of mammalian cell lines inducibly 
expressing SV5 proteins were isolated. These cell lines were subsequently used to 
examine viral protein : protein interactions within the replication complex.
When expressed alone, both P and V proteins exhibited diffuse cytoplasmic 
lluorescence and V was also found in the nucleus. However, when NP was expressed 
alone, it was seen as punctate and granular cytoplasmic fluorescence. The distribution 
patterns of the proteins changed when expressed in combination. Large cytoplasmic 
aggregates similar to those at late times in an SV5 infection were seen in cells which 
co-expressed NP and P. When NP was co-expressed with V, however, NP was partially 
redistributed to give diffuse cytoplasmic and nuclear fluorescence. This showed that 
both P and V proteins could interact with NP and suggested that V may play a role in 
keeping NP soluble prior to an ordered encapsidation process.
Extracts from these cell lines were then used in a novel protein : protein capture assay 
and demonstrated that NP could interact with both P and V proteins. NP expressed by 
the cell line was shown to contained both soluble and polymeric forms of NP. P was 
shown to bind both forms of NP, while V could only bind soluble NP. Since P and V 
proteins are amino co-terminal, the site of interaction between P and polymeric NP was 
predicted to be in the P unique C-terminus. This was strengthened when a P-specific C- 
terminal mAh was found to block the binding of P with polymeric NP. Deletion mutant 
analysis in the C-terminus of the P protein showed that the mAh binding site was at the 
extreme C-terminus of the protein suggesting this is the point of interaction between P 
and polymeric NP. Possible roles for these protein : protein interactions and 
implications for the paramyxovirus replication complex are discussed.
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Chapter 1 : INTRODUCTION
This thesis aims to explore the mechanisms involved in the transcription and replication 
of simian virus 5 (SV5), a member of the paramyxovirus family. These mechanisms 
were investigated utilising both reverse genetics techniques and by examining specific 
viral protein : protein interactions within the replication complex. This chapter is 
therefore divided into three main sections: the first, gives an overview of what is 
currently known about the Paramyxoviridae transcription / replication mechanisms; the 
second, documents the development of genetic manipulation techniques for the 
examination of the biology of negative stranded RNA viruses; the third outlines the 
aims of the project presented in this thesis. Chapter 2 documents the materials and 
methods employed during the course of this work. The results are presented in Chapter 
3 where they have been divided into 3 sections. The first deals with the attempted 
development of a reverse genetics system for SV5; the second documents the 
development of cell lines expressing SV5 proteins; the third examines SV5 protein : 
protein interactions. In Chapter 4, the results, which give some insight into the possible 
roles played by these proteins in viral transcription and replication, are discussed, with 
future work also being outlined.
1 Classification, Molecular Structure and 
Replication of the Paramyxoviridae
The Paramyxoviridae is a family of enveloped viruses, with a single-stranded, non­
segmented, RNA genome of negative polarity. They resemble two other families of 
negative-stranded RNA viruses, namely the Rhabdoviridae, for a similarity of genome 
organisation and expression, and the Orthomyxovindae, for a similarity in the 
biological properties of the envelope glycoproteins.
The negative sense RNA genome has a dual purpose: firstly, it is the template for 
mRNA synthesis, and secondly, is a template for antigenome (full length positive strand 
copy of the genome) synthesis, which in turn, acts as a template for the synthesis of 
genomic (negative) sense RNA. These viruses encode their own RNA-dependent RNA  
polymerase, which acts as both a transcriptase, during the generation o f mRNA, and a 
leplicase, when synthesising genomes (or antigenomes). mRNA is generated once the 
virus has been uncoated in the infected cell and is followed by viral replication, which 
requires continuous synthesis of viral proteins.
1.1 Classification of the Paramyxoviridae
In 1995, the International Committee on Taxonomy of Viruses, reclassified the 
Paramyxoviridae family into 2 subfamilies, namely, the Paramyxovirinae and the 
Pneumovirinae. The Paramyxovirinae contains three genera, Parainfluenzavirus, 
Rubulavirus and Morbillivirus, while the Pneumovirinae contains only the 
Pneumovirus genus. This classification was based on morphological similarities, 
antigenic cross-reactivity between members of a genus, and the coding organisation of 
the P genes. Examples of viruses found in each genus aie given in Table 1. The 
Parainfluenzaviruses and Rubulaviruses are differentiated from the Morbilliviruses on 
the basis of biological activity of the attachment protein. In addition, the Rubulaviruses 
contain an extra gene, (SH), which is not seen in the Parainfluenza- or Morbilliviruses.
Family Paramyxoviridae
Subfamily Paramyxovirinae 
Genus Parainfluenzavirus
Sendai virus (mouse parainfluenza virus type I) 
Human parainfluenza virus type 1 and type 3 
Bovine parainfluenza virus type 3 
Genus Rubulavirus
Simian virus 5 (Canine parainfluenza virus type 2) 
Mumps virus 
Newcastle disease virus
Human parainfluenza virus type 2, type 4a and 4b
Genus Morbillivirus
Measles vims
Dolphin morbillivirus
Canine distemper virus
Peste-des-petits-ruminants virus
Phocine distemper vims
Rinderpest virus
Subfamily Pneumovirinae 
Genus Pneunovirus
Human respiratory syncytial virus 
Bovine respiratory syncytial virus 
Pneunonia virus of mice 
Turkey rhinotracheitis virus
Table 1 Members of the Paramyxoviridae
Examples from each genus within the Paramyxoviridae family. 
Taken from Lamb and Kolakofsky (1995).
The Pneumaviriuae are very dilTerenl from the Paramyxovirinae in that, although their 
gene order is similar, they encode a number of additional genes, (N Sl, NS2 and M2), 
and their attachment protein is different in terms of structure and biological activity.
1.2 Virion Structure
The Paramyxoviridae. although pleomorphic in shape, are generally spherical. They 
consist of a single stranded RNA genome, encapsidated in a helical core stmcture 
known as the nucleocapsid. This is surrounded by matrix protein (M) and a host derived 
lipid bilayer, through which two glycoprotein (HN and F) protrude. A schematic 
diagram of the Rubulavirus. SV5, is given in Fig.l.
The infectious cycle begins with virus atttachment to the target cell surface and fusion 
with the cell membrane, and is mediated by the glycoproteins. The attachment protein 
(H, HN or G), interacts with a specific receptor on the host cell surface whereupon the 
fusion protein (F) fuses with the cell membrane facilitating the release of the 
nucleocapsid into the cell cytoplasm (Reviewed in Choppin and Compans, 1975).
The nucleocapsid is comprised of the negative sense RNA genome in tight association 
with the nucleocapsid protein (NP) in a helical core structure which is resistant to 
nuclease attack. To this, the phosphoprotein (?) and the large protein (L) are attached. It 
has been reported that V protein is also in association with the nucleocapsid of SV5 
(Paterson et aL 1995). This nucleocapsid core serves as the template for both the 
generation of mRNA (transcription) and genomic/anti-genomic RNA (replication) as 
shown in Fig.2. Transcription and replication are functions of the viral polymerase, 
which requires both P and L proteins to constitute an active complex (Hamaguchi et al, 
1983).
Paramyxovirus nucleocapsids are not rigid structures, as they coil and uncoil in 
response to changes in salt concentration (Heggeness et aL 1980). Furthennore, Sendai 
virus has been shown to exist in several distinct morphological states at normal salt 
concentration (Engelman et at, 1989). The template is copied by the viral polymerase 
without dissociation of NP from the nucleocapsid core, thus uncoiling of the
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Fig. 2. Overview of transcription and replication steps for the 
Paramyxo viridae
Schematic diagram o f the steps involved in transcription and replication of the 
Rubulavirus SV5. The input viral nucleocapsid containing RNA, or ribonucleoprotein 
(RNP), are indicated as containing negative (-) or positive (+) strand RNA, as discussed 
in the text. Adapted from Kingsbury (1990).
nucleocapsid core may be necessary for the viral polymerase to gain access to the RNA 
bases. Therefore, the most extended form of the nucleocapsid structure, where the helix 
is almost completely unwound, may represent the structure adopted during the copying 
of the RNA template.
1.3 Genomes and Encoded Proteins
The genomes of the Paramyxoviridae are single stranded, non-segmented RNAs of 
negative polarity, and are approximately 15 kb in length. The genome encodes 6-10 
genes (Fig.3) depending on the virus being examined, where a 'gene' refers to a region 
of genomic RNA which encodes one (or more) specific mRNA(s). Flanking the genes, 
is a 3' extracistronic sequence known as the leader region and a 5' extracistronic 
sequence known as the trailer region. Both are around 50 nucleotides in length, are well 
conserved within the Paramyxoviridae, and contain conserved sequences at each end of 
the genome (Galinski and Weschler, 1991). In human parainfluenza virus type 3 
(hPIV3), 33 of the first 39 nucleotides are conserved in the leader and trailer sequences 
(Galinski, 1988 ) suggesting these sequences contain signals enabling polymerase 
attachment to the template and encapsidation of the nascent strand (Blumberg et al. 
1991). There are sequences found between the genes (i.e. after one gene end sequence 
and before the next gene start sequence) known as intergenic regions. These are 
variable in length for the Rubulaviruses (1-47 nucleotides) 'ànd Pneumoviruses (1-56 
nucleotides) but are exactly three nucleotides long in both the Parainfluenzaviruses and 
the Morbilliviruses. In measles virus (MeV), Sendai virus (SeV) and hPIV3, the 
intergenic sequences are GAA, GGG and GCT respectively (Galinski and Wechsler, 
1991). The influences on viral transcription of these intergenic sequences, and the 
leader and trailer sequences, are discussed further in section 1.4.2.
1.3.1 The Nucleocapsid Protein (NP)
The nucleocapsid protein (NP, N) is the most abundant protein in the viral nucleocapsid 
(Lamb eta l, 1976), and serves several functions in virus transcription/replication. It
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Fig.3 Genome organisation in the Paramyxoviridae,
Schematic diagram showing the genome organisation o f a representative 
member from each genus of the Paramyxoviridae. The L gene o f the 
Pneumoviruses ovCTlaps with that o f the M2 gene and is therefore shown as 
staggared. Adapted from Lamb and Kolakofs^ (1995).
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firstly encapsidates genomic (and anti-genomic) RNA, giving protection from nuclease 
attack (Banerjee, 1987), and also gives lise to the characteristic helical structure of the 
nucleocapsid (Das and Banerjee, 1993; Books et ciL 1993; Biichholtz eta l, 1993). NP 
interacts with both the polymerase complex (Kingsbury, 1974) and M protein 
(Markwell and Fox, 1980), suggesting a role for NP in transcription, replication and 
vims assembly. Furthermore, it is thought that the intracellular concentration of NP is a 
major factor in the switch from transcription to replication (Vidal and Kolakofsky,
1989).
The sequences of many NP proteins have been predicted (e.g. Neubert eta l, 1991;
Parks eta l, 1992; Rozenblatt é'f r//,1985; Collins etal, 1985) and range from 489-533 
amino acids (a a )  in length. Protein sequence alignments have suggested that NP 
contains 2 domains, a large globulai* N-terminal domain of around 500 amino acids 
which is relatively conseiwed between related viruses, and a small, hyper-variable, C- 
terminal tail region extending from the globular body of the protein (Heggeness, 1981). 
Trypsin digests of the NDV nucleocapsid (Kingsbury and Darlington, 1968) 
demonstrated that the C-terminal domain could be cleaved off without affecting the 
ability of NP to fomi RNase resistant nucleocapsids. These nucleocapsids were then 
examined by EM and were found to retain their characteristic helical confomiation.
This suggested that both the RNA-binding domain and the residues involved in the 
interactions resulting in helical nucleocapsid formation, were to be found in the 
globular N-terminal domain. A conserved hydrophobic motif of FX4 YX4 SYAMG 
(where X is any residue), is found in the middle of the protein, suggesting this may be 
the site of NP:NP interaction (Morgan et al, 1984). However, since this motif contains a 
number of aromatic amino acid residues (Tyr, Phe or Trp), it has been suggested that 
this could be the RNA binding site (Morgan etal, 1984).
The divergent C-ierminus of NP contains many negatively charged residues and the 
major sites of phosphorylation for the protein. In Sendai virus, a stretch of 7 acidic 
amino acids (Asp or G lu residues) is thought to be the site of NP:M interaction 
(Markwell and Fox, 1980).
Deletion of a  a  4-188 and 
a a  374-492 caused 
formation of unstructures 
aggregates
Requned for formation of 
soluble N:P complexes
304-373
a a  4-188 a a  374-492
Deletion here has no effect 
on N:P interaction but 
abolishes N:N interaction
Necessary for 
the stability of 
the protein
a a  240-303a a  189-239
‘525
Amino acids 1-398 are necessary for the formation of 
nucleocapsid-like structures
Fig. 4 Schematic diagram of measles virus N protein
Sites of proteiniprotein interaction on MeV N protein were identified by 
deletion mutant analysis. Two non contiguous regions (amino acids 4-188 
and 304-373) are required for the formation o f soluble N:P complexes, while 
deletion of amino acids 189-239 did not affect N:P binding. Amino acids 
240-303 appear necessary for the stability of the protein. The N-terminal 398 
amino acids are all required for the formation of organised nucleocapsid-like 
particles, since deletion o f the central region from amino acids 189-373 
completely abolish N:N interaction, and deletion o f amino acids 4-188 and 
374-492 caused the formation o f unstructured aggregates.
Data taken from Bankamp et a l , 1996.
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Structure / function analysis of Sendai virus NP protein found that the C-terminal tail 
was not essential for encapsidation of a synthetic defective interfering (DI) particle but 
was required for this template to be functional in subsequent replication assays (Curran 
et aL 1993). The role of the NP C-terminus remains unclear, but since NP protein with 
C-terminal deletions can form nucleocapsid-like structures containing cellular RNA, it 
may play a role in the specificity of RNA assembly (Buchholz et al, 1993).
During viral replication, soluble (unassembled) NP must be transported to the site of 
nucleocapsid assembly since genome replication and encapsidation are concurrent 
(Vidal and Kolakofsky, 1989). There is evidence to suggest that P protein chaperones 
NP to the polymerase complex (Horikami etal, 1992; Buchholz etal, 1993; Cuiran et 
al, 1993) and in doing so, prevents NP from self-aggregating. Evidence presented in 
this thesis, and elsewhere, suggests that V protein may play a similar role in preventing 
NP from self-aggregating (Randall and Bermingham, 1996; Horikami eta l, 1996). A 
further interaction, probably with the viral polymerase complex, must take place, which 
allows NP to specifically assemble the nascent RNA and which, presumably also 
releases P.
Deletion mutant analysis on both Sendai virus and measles virus, have identified areas 
of NP:NP and NP:P interaction (Buchholz et al, 1993, Bankamp et al, 1996) as shown 
in Fig.4. The N-terminal 398 amino acids were required for the formation of 
nucleocapsid-like structures and deletion of amino acids 189-373, abolished NP:NP 
interaction. Two regions (amino acids 4-188 and 304-373) were also identified as being 
required for soluble N:P complex formation. Measles N also undergoes a 
conformational maturation upon phosphorylation, whereupon it is available for 
assembly into nucleocapsid structures (Gombart et al, 1993).
1.3.2 Proteins encoded by the F Gene
When comparing the P genes, a major difference is found between the Pneumovirinae 
and the Paramyxoviniwe. The P gene of the Pneumovirinae gives rise to a single P 
protein while that of the Paramyxovirinae, encodes multiple proteins by the use of
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multiple reading frames. These reading frames are accessed during viral transcription 
either by the use of a variable number of initiation codons or by a process known as 
RNA editing. For the latter, a frameshift is generated by the addition of non-templated 
residues due to a polymerase stuttering mechanism. Thus, proteins with common N- 
terminal sequences but unique C-termini are generated. These proteins, and their 
generation, are discussed in more detail below.
1.3.2.1 P Protein
The sequences of many paramyxovirus P proteins have now been predicted and are 
found to be variable in length within the family (e.g. Bellini et al, 1985, Thomas et al, 
1988, Shioda et al, 1986, Southern et al, 1990, Spriggs and Collins, 1986). The P 
proteins, named because they are highly phosphorylated, play a pivotal role in RNA 
synthesis. P functions as a subunit of the viral polymerase as both P and L proteins are 
necessary to constitute an active polymerase complex (Hamaguchi et al, 1983). It also 
binds soluble (unassembled) NP, forming an NP-P complex which prevents NP from 
self aggregating and possibly delivers NP to the nascent RNA chain for encapsidation 
during viral replication (Curran et al, 1995a). As previously mentioned, there is some 
evidence to suggest that NP-P complexes prevent NP from non-specifically 
encapsidating cellular RNA (CuiTan et aL 1993, Buchholz et al, 1993, Masters and 
Banerjee, 1988).
The P protein can be divided^into an N-terminal domain, a C-terminal domain and a 
hypervariable region in between as shown in Fig.5, The N-terminal region of P proteins 
contain the phosphorylation sites (Das etal, 1995; Byrappa eta l, 1995;Vidal eta l, 
1988) and areas involved in RNA synthesis (CuiTan eta l, 1994 and 1995a).
The immediate N-terminal residues (amino acids 1-77) in Sendai virus (SeV) were 
shown to be essential for RNA encapsidation (Curran et al, 1994). This study also 
demonstrated that 9 amino acids within this region (amino acids 33-41) were required 
to bind soluble NP for delivery to the nascent chain during genome replication, 
therefore acting as a chaperone for NP.
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Soluble NP binding site 
33,-------------- ,41
Nucleocapsid binding 
Trimérisation domain site
344 411 479 568
+ G  412 445
L binding site
100 200 300
No. of amino acids
400 500 568
Fig.5 Schematic diagram of SeV P protein
Illustration of the areas of contact be ween P and the other viral 
proteins indicated. Residues 33-41 are required for the chaperoning 
of unassemled NP during the nascent chain assembly step of 
genome replication. Two blocks within the C-terminal 40% of the
protein (ao344-411 and 479-568) are involved in binding to 
nucleocapsids. Residues 344-411 are also required for 
trimérisation and only trimers bind to the nucleocapsid template. 
Residues 412-478 represent the stable binding site for the L 
protein. The site for the addition of a non-templated G residue at 
codon 308 during mRNA synthesis is also indicated.
Adapted from Curran (1996)
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The C-terminal portion of SeV P protein contains 2 nucleocapsid (assembled NP) 
binding sites at amino acids 345-411 and 479-568 (Ryan and Kingsbury, 1988; Ryan eî 
aL 1991), one of which (amino acids 344-411) is also the region essential for 
oligomerisation of the P protein (amino acids 344-411) into homotrimers (Curran etaL
1995) and only trimers bind to the nucleocapsid template. Between the NP binding 
sites, lies the L binding site (amino acids 412-445) which loops out to contact L and 
does not overlap with either of the NP binding sites (Curran et aL 1994; Smallwood et 
a/, 1994).
1.3.2.2 C Proteins
Only members of the Parainfluenzavirus and Morbillivirus genera express small basic 
C proteins from their P genes (Barrett etaL  1985, Bellini et aL 1985, Spriggs and 
Collins, 1986). SeV encodes 4 'C-ltke' proteins, namely C , C. Y1 and Y2 (CuiTan and 
Kolakofsky, 1989) while hPIVl expresses C , C and Y1 (Power eta tl 1992). These 
proteins are expressed both in vivo and in vitro and are generated from a variable 
number of start codons, including non-AUG initiation codons (reviewed in Kolakofsky 
et al, 1991). SeV C  and C (But not Y 1 or Y2) proteins have been shown to inhibit 
mRNA synthesis and genome replication by possibly forming inactive complexes with 
L protein. It has been suggested that the C proteins exhibit a negative regulatory role 
during virus infection to limit both genome amplification and mRNA synthesis (Cadd et 
aL 1996; Curran etaL  1992). Given the very different levels of C expression among the 
different Paramyxoviridae, the viruses may have differing requirements for down- 
regulation of genome amplification and expression in the later stages of infection. A C- 
deleted measles virus has recently been found to be viable and essentially without 
mutant phenotype in cell culture (Radecke and Billeter, 1996) as has the analogous 
rhabdovirus, vesicular stomatitis virus (VSV; Kretzschmar et aL 1996). However, 
whether these C-deleted viruses will exhibit any phenotypic effect in vivo, remains to 
be determined.
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1.3.2.3 V, W and  I  Proteins
The P genes of most of the Paramyxovirinae are able to express two mRNA species by 
a mechanism of RNA editing which inserts non-templated G residues. It is a virus 
specific event which takes place co-transcriptionally by reiterative copying of a short C- 
stretch at a specific region on the genome template (Vidal et al, 1990a). The 
septanucleotide consensus motif (3 - UUU/CUCCC -5'), (Fig. 6) including the C- 
stretch, has been proposed as a requirement for editing (Park and Krystal, 1992). A 
'stuttering' model proposes that the polymerase pauses at this site, and when the pause is 
sufficiently long, slippage of the nascent mRNA occurs by one or two nucleotides, 
thereby reiteratively inserting one or two Gs (Vidal et al, 1990b).
For the parainfluenzaviuses (SeV, hPIVS) and Morbillivirus es (measles virus), the 
unedited mRNA that is a faithful copy of the genome, encodes llie P protein while the 
edited mRNA, with IG addition, encodes the V protein (Vidal et al, 1990a; Galinski et 
al, 1992). However, for the Rubulaviruses (SV5, MuV), the unedited mRNA encodes 
the V protein while the edited mRNA, with a 2G insertion, encodes the P protein 
(Thomas eta l, 1988; Southern etal, 1990; Paterson and Lamb, 1990; Ohgimoto eta l,
1990). In either case, the P and V proteins are amino-coterminal, while the -1 or -2 
frame is used to generate unique C-termini from the edited mRNA.
For the Morbilliviruses and some of the SeV group which require a IG  insertion to 
access the V open reading frame (ORF), a 2G iiisertional event (at a much reduced 
frequency) leads to a protein called W. This is essentially the N-terminal part of the P 
protein up to the editing site as the downstream ORF is quickly closed by a stop codon 
(Vidal e ta l, 1990a,b; Kolakofsky et al, 1991). The remaining P gene product of the 
Rubulaviruses, represents tlie N-terminal part of the V or P protein up to the editing 
site, referred to as the I protein, is accessed by the insertion of 4Gs rather than 2Gs 
(Paterson and Lamb, 1990).
Of the distinct P gene products, the V protein is of particular interest because of its 
almost universal conservation in all three genera of the Paramyxovirinae. To date, 
human parainfluenza virus type 1 (hPIVl) seems to be the only exception, as it has 
neither the consensus editing motif nor the V ORF (Matsuoka et al, 1991; Power et al,
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MeV A A U U U U U C C C G U g U C 5‘
SeV g u U U U U U C C C G U a U C 5'
MuV A A A U U C U C C C C c c g g 5'
SV5 A A A U Ü C U C C C C g u c C 5’
consensus U U Y U C C C
Fig. 6 Consensus Sequence for P mRNA Editing
The four paramyxovirus minus-strand genome sequences where G 
insertion are known to occur, written 3' to 5' are shown. Exact homologies 
are highlighted in underlined bold script and other homologies are given in 
capital letters. The consensus sequence is given underneath.
Tà:en from Vidal et al (1990)
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1992; Rochat et al, 1992). The V protein is structurally characterised by a highly 
coiisei*ved cysteine-rich domain in its carboxy-terminal half, which is fused to the 
amino-terminal half of the P protein. The V proteins of MeV, SV5 and NDV have all 
been shown to bind zinc (Liston and Briedis, 1994; Paterson etal, 1995; Steward eta l,
1995), although the functional significance of this remains unclear.
The V proteins of SeV and measles virus (MeV) are not present in virions and are not 
associated with the RNP, probably because these V proteins are missing the 
trimérisation site, L binding site and assembled NP (nucleocapsid) binding sites, which 
are located in the C-terminal half of the protein (see 1.3.2.1 for further details). 
However, the V protein of the Rubulaviruses does appear to be present in virions 
(Paterson et al, 1995; Takeuchi eta l, 1990, Kawano et al, 1993) and unlike the 
Parainfluenza- and Morbilliviruses, their N-terminal halves are predicted to be basic 
rather than acidic in character. The strong conseivation of the V ORF throughout 
almost all the Paramyxovirinae suggests that it may interact with a structurally 
invariant surface e.g. a cellular protein which is highly conserved from chickens (NDV) 
to man. Interactions between V and cellular proteins have been reported for MeV 
(Liston et al, 1995) and SV5 (Precious et al, 1995) although the cellular proteins 
involved were of markedly differing size.
The function of V protein has been studied using SeV defective interfeiing (DI) 
particles as a genome analogue. The V (and W) protein was found to inhibit DI genome 
replication (Curran et al, 1991a) possibly by interfeiiing with the RNA encapsidation 
step (Curran et al, 1994) but did not appear to affect viral mRNA synthesis (CuiTan et 
al, 1994). However, when a V-minus (but W-augmented) SeV was engineered from 
cDNA, it was found to replicate normally in cell culture and embryonated chicken eggs 
(Deienda et al, 1997). Moreover, when a similar V-minus SeV was generated which 
also did not produce W protein, it displayed markedly increased gene expression and 
cytopathogenicity at the cellular level in vitro, but was strongly attenuated in 
pathogenicity for mice. Therefore, V may act in animal infections to avoid the anti-viral 
response of the host (Kato eta l, 1997a).
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The recovery of V-minus viruses from cDNA indicaies that V protein is not an essential 
factor for SeV replication. This suggests that V may be an accessory protein, not 
absolutely required by all viruses, and therefore some viruses have adapted to do 
without them e.g. hPlV l. Similar conclusions have been drawn for the role of C protein 
in MeV and VSV (Radecke and Billeter, 1996; Kretzschmar er al, 1996; and section 
1.3.2.2).
1.3.3 The Large (L) Protein
The large (L) protein is, as its name suggests, the largest and least abundant protein in 
the virion. Both P and L proteins are necessary to constitute an active polymerase 
complex (Hamaguchi et al, 1983), although L is thought to be responsible for the 
majority of enzymatic activities involved in viral transcription and replication. Many of 
these activities have been demonstrated in genetic or biochemical studies on the L 
protein of the rhabdovirus VSV. Viral mRNA capping, methyl-transferase activities and 
polyadenylation have all been attributed to VSV L protein (Abraham eta l, 1975; 
Hercyk et al, 1988; Hunt et al, 1984). The L proteins of VSV and SeV also have kinase 
activity since they phosphorylate both NP and P proteins (Sanchez eta l, 1985; 
Einberger et al, 1990).
Sequence alignments with several L proteins from rhabdoviruses and paramyxoviruses 
have shown six conserved regions, separated by variable regions, suggesting a structure 
of concatenated functional domains (Poch etal. 1990). FurtheiTnore, four short 
conserved sequence motifs were found in domain III of the L proteins which were also 
conserved in the RNA-dependent RNA polymerases of other virus families (Poch et al,
1990). These motifs surrounded an invariant pentapeptide (QGDNQ) and were 
suggested to represent important elements of the active site for template recognition 
and/or phosphodiester bond formation by the L proteins.
The N-terminal of both SV5 and MeV L proteins have been shown to contain 
sequences important for stable L-P complex formation (Parks, 1994; Horikami eta l, 
1994). Site directed mutagenesis in conserved domain I (amino acids 348-379) of SeV
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L protein, showed that this region was important for both transcription and replication 
functions of the protein (Chandiika et al, 1995).
1.3.4 Matrix (M) Protein
The matrix (M) protein is the most abundant protein in the virion and lies between the 
nucleocapsid and the glycoprotein-containing envelope. The sequences of many of the 
Paramyxoviridae M proteins have been predicted (Bellini et al, 1986; Blumberg eta l, 
1984; Satake and Venkatesan, 1984; Sheshberaderan and Lamb, 1990), indicating they 
are basic proteins of between 341-375 amino acid residues. M protein is hydrophobic in 
nature but does not have any hydrophobic stretches long enough to span a lipid bilayer 
(Reviewed in Peeples, 1991). Very little is known about the structure of the M protein, 
but a recent report on the M protein of the rhabdovirus VSV suggested a rod-like shape 
(Barge et al, 1996).
It is generally accepted that M protein is the central organiser of virion assembly, as its 
hydrophobic character allows it to interact with the glycoprotein-containing plasma 
membrane and its positively charged residues allows interaction with the newly 
synthesized (and negatively charged) nucleocapsids (Yoshida etal, 1976; 
Sheshberaderan and Lamb, 1990; Morrison, 1988). M protein can also bind to itself and 
forms a paracrystalline anay with defined periodicity on the inner side of the infected 
cell plasma membrane (Bachi, 1980). This self-association and its contact with the 
nucleocapsid may be the driving force in forming a budding virus particle (Peeples,
1991). It has also been reported that M protein binds actin (Giuffre etal, 1992; Bohn et 
al, 1986) which may also prove important for virus budding.
There is clear evidence that M proteins of VSV and influenza virus down-regulate 
transcription from RNP cores (Ye et al, 1989; Zvinarjev and Ghendon, 1980; Ye and 
Wagner, 1992; Black etal, 1993) and there is some evidence to suggest measles virus 
M protein is an endogenous inhibitor of RNP transcription (Suryanarayana et al, 1994). 
This study, and elsewhere (Cattaneo etal, 1988a; Cattaneo eta l, 1988b) suggested that 
MeV encephalitis arises from selective hypermutation in the M gene resulting in either
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an inability of the M protein to bind RNPs or associate with budding structures. 
Therefore, the striking abundance of RNP cores in brain cells of patients with the fatal 
persistent measles vims infection, subacute sclerosing panencephalitis (SSPE), could 
possibly result from unrestricted transcription and replication of RNP cores as a result 
of certain mutated M proteins. These mutated M proteins could either be defective in 
transcription inhibition, or may just have lost their ability to bind RNP cores 
(Suryanarayana et al, 1994).
1.3.5 The Envelope Glycoproteins
The membranes of Paramyxoviridae virions are studded with spike structures which 
can readily be visualised by electron microscopy. Biochemical characterisation of these 
structures has revealed there to be two different glycoprotein spikes on the surface of 
the virion. One acts as an attachment protein which serves to bind the vims to the cell 
suface and is composed of a protein termed haemagglutinin-neuraminidase (HN) 
protein in the Parainfluenza- and Rubulavirus genera, Haemagglutinin (H) protein in 
the Morbillivirus genus and G protein in the Pneumovirus genus. As their names 
suggest, the attachment protein of the Parainfluenza- and Rubulavirus genera also 
contains a neuraminidase activity not demonstrated for the attachment proteins of the 
other genera (Scheid et al, 1972). The other spike is composed of the fusion protein and 
mediates the fusion of the viral membrane with that of the host cell, facilitating the 
release of the nucleocapsid into the cell cytoplasm. This protein also mediates cell-to- 
cell spread of the genetic information, and a prominant feature of the cytopathic effect 
of paramyxoviruses is syncytium formation (reviewed in Choppin and Compans, 1975). 
The virus utilises the host cell pathways for synthesis, transport and post-translational 
modifications of the surface glycoproteins for insertion into the plasma membrane.
Once the two glycoproteins are inserted into the plasma membrane of infected cells, 
they are subsequently incorporated into virions as the virus buds from the cell surface.
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Signal sequence Transmembrame Domain
485 509Cleavage site (R5)
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128103
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Fig. 7 Schematic diagram of the paramyxovirus 
glycoproteins
(A) Haemagglutinin-neuraminidase attachment protein of SV5 
indicating the signal anchor transmembrane domain and the sites used 
for the addition of N-linked carbohydrates.
(B) Fusion protein o f S V5 indicating the position o f the signal 
sequence, the transmembrane domain, the cleavage site and the 
hydrophobic fusion peptide.
Adapted from Lamb and Kolakofsky (1995)..
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ER lumen, cell surface or virion surface
Fusion Pqjtide
Cytoplasm
Fig.8 Schematic diagram of integral membrane proteins
The type I and type II integral membrane proteins F and HN 
of the Paramyxoviridae. Of the Paramyxovirinae, only SV5 
has been shown to encode an SH protein, although there is an 
SH ORF in mumps virus.
Adapted from Lamb and Kolakofsky, 1995.
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1.3.5.1 A ttachm ent Protein
The HN protein of the Parainfluenzavinises and the Rubulaviruses is a multifunctional 
protein. It is responsible for the binding of the virus to sialic acid-containing cellular 
receptors such as glycoproteins or glycolipids, and mediates enzymatic cleavage of 
sialic acid from the surface of virions and the surface of infected cells (Morrison and 
Portner, 1991). By analogy to the influenza virus neuraminidase, it seems likely that the 
neuraminidase activity of HN prevents self-aggregation of the virus particles when 
budding from the plasma membrane.
The sequences of many attachment proteins have been predicted (Blumberg et al,
1985a; Hiebert etal, 1985a; Alkhatib and Briedis, 1986; Wertz e ta l  1985) indicating 
that they are 565-582 amino acids in length. HN proteins are type II integral membrane 
proteins, which span the membrane once, and contain a single hydrophobic-domain at 
the N-terminus. This acts as both a signal and anchorage domain, leaving a long C- 
terminal ectodomain (Reviewed in Moii’ison, 1988). Conserved cysteine, proline and 
glycine residues between paramyxovirus HN proteins, has suggested a similarity in 
protein structure across the family (Figs. 7A and 8).
HN exists as a disulphide linked dimer which forms a non-covalently linked tetramer 
(Ng gf a I  1989), The stable formation of the tetramer is dependent on the 
transmembrane domain and the cytoplasmic tail of the protein (Ng et a l  1989; Parks 
and Lamb, 1990; McGinnes e ta l  1993). The intramolecular disulphide bonds are 
formed during folding of the protein (McGinnes and Morrison, 1994a) forming the 
covalently linked dimer (McGinnes and Morrison, 1994b). This disulphide bond 
formation has recently been shown to be cotranslational and important to the 
subsequent folding of a conformationally normal and active HN protein (McGinnes and 
Morrison, 1996). Furthermore, during its synthesis, HN binds the cellular protein 
GRP78-B1P (Ng et a I  1989) which prevents transport of defective proteins from the 
endoplasmic reticulum to the Golgi network (Pelham, 1986; Hurtley et aL 1989).
HN has 4-6 sites for the addition of N-linked carbohydrate chains (Ng et a l  1990) 
which, in the case of MuV and SeV, is necessary for incorporation into virions (Herrler 
and Compans, 1983; Nakamura e ta l  1982). However, this is not the case for NDV,
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where glycOvSylation is required for virus infectiviiy but not incorporation into virions 
(Morrison et al, 1981). These glycosylation sites are found towards the C-terminal end 
of HN (Monison, 1988), suggesting the protein consists of a globular head, containing 
the enzymatic activités, supported by a stalk-like structure which is inserted into the 
plasma membrane (Thompson eta l, 1988). In addition, HN contains a conserved 
sequence, NRKSKS, which is similar to the known sialic acid binding site of influenza 
vims neuraminidase (Monison and Portner, 1991). On comparing the primary protein 
sequences of the paramyxovirus HN proteins with influenza virus NA, four regions 
containing conserved motifs were found. These motifs in NA, and by analogy in HN, 
were postulated to be brought together to form the neuraminidase active site in the 
conformationally mature protein (Colman et al, 1993). Supporting this hypothesis was 
the finding that measles virus H, which does not have neuraminidase activity, contains 
only one of these conserved motifs.
There is still some disagreement whether the sites of haemagglutinin and neuraminidase 
activities are combined (Scheid and Choppin, 1974) or are separate. If the analogy with 
influenza virus NA can be continued to include an NA with haemagglutinating activity, 
then the HN activities would be expected to be located at separate sites (Laver et al, 
1984).
As mentioned previously, the H protein of the Morbilliviruses had no neuraminidase 
activity (Morrison and Portner, 1991 and references therein). It specifically interacts 
with the CD46 cellular receptor molecule (Dorig etal, 1993; Naniche, 1993). Since 
CD46 is expressed at a low level on the cell surface, aggregation during virus budding 
is unlikely, thus negating the need for Morbilliviruses to exibit neuraminidase activity 
to free themselves from the cell surface.
Like HN, measles virus H is a type II integral membrane protein and also forms 
disulphide linked dimers which are also possibly homotetramers. They also contain N- 
linked carbohydrate chains which are located in the N-terminus of the protein (Alkhatib 
and Briedis, 1986). unlike HN where the glycosylation sites are distributed towards the 
C-terminus. These H glycosylation sites are collectively required for folding of the 
protein into a native structure (Hu et al, 1994).
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The G protein of the Pneumovirinae is, like HN and H, a type II integral membrane 
protein but has neither haemagglutinin nor neuraminidase activities. At 298 amino 
acids, it is much smaller than either HN or H (Wertz et al, 1985) and is found in 
infected cells in both a proteolytically cleaved, soluble form, and membrane bound. The 
protein is extensively modified by the addition of both 0-linked and N-linked 
oligosaccharides (Wertz etal, 1985; Grober and Levine, 1985). These differences have 
led to speculation that G protein has a different evolutionary ancestry to HN and H, and 
is more structurally similar to a group of cellular mucinous proteins (Wertz et al, 1985; 
Sullender and Wertz, 1991).
1.3.5.2 Fusion (F) Protein
The fusion (F) protein of the Paramyxoviridae mediates fusion of vims to the host cell 
membrane and between the infected ceU to the adjacent cell, promoting viral spread 
(Choppin and Compans, 1975). F is synthesised as an inactive precursor Fq, and 
subsequently cleaved to Fi and F  ^subunits, which are disulphide linked in the 
biologically active form (Scheid and Choppin, 1974, and 1977). The protein sequences 
of the F proteins have been predicted (Blumberg et al, 1985b; Paterson et al, 1984a; 
Richarson et al, 1986; Elango et al, 1985) indicating the encoded proteins contained 
540-580 amino acid residues (Figs. 7B and 8).
F is a type I integral membrane protein that spans the membrane once and contains a 
cleavable signal sequence at the N-terminus of the protein. It has a typical three-domain 
structure, consisting of a large, relatively hydrophilic domain external to the virion, a 
second domain of 20 or more uncharged residues that anchors the protein to the lipid 
bilayer, and immediately adjacent, a hydrophilic C-terminal domain, which exists on 
the inner side of the virion bilayer or host cell plasma membrane (Monison and 
Portner, 1991). Although no overall homology between the different paramyxovirus F 
protein sequences was found, similar placement of cysteine, proline and glycine 
residues, together with the hydrophobicity of the proteins, suggested a similar structuie 
for the F proteins.
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The Parainfluenzaviruses and the Rubulaviruses Fi and F2 subunits are glycosylated by 
the addition of N-linked carbohydrate chains (Morrison and Portner, 1991). In the 
Morbilliviruses, F2 is glycosylated while Fi is not (Alkhatib et al, 1994). The cleavage 
of Fo to the active molecule is an important determinant of virus host range and 
pathogenicity (Scheid and Choppin, 1974; Nagai etal, 1976). This proteolytic cleavage 
in the Golgi network, results in a new C-terminus of Fi and a conformational change in 
the molecule, exposing a previously hidden hydrophobic region (Hsu et al, 1981; 
Kohama et al, 1981). This region has been identified as the first 20 N-terminal residues 
of F i, and is known as the fusion peptide. The paramyxovirus fusion peptides are 
thought to intercalate into target membranes, initiating the fusion process (Novick and 
Hoekstra, 1988) and have been shown to act as a transmembrane anchor domain, 
converting former soluble proteins to membrane bound forms (Paterson and Lamb, 
1987).
F is the major glycoprotein involved in virus-cell and cell-cell fusion, but some 
disagreement remains over the ability of F alone to promote fusion. When cDNAs 
encoding the SV5 or measles virus F are expressed, syncytium formation is observed 
(Alkhatib et al, 1990 and 1994; Horvath et al, 1992). However, for many more of the 
Paramyxovirinae, co-expression of F and HN is necessary for syncytium formation 
(Cattaneo and Rose, 1993; Ebata eta l, 1991; Tanabayashi e ta l, 1992). Furthermore, the 
requirement for the HN protein is generally restricted to HN proteins from the same 
species of virus (Cattaneo and Rose, 1993; Wild et al, 1994; Heminway et al, 1995).
It had also been proposed that the HN protein may trigger the conformational change in 
F which may allow the fusion peptide to insert into the membrane (Lamb, 1993). For 
this interaction between F and HN to occur, the fusion promoting domain of HN (amino 
acids 59-140 in SeV), may play a central role in a virus type-specific manner 
(Tanabayashi and Compans, 1996).
1.3.5.3 Other Envelope Glycoproteins
The Rubulavirus SV5 expresses a small hydrophobic protein, designated SH, from an 
ORF situated beween those of F and HN (Fig.3). SH protein is 44 amino acid residues
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in length (Hiebert et al, 1985b) and is expressed on the infected cell surface (Hiebert et 
al, 1988). This study also demonstrated SH to be a type-II integral membrane protein as 
the N -terminal domain was expressed on the cytoplasmic face of the plasma 
membrane, and the C-terminus, of approximately 5 amino acid residues, was expressed 
on the cell surface (Fig.8). The function of SH in the infectious life cycle of the virus 
has not yet been determined.
For mumps virus, a similar ORF had been identified and indeed an mRNA transcript 
derived from this ORF has been detected (Elango et al, 1989; Elliot eta l, 1989). 
However, attempts to detect SH protein have been unsuccessful. From the mRNA 
sequence, the predicted SH protein from mumps virus does contain a hydrophobic 
domain sufficient to span a lipid bilayer.
The Pneumovims RSV also encodes an SH protein whose ORF lies between M and G 
on the genome (Fig.3), (Collins et al, 1986; Olmstead and Collins, 1989). It contains 64 
amino acid residues and is also a type II integral membrane protein with no known 
function in the virus life cycle.
1.4 Genome Replication
A schematic diagram giving an overview of the paramyxovirus lifecycle is shown in 
Fig. 9. This depicts all aspects of viral transcription and replication taking place in the 
cell cytoplasm. In summary, the virus first contacts the host cell surface via attachment 
protein interaction with specific receptors. This interaction facilitates virus fusion with 
the cell membrane, releasing the nucleocapsid into the cytoplasm. The nucleocapsid 
acts first as a template for viral transcription, thus generating viral proteins, and then as 
a template for replication, to generate further nucleocapsids for assembly and release as 
progeny virions. These processes are described in detail below.
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ADSORBTION
PROGENYVIRIONFUSION
UNCOATING
GENOME (-) ANTI-GENOME (+)
REPLICATIONTRANSCRIPTION
GENOME (-) GENOME!-)
SYNTHESIS AND GLYCOSYLATION OF THE ENVELOPE GLYCOPROTEINS
NUCLEUS
OSOMES ENDOPLASMIC
REnCULUM GOLGI APARATUS
INSERTION OF ENVELOPE GLYCOPROTEIN INTO PLASMA MEMBRANE
GLYCOSYLATION OF ENVELOPE PROTEINS IS COMPLETED
Fig. 9 Schematic diagram of the paramyxovirus life cycle.
Adapted from Lamb and Kolakofsky (1995).
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1.4.1 Virus Adsorption and Entry
The attachment protein of the Paramyxoviridae mediates the first stage of virus 
adsorption to the host ceil surface. As mentioned previously, the specific receptors 
involved in attachment by the Parainfluenzaviruses and the Rubulaviruses have long 
been accepted as sialic acid containing molecules such as glycoproteins and 
gangliosides (Markwell eta l, 1981). The Morbilliviruses, however, have a different 
receptor which was identified as the cell surface protein CD46 (Dorig et al, 1993; 
Naniche et a I, 1993) while the receptor for the Pneumoviriises is not yet known.
Once the virus had adsorbed to the cell surface receptor, the virus fuses with the cell 
membrane. The fusion mechanism in some viruses needs both the HN and the F 
proteins as discussed earlier ( 1.3.4.1 and 1.3.4.2). The attachment protein (H or HN) 
has been proposed to trigger a conformational change in the fusion (F) protein. This 
confonnational change involves the insertion of the fusion peptide into the host cell 
lipid bilayer resulting in fusion with the host cell membrane and subsequent release of 
the nucleocapsid into the cell cytoplasm.
Once inside the cell, the nucleocapsid must be uncoated in preparation for ti'anscription. 
In the virus particle, M protein is thought to act as a bridge between the nucleocapsid 
and the virus envelope, and is also known to be responsible for inhibiting virus 
transcription during virus assembly (see 1.3.3 for details). Therefore there must be some 
mechanism to remove M from newly released nucleocapsids before transcription 
commences which is not yet understood.
1.4.2 Viral Transcription
Most of the information on RNA transcription by the non-segmented RNA viruses is 
based on studies on the rhabdovirus vesicular stomatitis virus (VSV) or SeV (Emerson, 
1982; Rose, 1980; Vidal and Kolakofsky, 1989). Evidence from these studies support a 
model in which the polymerase complex enters the genome at a promoter in the 3' 
extracistronic leader region. Transcription proceeds along the linear anay of genes in a
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sequential terminatioii-reinitiation (stop-start) mechanism, during which the polymerase 
remains bound to the template. Transcription yields a series of sub-genomic 
monocistronic mRNAs. The stop-start mechanism is thought to be directed by short 
conserved sequence elements found at gene boundaries. For VSV and SeV, these 
include i) the gene-start (GS) motif at the upstream border of each gene, which encodes 
the precise 5' mRNA end and is assumed to be involved in mRNA initiation ii) the 
gene-end (GE) motif at the downstream border of each gene, which encodes the precise 
3' end of mRNA, is assumed to direct transcriptional termination and is thought to 
direct polyadenylation by reiterative copying of the short tracts of U residues at the 
downstream end of tlie signal.
Similarly for RSV, consensus GS and GE motifs were identified at the begining and 
end of each gene which were shown to encode the precise 5' and 3' ends of mRNA with 
the latter being followed by a polyA tail (Collins et al, 1996b: Collins, 1991b). The 
RSV GS and GE motifs were identified as signals which direct transcriptional initiation 
and tennination / polyadenylation respectively. They appear to operate independently to 
switch the polymerase into 'on' and 'off modes respectively, and in which the 
polymerase moves along the genome with and without RNA synthesis respectively, hi 
the 'on' mode, triggered by the GS motif, the polymerase transcribes until it encounters 
a GE signal. In the 'off mode, triggered by the GE signal, the polymerase moves along 
the genome until it encounters the next GS signal and synthesis restarts.
However, during genome replication, the polymerase somehow switches to a read- 
through mode in which these GS and GE signals are ignored and a complete positive 
sense replicative intermediate, the anti-genome, is generated (Kuo eta l, 1996).
Other cw-acting elements which might be involved in transcription and / or replication 
have been proposed. Studies on the 3' end of human parainfluenza virus type 3 (hPIV3) 
indicated that the promoter-proximal gene contained an additional cz^-acting element 
located in the non-translated region following the GS motif (Collins et al, 1993,
Dimock et al, 1994). Whereas in measles virus, terminal complementarity of the 
genome suggested the presence of an additional conseived element located at 75-90 
nucleotides from the 3' ends of the genome and antigenome (Crowley eta l, 1988).
30
Mutational analysis of the VSV genome also suggested that the amount of terminal 
complementarity can influence transcription and RNA replication (Wertz et al, 1994). 
However, for a SeV DI, replication efficiency was affected by the promoter end 
primary sequence, but this was found to be independent of teiminal complementarity 
(Tapparel and Roux, 1996). This finding was recently supported by a rival VSV study 
which concluded that the presence of specific sequences, rather than the extent of 
terminal complementarity, was a major determinant of replication efficiency (Li and 
Pattnaik, 1997).
There are also sequences found after one GE and before the next GS, known as 
intergenic regions which are variable in length for the Rubulaviruses and 
Pneumoviruses , but are exactly 3 nucleotides long in both the Parainfluenzaviruses 
and the Morbilliviruses. The influence of these intergenic regions on the polymerase 
complex varies from virus to virus due to the diversity of the intergenic sequences. It 
seems likely that the consensus-type intergenic regions of the Parainfluenzaviruses and 
the Morbilliviruses are part of the cw-acting sequence elements that guide transcription, 
as suggested by their conserved nature and close proximity to the GS and GE signals. 
Moreover, a higher level of readthrough mRNA is associated with naturally occuiiing 
nucleotide differences in VSV and SeV (Masters and Samuels, 1984; Gupta and 
Kinsbury, 1985), suggesting an effect on the activity of transcription signals. The 
nonconsensus intergenic regions of the Rubulavirus and Pneumovirus genera may play 
a variety of roles in gene regulation. For example, they may contain cw-acting 
sequences thus fai* unidentified or intergenic length may control transcriptional 
attenuation. However, studies on the intergenic regions of RSV showed that they had 
no effect on replication or transcription of a dicistronic RSV minigenome (Collins et al, 
1996a).
1.43 Genome Replication
As in viral transcription, genome replication is initiated by the viral polymerase 
complex binding to the 3' extracistronic region. However, during replication, the
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polymerase ignores all the GS and GE signals which give rise to the specific mRNAs 
during transcription, and instead, generates a complete positive strand, replicative 
intermediate, the antigenome. Like the genome, the antigenome is encapsidated but 
cannot itself act as a template for mRNA synthesis (Portner, 1982; Carlsen et al, 1985). 
Instead, it acts as a template for the generation of further genomic sense RNA 
(Reviewed in Galinski and Wechsler, 1991). Genome synthesis from antigenome 
templates is thought to take place in a similar fashion to that for antigenome synthesis.
' Since both genomic and antigenomic RNAs are encapsidated in a ribonucleocapsid 
complex (RNP), and constant protein synthesis is a prerequisite for replication of all 
negative-strand RNA vimses, it is assumed that RNA polymerisation and encapsidation 
with nucleocapsid protein are mechanistically linked. The genomic 3’ region 
simultaneously represents the promoter and the 'encapsidation' signal, and therefore a 
mechanism must exist which prevents the encapsidation of mRNAs. In non-segmented 
viruses, this may be achieved through the release of the leader RNA carrying the 
encapsidation signal. Reinitiation at the junction between the leader and the first 
protein-coding gene appears to be necessary to convert the polymerase to transcription 
mode in which elongation is independent of assembly with NP protein (Vidal and 
Kolakofsky, 1989). For VSV, the site for initiation of antigenome encapsidation has 
been mapped to the first 14 nucleotides of the leader sequence (Blumberg et al, 1983). 
When proposing a replication model, one has to take into consideration that replication 
and encapsidation are concurrent, and involve the participation of preformed NP-P and 
P-L complexes (Hoiikami et al, 1992). A possible replication model is shown in Fig. 10 
where the moveable polymerase complex (P-L) is associated with the RNP template via 
an interaction of P with assembled NP, Soluble NP protein is prevented from self­
aggregation by forming an NP-P complex. During replication, P delivers NP to the site 
of RNA synthesis, possibly by interaction with a second P binding site on L, facilitating 
concominant RNA encapsidation. This step would rely on release of the P molecule 
after NP delivery. Both V and W proteins, also products from the P gene (see 1.3.2.3 
for details), can bind soluble NP (Randall and Bermingham, 1996; Horikami et al,
1996)
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Polymerase complex Encapsidated replication template 
(Genome or Antigenome)
a #
aCÉNascent encapsidated RNA (Antigenome or 
Genome)
Soluble (unassembled) NP protein 
P protein 
V or W protein
P interaction with soluble NP 
Vor W interaction with soluble NP
NP interaction with itself forming aggregates
Fig. 10 Model for paramyxovirus replication
P-L polymerase complex is anchored to the RNP via P-RNP 
complexes. P binds to soluble NP protein preventing NP 
aggregation and subsequently chaperones NP to the nascent RNA 
for assembly. Both V and W protdns can bind soluble NP and can 
therefore inhibit rq)lication by dther preventing formation of, or 
binding by the NP-P encapsidation substrate.
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and presumably inhibit replication by interfering with the formation of the NP-P 
encapsidation substrate (Horikami et ciL 1996).
1.44 Virus M aturation and Release
Once synthesised, the nucleocapsid is transported to the plasma membrane for assembly 
into a viiTis particle. The conventional model for virus assembly is that M protein 
interacts with the viral glycoproteins via their cytoplasmic or transmembrane domains. 
An M protein with a glycoprotein spike attached, may diffuse in the plane of the plasma 
membrane until it contacts another M protein, and so on. A patch of M proteins forms 
on the cytoplasmic face of the membrane with its associated glycoprotein spikes on tlie 
external plasma membrane. Shortly thereafter, free nucleocapsids associate with the 
plasma membrane-bound M protein whereupon the budding process begins (Peeples,
1991).
Virions form by budding or outfolding through areas of cell membrane containing 
glycoprotein spikes. The virions acquire a lipid bilayer from the host cell in this highly 
specific process of virus assembly, during which host cell proteins are effectively 
excluded from the virus. Virions are also devoid of neuraminic acid residues due to the 
presence of neuraminidase activity in the virus which aids release (Reviewed by Ray et 
al, 1991).
2 Genetic Manipulation of Non-Segmented 
Negative-Strand RNA viruses
Recombinant DNA techniques have been used extensively to genetically manipulate 
DNA viruses and many RNA viruses. These studies have contributed to a better 
understanding of the molecular biology of virus infection, replication and 
pathogenicity, and have enabled the engineering of viral vectors suitable for the 
expression of foreign proteins in host cells. Several DNA viruses, including vaccinia 
viruses, herpes simplex viruses and adenoviruses, have been used to express foreign
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proteins in cell culture, while many have potential as vaccine vectors or for the transfer 
of novel genes to target cells.
Recombinant DNA technology has also led to the construction of infectious full length 
cDNA clones of positive-strand RNA viruses such as picomaviruses (Racaniello and 
Baltimore, 1981) and bacteriophages (Taniguchi et al, 1978). Specific mutagenesis of 
these cDNA clones has provided important insights into the molecular biology of these 
viruses. In addition, many of these viruses, such as poliovirus (Percy et at, 1992) and 
SemliM Forest virus (Liljestrom and Garoff, 1991), can be genetically manipulated to 
express foreign genes and are therefore being developed as virus vectors. The RNA of 
positive-strand viruses can be used directly as mRNA and so RNA transcription in vitro 
of a linearized full length cDNA copy of the genome, results in infectious RNA 
molecules. These genomic RNA molecules can be transfected directly into the 
appropriate host cell to initiate productive virus infections via translation of the input 
RNA, thus generating the proteins responsible for both amplification and packaging of 
the progeny virions.
However, genetic manipulation and analysis of negative-strand RNA virus biology has 
lagged far behind DNA viruses and indeed that of other RNA viruses. In contrast to the 
positive-strand RNA viruses, the genomes of the negative-strand viruses are not 
infectious. The initiation of the infectious cycle requires the presence o f a complete 
nucleocapsid structure. Only in this form can the RNA function as a template for the 
viral polymerase. Techniques to introduce recombinant RNA into the genome of a 
negative-strand RNA virus were first described for the segmented influenza virus 
(reviewed in Garcia-Sastre and Palese, 1993), and these techniques have been adapted 
to study cis- and trans-acting elements involved in paramyxovirus transcription and 
replication.
2.1 Reverse Genetics Approaches
Luytjes et at (1989) described a system that allowed the successful generation of 
biologically active influenza virus RNPs which contained airificial RNA. Genomic
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sense transcripts were generated which contained authentic terminal sequences from an 
influenza virus segment, flanking the chloramphenicol acetyltransferase (CAT) reporter 
gene. These transcripts were encapsidated in vitro by purified virus necleocapsid 
protein (NP) and polymerase proteins (PA, PBl and PB2). Once encapsidated, the 
synthetic nucleocapsid was transfected into influenza virus infected cells and was 
replicated, transcribed and translated by the helper virus. This breakthrough heralded 
influenza virus accessible to experimental investigations addressing the role of cis- 
acting sequences as well as the functions of several proteins in virus-host interactions. 
This work aided similar attempts in non-segmented RNA virus systems. In contrast to 
influenza virus, in vitro encapsidation of the non-segmented RNA genome is 
ineffective, probably because of the tighter RNP structure (Baudin et al, 1994). Only a 
few nucleotides corresponding to the genome ends of VSV could be associated in vitro 
with RNP proteins (Moyer et al, 1991; Smallwood and Moyer, 1993). However, these 
studies showed that functional encapsidation of preformed RNAs from non-segmented 
viruses was possible in principle, and confirmed the location of the RNA encapsidation 
signal close to the 3' end of the genome.
Further work was then done to encapsidate a synthetic RNA into a biologically active 
nucleocapsid and success was first reported for SeV by Park et al (1991). The synthetic 
RNA was generated in vitro by T7 RNA polymerase from a linearised plasmid, in order 
to create a precise 3' end for encapsidation. This genome analogue possessed authentic 
SeV 3’ terminal sequences (which included the putative polymerase promoter and 
signal(s) directing leader RNA transcription / release and mRNA transcription 
initiation) and 5' trailer region (which included the transcriptional stop / 
polyadenylation signal drived from the 5’ terminal L gene, and antigenomic replication 
promoter) as shown in Fig 11. The RNA transcript was tr ansfected into SeV infected 
cells for encapsidation, and the resultant synthetic RNP had the potential to act both as 
a template for mRNA synthesis and as a template for replication. This study 
demonstrated that transfection of the in vitro transcribed RNA into SeV infected cells, 
led to the detection of CAT activity which was shown to by SeV specific. Furthermore, 
CAT activity was sucessfully passaged by transfer of cell-free supernatants.
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demonstrating that the synthetic RNPs had been packaged into infectious virus 
particles. This contirmed that all cw-acting sequences required for encapsidation and 
initiation of both replication and transcription of SeV, resided in the terminal sequences 
of the genome.
Other paramyxovirus systems have also been successful in rescuing transfected RNAs 
with infectious helper virus. These included RSV (Collins et al, 1991b), PIV3 (De and 
Banerjee, 1993; Dimock and Collins, 1993) and MeV (Sidhii et al, 1995), where assays 
of reporter gene activity expressed from a negative-sense minigenome, again indicated 
that they were transcribed, replicated and incorporated into infectious particles. The 
roles of c/.y-acting sequences in paramyxovirus transcription and replication had 
therefore been rendered accessible to experimental investigation. Subsequent 
experiments revealed that the sequence coiTesponding to the virus 3' terminus, had to be 
at the end of the synthetic transcript, as replication cannot proceed from an internal site 
(Collins et al, 1991b; De and Banerjee, 1993). In contrast, the 5' end appeared to 
tolerate additional nucleotides (De and Banerjee, 1993). Furthennore, for RSV it was 
shown that sequences of the 3' promoter could be replaced by sequences 
complementary to the 5' end (ie the antigenome promoter; Collins et al, 1991b). Similai* 
reporter gene constructs have been used to study the roles of intergenic regions as 
internal transcription signals, where two different reporter genes, flanked by the 3' and 
5' viral sequences described above, were seperated by the intergenic region of interest 
(Kuo et al, 1996).
2.2 RNPs derived from cDNA components
Defective interfering (DI) particles have been extensively used to investigate 
transcription mechanisms of the negative-strand RNA viruses. Most are naturally 
occurring and can be catagorised as non-transcribing copyback Dis, since they contain 
the parental 5' terminus and complementary 3' end (Fig. 11). Therefore, these Dis are 
replication competent but cannot initiate transcription and have been used to elucidate 
trans-'àcting factors necessary for their propagation.
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Fig. 11 Schematic diagram of genome analogues
Schematic representation o f the organisation of genomes and 
genome analogues from non-segmented negative-strand RNA 
viruses. Terminal non-coding regions of the standard goiome 
are hatched (3’) or checked (5’), polymause promoters are 
represented by blue arrowheads (gaiome promoter above, 
and antigenome promoter below the genome). Transcriptional 
restart signals are represented by green arrowheads, and 
transcription stop/polyadenylation signals by green bars 
above the genomes. The resultant transcrition products are 
indicated. In copyback genomes, the 3’ terminal sequences 
are replaced by the complement o f 5 ’-terminal sequences. 
Both copyback and transcribing copyback genomes (either 
defective or non-defective) int^fere with the rq)lication of 
standard genomes.
Adapted from Conzelmann (1996).
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NP, P and L proteins were demonstrated to be necessary and sufficient to replicate a 
VSV DI (Pattniak and Wertz, 1990) and a SeV DI (Curran et al, 1991). These proteins 
were supplied in trans by transfecting cDNA clones of NP, P and L under the control of 
a T7 promoter, which were driven by a recombinant vaccinia virus expressing T7- RNA 
polymerase (vTF7-3; Fuerst et al, 1986). Furthermore for VSV, if the cells co-infected 
with vTF7-3 and VSV DI, also expressed the envelope proteins (in addition to NP, P 
and L) from plasmids, then assembly and budding of an infectious virus was obtained 
(Pattnaik and Wertz, 1991). This allowed helper viras to be replaced by cDNA clones 
in rescue experiments.
2.2,1 The Use of vTF7-3 for the Generation of Genome Analogues
The use of vTF7-3 (VacT7) allowed the expression of a number of viral proteins from 
different co-transfected plasmids. It also allowed the generation o f intracellular genome 
analogues as a replacement for the in vitro transcribed templates described in section 
2.1. cDNA clones encoding the genome analogues under T7 promoter control, could be 
co-transfected with those encoding the viral proteins into VacT7 infected cells. Thus, 
simultaneous generation of intracellular genome analogues and viral proteins could be 
achieved. The termini of the genome analogues were paramount. The 5' end was 
determined by the positioning of the T7 promoter, while the autolytic activity of 
ribozyme sequences were utilised to generate a discrete 3' terminus. The ribozyme 
sequences were usually derived from the antigenomic strand of the hepatitis delta virus 
(HDV; Perrotta and Been, 1990,1991) and were followed by aT7 transcriptional 
termination sequence. Only sequences downstream of the cleavage site seem to be 
required for auto-catalytic activity, as the ribozyme is aparendy indiscriminate with 
regard to the upstream sequences.
A VSV DI sequence was cloned between the T7 promoter and ribozyme sequences for 
the generation of a synthetic DI. This plasmid was co-transfected with those of NP, P 
and L into VacT7 infected cells and resulted in the efficient encapsidation and 
replication of the synthetic DI RNA (Pattnaik et al, 1992).
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2.2.2 Transcriptionally Active Genome Analogues
An RNA construct corresponding to a transcriptionally active internal deletion 
minigenome of the Rhabdoviriis rabies virus, was the first to be rescued by plasmid- 
encoded (NP, P and L) proteins alone (Conzelmann and Schnell, 1994). As seen with 
VSV, infectious DI virions of rabies virus were assembled after addition of the 
envelope proteins, thus opening aU aspects of the life-cycle to experimental analysis. 
This breakthrough led to similar constructs for several non-segmented viruses (VSV, 
SeV, MeV, RSV), corresponding to transcribing or non-transcribing model genomes, 
expressed in the VacT7 /  HDV expression system (Reviewed in Conzelmann, 1996). 
These studies revealed virus- and genus-specific peculiarities which have to be taken 
into account when designing reverse genetics experiments. For example, SeV virion 
assembly is inhibited by vaccinia virus (Calain and Roux, 1993) whereas the entire life­
cycle of rabies virus is unaffected by the presence of vaccinia virus. These authors have 
also reported that model genomes of SeV which consist of a multiple of six nucleotides, 
replicate more efficiently than those that do not (Calain and Roux, 1993, Pellet et al,
1996). This has been explained by the NP protein having been predicted to cover a 
stretch of 6 nucleotides in the RNP and is known as ' The Rule of Six '. It seems to 
apply to the Morbillivirus MeV (Kahn et al, 1994), and the Rubulavirus SV5 (Murphy 
and Parks, 1997) but not the Pneumovirus RSV (Samal and Collins, 1996) or 
rhabdoviruses. However, NP, P and L proteins seem to be necessary and sufficient for 
both transcription and repHcation of all of these minigenomes (e.g. Yu et al, 1995; 
Grosfeld et al, 1995). In addition to these proteins, some paramyxoviruses may express 
auxilHary proteins which regulate RNA synthesis. For SeV, V and W proteins have 
been shown to inhibit genome replication (Curran et al, 1991, Horikami et al, 1996) 
whereas the RSV M2 protein seems to have a positive effect on mRNA transcription 
(Grosfeld et al, 1995). Reverse genetics approaches using model genomes wifi provide 
a positive tool for the investigation of mechanisms involved in paramyxovirus biology.
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2.3 Recovery of Infectious Virus from cDNA clones
Using the techniques described above, the generation of a full-length infectious clone 
entirely from cDNA was theoretically possible. One main stumbling block remained. 
The encapsidation efficiency of long RNA molecules was very low and in the rabies 
virus system, each additional kilobase of RNA in the model genome, resulted in a 10- 
fold drop in recovery rate (Conzelmann and Schnell, 1994). However, a 50% full-length 
genome analogue of RSV was described, which contained the entire RSV L gene and 
the CAT reporter gene, and was rescued by transfection of the synthetic transciipt into 
RSV infected cells.
The generation of a full length infectious clone from the VacT7 system described above 
had an additional problem. A synthetic full-length genome-sense clone would contain 
the NP, P and L coding sequences. Large amounts of the mRNAs encoding the NP, P 
and L proteins which are required for encapsidation, replication and transcription of the 
synthetic transcript would be expected to hybridize to the negative sense RNA template 
thus blocking proper encapsidation and / or synthesis of the necessary proteins.
To overcome these problems, a cDNA clone for rabies virus was constructed which 
gave rise to an antigenomic (positive) sense RNA transcript. This transcript was 
encapsidated and replicated by plasmid-encoded proteins. Transcription was achieved 
from the resultant genomic RNA template, initially also by the plasmid-encoded 
proteins, and then by autonomous propagation of recombinant virus (Schnell et al, 
1994). Although rescue efficiency was low (occurring in only one per 10"^  cells), this 
did not constitute a difficulty as the system worked in the absence of helper vims, 
allowing the isolation of variants with titres much lower than the parental strain. 
Vaccinia virus was easily removed by filtration or by passage in non-permissive cells, 
allowing the isolation of pure clonal virus stocks.
Recent successful recovery of other recombinant viruses confirmed that the use of 
antigenomic rather than genomic transcripts may generally tip the balance towards 
success. Two groups working with VSV found recovery was not possible when starting 
with plasmids yielding genome sense transcripts but recovery of full-length antigenome 
RNA was reported (Lawson et ai, 1995; Whelan et at, 1995). One reason for their
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failure was suggesicd by Whelan et al (1995) as they found premature termination of 
transcription by T7 RNA polymerase in in vitro transcription experiments.
The first recovery of a recombinant paramyxovirus was achieved for MeV in a similar 
fashion to rabies virus (Radecke et aL 1995). Here, cell lines constitutively expressing 
T7 RNA polymerase and the virus NP and P proteins, were transfected with additional 
plasmids driven by the T7 promoter. These plasmids encoded MeV L protein and a full- 
length MeV antigenome RNA. The appearance of syncytia demonstrated rescue of 
infectious virus.
Recombinant SeV was also recovered from a full-length antigenomic transciipt using 
the VacT7 system, despite vaccinia virus inhibition of SeV virion assembly. This 
inhibition was overcome by treating the transfected cells with an inhibitor of DNA 
synthesis, injection of the transfected cells into the allantoic cavity of embryonated 
chicken eggs and subsequent passage in eggs, resulting in the loss of VacT7 and 
recovery of infectious SeV (Garcin et aL 1996).
Genetic manipulation of the negative strand viruses has now become a reality for both 
the segmented viruses, such as influenza virus, and for the non-segmented viruses 
within the rhabdo- and paramyxovirus families. Recombinant viruses can now be used 
to study the cA-acting sequences controlling viral RNA synthesis as well as the 
function of each virus protein in replication, assembly and interaction with the host, 
thus, fundamentally changing this field of virology.
3 Aims of this project
3.1 Development of a Reverse Genetics System for SV5
The initial aim of the project, which was begun in 1992, before reverse genetics was 
well established for non-segmented, negative-strand RNA viruses, was to elucidate the 
mechanisms of transcription and replication of the Riihidavinis SV5 by utilising some 
of the reverse genetics techniques outlined above. A synthetic genome sense RNA 
transcript, containing the CAT reporter gene, was used as the template for rescue
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experiments. Three approaches were employed which aimed to encapsidate the 
synthetic transcript into an RNP recognisable to the viral polymerase as a transcription 
template. The first involved intracellular transcription of the synthetic RNA by VacT7 
in SV5 infected cells. It was hoped that SV5 would supply the viral proteins necessary 
for encapsidation and transcription of the synthetic RNA. The second approach 
involved transcfection of the synthetic transcript into cells expressing plasmid-encoded 
viral proteins. Here, it was hoped that the viral proteins supplied in trans would 
encapsidate and transcribe the synthetic transcript The third approach involved 
transfecting the synthetic RNA into a cell line co-expressing NP, P and V proteins for 
encapsidation, with the viral polymerase being supplied by a subsequent SV5 helper 
virus infection. It was hoped that once the transcript was encapsidated, the viral 
polymerase would recognise the synthetic RNP as a template for transcription and 
possibly replication.
3.2 Development of Inducible Cell Lines Expressing Viral 
Proteins
Mammalian cell lines expressing NP, P and V proteins of SV5, either singly or in 
combination, were isolated with the aim of supplying the viral proteins in trans for 
CAT rescue experiments outlined above. The cell lines subsequently proved extermely 
useful for examining viral proteiniprotein interactions. The change in intracellular 
distribition of the viral proteins was monitored by comparing the immunofluorescence 
patterns of the proteins expressed alone and in combination, indicating viral 
proteiniprotein interactions were taking place.
3.3 Viral Protein ; Protein Interactions
A novel protein : protein capture assay was developed to examine more closely the viral 
protein interactions and perhaps understand more clearly the roles these interactions 
play in viral transcription and replication. Results from both the immunofluorescence
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and the capture assay studies gave some insight into, and possible explanation for, the 
lack of success of the SV5 reverse genetics /  infectious clone project to date.
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Chapter 2 : Materials and Methods
1 Cells and viruses
1.1 Maintenance of mammalian cell lines
The following cell lines were used during the course of this study.
Vero cells - a continuous line of African Green Monkey kidney cells (Flow Labs) 
BHK-21 C1.13 - (referred to as BHK) are a continuous line of baby hamster kidney 
cells (Flow Labs)
HeLa cells - a continuous cell line of human cervical cai'cinoma cells (Flow Labs) 
Balb/c mouse fibroblasts - (referred to as BalbC) are a continuous line of fibroblasts 
cloned from a primary culture of a Balb/c mouse embryo.
293 cells - human cell line transformed by human adenovirus type 5 and generously 
provided by Frank Graham, McMaster University, Hamilton, Ontario, Canada (Graham 
eta l, 1977).
Cell lines were routinely grown in Glasgow Modified Eagle’s Medium (GMEM), 
(Gibco-BRL), supplemented with 10% (v/v) newborn calf serum (NBCS) or foetal calf 
serum (FCS), 50 units /ml of penicillin and 50 fig/ml streptomycin at 37 °C under 5% 
CO2. Cells were passaged every 4 - 5  days using trypsin (BHK, HeLa, BalbC, Vero) or 
versene (293).
1.2 Preparation of SV5
1.2.1 Preparation of SV5 W3 working stock
The strain of SV5 used throughout this work was W3 (Choppin, 1964). A working 
stock was made by first plating 2x10"^  cells per well of a 96 well dish. These cells were
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infected with 50 jil of vims in a series of 5-fold dilutions star ting from a one in ten 
dilution of a master virus stock prepared by Dan Young in this lab. The vims was 
diluted in GMEM+1% NBCS and 8 wells were infected at each dilution. The ceils were 
incubated at 37 °C until the cytopathic effect (CPE) caused by the virus was obvious. 
The medium from the well with most complete cell lysis was transferred onto a 
confluent 25 cm  ^tissue culture flask of Vero cells. The cells were incubated again until 
CPE was obvious, whereupon the medium was used to infect 4 confluent roller bottles 
of Vero cells. Here, the vims was adsorbed for 2 hours at 37 °C and then the inoculum 
was replaced with 20 mis GMEM+1% NBCS. The roller bottles were rotated at 37 °C 
for 36-40 hours or until tlie CPE was again obvious. The supernatant was collected and 
the cell debris was pelleted by centrifugation at 5,000 x g  for 5 mins. The supernatant 
containing the vims was aliquotted in 5ml and 1 ml amounts and stored at -70 °C. 
Titration of the new vims stock was done by plaque assay (1.2.2). Both cells and virus 
were examined for mycoplasma contamination by DAPI staining (Russell et al, 1975),
(1.4).
1.2.2 Plaque assay titration of SV5 stock
Vero cells were seeded in 6 well dishes at 5x10^ cells per well and incubated overnight 
(O/N). A series of 10-fold dilutions were then made of the new vims stock in 
GMEM+10% NBCS. 1 ml of vims from 10 10 and 10 dilutions were used to
infect the plate in duplicate. Vims was adsorbed to the cells for 2-3 hours at 37 °C in a 
gassed box set on a rocking platform. The inoculum was removed and replaced with 5 
mis of GMEM containing 2% (v/v) NBCS and 0.5% (w/v) carboxymethyl cellulose 
whereupon the cells were incubated for 4-5 days in a 37 °C incubator under 5% CO2. 
The cells were then fixed by the addition of 2.5 mis of a PBS solution containing 5% 
(v/v) formaldehyde and 2% (w/v) sucrose for 10 mins. The fixing solution was removed 
by aspiration and the cells were washed in PBS then permeabilized for 5 mins in a PBS 
solution containing 0.5% (v/v) NP40 and 10% (w/v) sucrose. The cells were then 
washed three times in PBS containing 1% (v/v) NBCS and 0.1% (v/v) sodium azide 
(NaAz). Areas of cell lysis and therefore sites of vims infection or plaques were
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detected by incubating the monolayers with a panel of monoclonal antibodies (mAbs) 
in 0.5 mis of PBS+1% NBCS (1/500 dilution of each mAh) per well for 1 hour on a 
shaker at room temperature (RT). The cells were then washed three times in PBS+1% 
NBCS, twice in PBS and once in d ^ O  whereupon an ELISA reaction was carried out 
using o-dianisidine. Approximately 0.3g of o-dianisidine was dissolved in 0.5 mis of 
100% ethanol, added to 50 mis of dH^O and filtered through Whatman N o.l filter paper 
to remove any undissolved o-dianisidine. 0.6% (v/v) hydrogen peroxide was added to 
the filtrate and mixed well. 2mls per well was added to the cells which were incubated 
in the dark on a shaker until brown plaques were obvious. The reaction was stopped by 
washing in tap water and plaques were counted to give a virus titre of plaque forming 
units (pfu) per ml of stock. This was typically found to be 1x10^ to 1x10^ pfu / ml.
1.2.3 Infection of mammalian cells with SV5 W3
Typically BHK, BalbC or 293 cells were plated at 1x10^ cells per well in 6 well dishes 
and incubated O/N or until the monolayer was 70-80% confluent. Cells were infected at 
a multiplicity of infection (m.o.i.) of 1, (i.e. 1 pfu/cell), in GMEM+1% NBCS, The 
virus was adsorbed to the cells by incubation at 37 °C in a gassed box on a rocker for 2 
hours. The inoculum was removed and replaced by GMEM+1% NBCS and harvested 
36-48 hours post-infection.
1.3 Preparation of vaccinia virus vTF7-3 (VacT7)
1.3.1 Small scale preparation of VacT7
A  recombinant vaccinia virus expressing the bacteriophage T7 DNA-dependent RNA  
polymerase (vTF7-3) was constnicted by Fuerst et a l , (1986) and is usually referred to 
here as VacT7. Small scale virus preparations were made by infecting a confluent 25 
cm^ tissue culture flask of HeLa cells at a m.o.i. of 1 with the master virus stock (made 
by Bemie Precious in this lab) in GMEM+1% NBCS. The virus was adsorbed to the 
cells for 1-2 hours in a 37 °C incubator whereupon the inoculum was removed and 5
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mis of fresh GMEM+1% NBCS was added. The cells were incubated at 37 °C for a 
further 48 hours and harvested by scraping into the medium. Cells were pelleted by 
centrifugation at 3,000 x g for 5 mins and the pellet was resuspended in 2 mis of 10 
mM Tris-HCl pH 7.0,1 mM EDTA and the virus was released by six freeze / thaw 
cycles at - 70 °C and 37 °C. This preparation was used as the inoculum for large scale 
virus preparation.
1*3.2 Large scale production of VacT7
Ten 75 cm^ tissue culture flasks were seeded with HeLa cells and grown to 90% 
confluency for infection with VacT7, The 2 mis of vims from a small scale preparation 
of VacT7 (1.3.1) was added to 18 mis of GMEM+1% NBCS and 2 mis of the dilution 
was added to each confluent monolayer. The vims was adsorbed for 1-2 hours at 37 °C 
on a rocker whereupon the inolculum was removed and replaced with 20 mis of 
GMEM+1% NBCS and grown for 24-48 hours. Cells were again scraped into the 
medium and pelleted by centrifugation at 3,000 x g for 5 mins. Cell pellets were 
resuspended in a total volume of 2 mis of 10 mM Tris-HCl pH 7 .0 ,1  mM EDTA and 
pooled into one tube. Cells were subjected to 5 freeze / thaw cycles at -70 °C and 37 °C 
and were aliquotted in 10 fil and 100 jj.1 amounts for storage at -70 °C. Titration of the 
VacT7 stock was done by plaque assay (1.3.3).
1.3.3 Plaque assay titration of VacT7 stock
Titration of new large scale preparations of VacT7 (1.3.2) was done by plaque assay. 
293 cells were seeded at 1x10® cells per well in duplicate 6 well dishes and grown O/N 
or until 90% confluent. The vims was diluted in a series of 10-fold dilutions in 
GMEM+1% NBCS and 1 ml of the dilutions from 10 to 10-  ^was added to the 
duplicate plates and adsorbed for 1-2 hours at 37 °C. The inoculum was removed and 
replaced with 2.5 mis of GMEM+1% NBCS and the cells were incubated for a further 
48 hours at 37 °C. The medium was removed and the monolayer was stained with a 
solution of 0.1% (w/v) Crystal Violet, 2% (v/v) ethanol in dH20 for 2-3 mins at RT. 
Areas of cell lysis caused by virus infection (plaques) were visualised as unstained
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holes in the monolayer and were counted to determine virus titre in pfu /ml of stock. 
This was typically found to be 1x10^ to 1x10^ pfu / ml.
1.3.4 Infection of mammalian cells with VacT7
Routinely mammalian cells were infected at a m.o.i. of 1 (i.e. 1 pfu / cell) in a 1 ml 
volume of GMEM+1% NBGS per well of a 6 well dish. The virus was adsorbed to the 
cells for 1 hour at 37 °C under 5% CO2 whereupon the inoculum was removed and 
replaced with 2.5 mis of GMEM+1% NBCS until harvesting. Normally cells were 
transfected (2.3.2) at 1 hour post-infection and harvested at 18 hours post-infection. For 
90 mm diameter tissue culture dishes, infection at m.o.i. of 1 was carried out in 2.5 mis 
of GMEM+1% NBCS and incubated with 5 mis of GMEM+1% NBCS until harvesting.
1.4 DAPI staining of cells and viras
Cells were seeded onto multispot slides (C.A. Hendley, (Essex) Ltd) at a density of 
IxlO'  ^cells per well and were incubated O/N or until slightly sub-confluent. The 
medium was removed and the slides were washed in 100% methanol. Each well was 
ti^ated with 50 |il of a 1 mg/ml solution of 4 ,6 , diamidino-2-phenyl-indole (DAPI) in 
methanol for 15 mins at 37 °C. The cells were then washed again in methanol, dried 
and coverslips were mounted on the slides in Citifluor (Citifluor Ltd) for examination 
by immunofluorescence microscopy. Uncontaminated cells had a fluoiescent nucleus 
but no visible cytoplamic fluorescence. Mycoplasma contaminated cells exhibited 
cytoplasmic and extracellular fluorescence. By infecting an uncontaminated cell line 
with a new virus stock and staining the infected cells as described above, mycoplasma 
contamination of the virus stock was monitored.
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2. Transfection of mammalian cells
2.1 Calcium phosphate mediated transfection
2.1.1 Preparation of BBS for transfection
BES-buffered saline (BBS) was prepared as described by Chen and Okayama (1987) 
for use in calcium phosphate mediated transfection. BBS was prepared in 400 ml 
batches of a 2x stock solution consisting of 50 mM BES (2-[bis(2-hydroxyethyl)]-2- 
amino-ethanesulphonic acid; 2-[bis(2-hydroxyethyl)amino]-ethanesulphonic 
acid),(SIGMA), 280 mM NaCl, 1.5 mM Na2HP04 . The pH of the solution was adjusted 
to pH 6.95 before filtering through 0.45 [im disposable filter and aliquotting in 50 ml 
amounts for storage at -20 °C.
2.1.2 Preparation of HBS for transfection
HEPES-buffered saline was prepared as a 2x stock consisting of l.Og of HEPES (N-2- 
hydroxyethylpiperazine-N’-2-ethansulphonic acid), (SIGMA), 0.2g Glucose, 1.6g NaCl, 
0.074g KCl and 0.025g Na2HP0 4 .2H20  per 100 mis of d H2O. The pH of the solution 
was adjusted to 7.05 whereupon it was then filter sterilized through 0.45 pm disposable 
filter and stored at -20 °C until needed.
2.1.3 Transfection of mammalian cells with BBS or UBS
A common way of introducing DNA into mammalian cells is by calcium phosphate 
treatment. Although the mechanism remains obscure, it it thought that DNA enters the 
cytoplasm of the cell by endocytosis of the calcium phosphate - DNA precipitates, 
whereupon the DNA travels to the nucleus for processing. To utilise this method, cells 
were seeded in 6 well dishes at 1x10® cells per well in GMEM+10% NBCS and 
incubated at 37 °C O/N or until cells were 80% confluent. The medium was replaced 
with 2.5 mis of fresh GMEM+10% NBCS at least 2 hours prior to transfection. For 
each well a 250 pi transfection cocktail was prepared as follows 125 pi 2xBBS or 
2xHBS, appropriate DNA to be transfected, 12.5 pi of CaCl2 (2.5 M filter sterilized)
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and dH%0 to make the volume up to 250 pL Note that the CaClg was added last and 
mixed thoroughly to ensure formation of DNA-calcium phosphate complexes.
Cocktails were incubated at RT for 20 mins and added dropwise onto the medium of 
the appropriate wells of cells. The medium was changed 16 hours post-ti*ansfection and 
cells were incubated for a further 24 hours before harvesting.
2.2 DEAE-dextran mediated transfection
Diethylaminoethyl-dextran (DEAE-dextran) method of transfection described by 
Luytjes et al (1989) was used. Cells were seeded in 6 well dishes at 1x10® cells per well 
and incubated O/N or until cells were 80% confluent. Each well was treated with 1 ml 
of DEAE-dextran solution (300 pg/ml DEAE-dextran (Sigma), 0.5% (v/v) DMSG, in a 
PBS-gelatin solution (0.1 mg/ml gelatin )) for 30 mins at RT. The solution was 
aspirated off and replaced with DNA in a 200 pi volume of PBS-gelatin (0.1 mg/ml) 
and incubated for 1 hour in a 37 °C incubator. The transfection mix was replaced with
2.5 mis of GMEM+10% NBCS and the medium was changed 16 hours post­
transfection. Cells were harvested 24 hours later.
2.3 Liposome mediated transfection
2.3.1 Preparation of cationic liposomes
Cationic liposomes equivalent to TransfectACE (Gibco-BRL) were prepared according 
to the method of Rose et al, (1991) with a weightiweight ratio of 1:2.5 DDABiDOPE. 1 
ml of a 10 mg/ml solution of DOPE (dioleoyl-L-a-phosphatidyl ethanolamine),
(Sigma) in chloroform, was pipetted into a glass universal whereupon 4 mg of DDAB 
(dimethyldioctadecyl ammonium bromide),(Sigma), was added and dissolved. The 
choloform was evaporated off under a stream of nitrogen gas and the lipids were 
resuspended in 10 mis of sterile dHgO by placing in a sonicating water bath for 30 
mins. Once suspended, the cloudy lipid solution was clarified by sonication using a fine 
soniprobe for 30 second intervals at maximum power while keeping the universal on 
ice. The lipids were aliquotted in 500 pi amounts in small glass screw-capped tubes and
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stored at 4 °C until needed. Due to potential batch variation, the ti'ansfection efficiency 
of each batch was monitored by p-galactosidase assay on cells transfected with a known 
amount of the plasmid pPEpGal (5.9).
2.3.2 Liposome mediated transfection
Cells were seeded at 1x10® cells per well in 6 well dishes and incubated O/N or until 
80% confluent. Nucleic acid was diluted to 100 pi in OPTIMEM® Reduced Serum 
Medium (Gibco-BRL) and combined with separately diluted Lipofectin ™  (Gibco- 
BRL) or liposomes made as in 2.3.1. (10 pi of liposomes + 90 pi of OPTIMEM® per 
well made in bulk so each well received 100 pi of the same liposome mix). The nucleic 
acid and lipid were incubated together at RT for 15 mins. During this incubation, cell 
monolayers were washed with 2 mis of OPTIMEM®. After the 15 mill incubation, 800 
p i of OPTIMEM® was added to each reaction. Medium was aspirated off the cell 
monolayers and replaced with 1 ml of lipid-nucleic acid mix and incubated O/N. The 
medium was changed at 16 hours post-transfection to 2.5 mis of GMEM+10% NBCS 
and incubated for a further 24 hours before harvesting.
3 Recombinant DNA Technology
3.1 Large scale production and purification of plasmid 
DNA
This method was used to prepare DNA for transfection, dideoxynucleotide sequencing, 
in vitro transcription, PGR, coupled in vitro transcription/translation and cloning. If the 
plasmid yield was poor, then the culture volume was increased to 500 mis and the 
appropriate volume adjustments were made.
A single bacterial colony was used to inoculate 5 mis of Luria Broth (LB) containing 
the appropriate antibiotic for selection (e.g. 100 pg/ml Ampicillin) and incubated at 37 
°C overnight, (O/N), with shaking. 1ml of the O/N culture was then used to seed 50mls 
of LB + antibiotic, and grown for at least a further 12 hours at 37 °C with shaking. The 
culture was then centrifuged at 4,000 x g in a 50 ml screw-capped disposable (e.g.
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Falcon) tube tor 10 mins at 4 "C. The pelleted cells were resuspended in 4 mis of ice- 
cold TGE (25 mM Tris-HCl, pH 8.0, 50 mM Glucose, 10 mM EDTA). The bacterial 
cells were then lysed by addition of 8 mis of a 0.2 M NaOH, 1% SDS solution, shaken 
well to mix and incubated on ice for 5 mins. 6 mis of a 5 M potassium acetate solution 
(3 M with respect to potassium and 5 M with respect to acetate) was added to the lysate, 
shaken to mix and incubated on ice for 10 mins. Cellular debris was pelleted by 
centrifugation at 4,000 x g for 15 mins at 4 “C and the supernatant was filtered through 
a piece of muslin into a fresh tube. 17 mis of isopropanol was added to the filtrate and 
then chilled at - 70 "C for at least 1 hour. The tube was then centrifuged at 4, 000 x g 
for 15 mins at 4 ‘^ C whereupon the supernatant was discarded and the pellet was 
resuspended in 2 mis of TB (10 mM tris-HCl, pH 7.5, 1 mM EDTA). 2.5 mis of 4.4 M 
LiCl was added and then incubated on ice for at least 10 mins. The tube was centrifuged 
at 4,000 X g for 15 mins at 4 °C, the supernatant decanted into a fresh tube to which 10 
mis of 100% ethanol was added and incubated for 15 mins at RT. After spinning again 
at 4,000 X g for 15 mins at 4 °C, the supernatant was discarded and the pellet was 
washed in 70 % (v/v in water) ethanol, resuspended in 400 pi of TE and transferred to a
1.5 ml eppendorf tube. The solution was treated with 4 units (2 pi) of DNase-free 
RNase (Boehringer-Mannheim) and incubated at 37 °C for 15 mins. The reaction was 
terminated by the addition of 20 pi of 10 % sodium dodecylsulphate (SDS) and heated 
to 70 °C for 10 mins, followed by two phenol extractions, two phenol/chlorofoim 
extractions (1:1 ratio v/v) and two chloroform extractions. The DNA was precipitated 
by the addition of one tenth volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of 
100 % ethanol, and incubated at RT for al least 15 mins. The DNA was pelleted by 
centrifugation in a benchtop centrifuge at 14,000 x g for 15 mins, washed in 70 % 
ethanol (v/v in water), dried and resuspended in 100 pi of TE. The concentration and 
purity of the DNA was confirmed by both optical density analysis at 260 nm and 280 
nm and by restriction digests followed by electrophoresis through a 0.8 % (w/v) agarose 
gel (3.4). 1 absorbance unit at 260 nm is equal to 50 mg/ml of double stranded DNA 
and a comparison of the ratio of absorbance at 260 nm to 280 nm, gives an indication of 
protein contamination at 280 nm absorbance, and therefore the purity of the sample.
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an indication of protein contamination at 280 nm absorbance, and therefore the purity 
of the sample.
3.2 Small scale production of plasmid DNA
Small scale plasmid production was usually carried out for the screening of 
recombinant clones after DNA cloning procedures. The clones were screened by 
restriction digest to verify that fragments of the expected molecular weight were 
released. Once a positive clone was identified, a large scale preparation was made.
The alkali-lysis method used was based on that of Bimboim and Doly (1979). 5 mis of 
LB including the appropriate antibiotic was inoculated with a single bacterial colony 
and incubated overnight (O/N) at 37 °C with shaking. 1.5 mis of the O/N culture was 
transferred into a 1.5 ml eppendorf tube and centrifuged for 1 min at high speed in a 
benchtop microfuge. The supernatant was then aspirated off and the bacterial pellet was 
resuspended in 100 pi of ice cold TGE and then lysed with 200 pi of a freshly made 
0.2 M NaOH, 1 % SDS solution, mixed by inverting 3 times and incubated on ice for 5 
mins. 150 pi of potassium acetate solution (3 M with respect to potassium and 5 M with 
respect to acetate) was added and the tube was vortexed in an inverted position for 10 
seconds. The tube was then incubated on ice for 5 mins and then centrifuged at high 
speed in a benchtop microfuge for 5 mins. The supernatant was transfeiTed to a fresh 
eppendorf tube avoiding all the floating debris whereupon 2 volumes of 100 % ethanol 
were added and incubated at RT for at least 5 mins. DNA was precipitated by 
centrifugation at high speed in a benchtop microfuge for 10 mins, washed in 70 % 
ethanol (v/v in water), dried and resuspended in 50 pi of TE. 1 pi of miniprep DNA was 
used in a restriction digest reaction for analysis of DNA fragments by agarose gel 
electrophoresis.
3.3 Restriction digestion of plasmid DNA
Digestion of DNA by the appropriate restriction enzyme was caiiied out as part of a 
cloning procedure or screening procedure to verify DNA restricted as expected. For 
small scale plasmid preparations, typically 1-5 pi DNA was digested in a total reaction
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volume of 20 pi which included buffers supplied by the maufacturer (Gibco-BRL or 
New England Biolabs) diluted to the appropriate concentration, 0.1 units of restriction 
enzyme and 0.2 units of DNase-free RNase (Boehringer Mannheim). Digestions were 
canied out from 1-4 hours at the appropriate temperature as stipulated by the 
manufacturer. Typically 1 pg of a large scale DNA preparation was digested in a 20 pi 
reaction volume containing the appropriate buffer supplied by the manufacturer, and 1 
unit of restriction enzyme for at least 1 hour at the appropriate reaction temperature. If 
the DNA preparation was the vector backbone for use in a ligation reaction, its ends 
were dephosphorylated by the addition of 0.5 pi (12 units) of alkaline phosphatase 
(Boehringer Mannheim) for the last hour of the digest. The alkaline phosphatase was 
inactivated by the addition of EGTA to a final concentration of 20 mM and heating to 
65 for 10 mins. After digestion, DNA fragments were seperated by agarose gel 
electrophoresis.
3.4 Agarose gel electrophoresis of digested DNA
Electrophoresis of DNA was carried out in a horizontal slab gel consisting of 0.8 % 
(w/v) agarose (Sigma) dissolved in Ix TBE (0.089 M Tris-borate, 0.089 M boric acid, 
0.02 M EDTA). DNA was loaded into the agarose gel in gel loading buffer (5 % (v/v) 
glycerol, 0.05 % (w/v) bromophenol blue, 0.05 % (w/v) xylene cyanol) and 
electrophoresis was carried out in Ix TBE buffer containing 1 pg/ml of ethidium 
bromide, at 70 volts. Following electrophoresis, the DNA bands were visualised on a 
UV transiUuminator and were compared to a known DNA molecular weight ladder. The 
marker used was bacteriophage X DNA (Promega) which had been digested with Hind 
111 and EcoRl restriction enzymes (XH/E) and diluted to a concentration of 40 ng/pl. 
Typically 10 pi of X H/E was run on a gel.
3.5 Purification of DNA fragments from agarose gels
Once digested with the appropriate restriction enzyme (3.3), DNA fragments were 
electrophoresed through a 0.8% (w/v) agarose gel (3.4) and visualised on an ultra-violet 
(UV) transilluminator after staining with ethidium bromide. Once the band of interest
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was identified, excised using a sterile scalpel and placed in a pre-weighed Eppendorf 
tube, the DNA was extracted from the agarose using a QIAquick Gel Extraction Kit 
(QIAGEN Inc.) in accordance with the manufacturers' instructions. Tlie weight of the 
gel slice was determined and 3 volumes of buffer QXl (supplied by the manufacturer) 
was added per volume of gel (i.e. 300 pi of buffer per 100 mgs of gel). The gel slice 
was dissolved in the buffer by heating at 50 °C for 10 mins and flicking every 2-3 mins. 
Once the gel slice was completely dissolved, 1 gel volume of isopropanol was added 
and mixed. A QIAquick spin column was placed in a collection tube and the sample 
was loaded and centrifuged for 1 min at top speed in a microfuge. The column was 
washed with 0.75 mis of buffer PE containing ethanol by first leaving the column 
standing in PE wash buffer for 5 mins and then centrifuging for 1 min. Flow-through 
was discarded and the column was centrifuged again to remove any residual wash 
buffer. The column was then placed in a fresh microfuge tube and DNA was eluted by 
adding 50 pi of 10 mM Tris-HCl pH 8.5 to the center of the membrane. The column 
was left standing for 1 min and then centrifugated for 1 min and the collected DNA was 
transferred to a 500 pi Eppendorf tube for storage. 5 pi of the recovered DNA was run 
on another agarose gel to check recovery of the fragment before ligation.
3.6 Ligation of DNA fragments
Previously digested and gel purified DNA fragments were ligated together in 
approximately 1:1 molar ratios and was typically 100 ng of insert to 10-50 ng of vector 
DNA. Ligations were carried out in 10 pi reaction volumes which contained the 
appropriate dilution of ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCU, 10 mM 
DTT, 1 mM ATP, 25 pg/ml BS A ) supplied by the manufacturer and 200 units o f T4 
DNA Ligase (New England BioLabs). Reactions were incubated at 16 °C for 12 hours 
or at 20 °C for 3 hours and were used directly to transform competent E. coli cells.
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trciD36 lacl^ A(/acZ)M15 /?/y;A+B+/ supE A{hsciM- mc’7-B)5(rKTnK‘ McrB”) thi A{lac- 
proAB). The strain used for protein production using the pET system was BL21(DE3) 
(F“ ompT[lon\ hstlSu (ib" iub"; an E.coli B strain) with DE3, a A, prophage cairying the 
T7 RNA polymerase gene). Liquid bacterial cultures were grown in Luria Broth (LB) 
which contained 10 g/1 bacto-tryptone(Difco), 5 g/l yeast extract (Difco), 10 mM NaCl, 
at pH 7.5, supplemented with the appropriate antibiotic. Solid medium contained LB 
supplemented with 1.5 % (w/v) agar (Difco), 10 mM MgS0 4  and the appropriate 
antibiotic.
3.8 Preparation of competent E.coli cells
A single bacterial colony was used to inoculate 5 mis of LB and was incubated O/N at 
37 °C with shaking. 1ml of the O/N culture was used to seed 50 mis of LB in a 250 ml 
flask which was then incubated as before for 3 hours or until the optical density at 600 
nm (OD 600) read 0.5. The culture was chilled for 10 mins on ice and centrifuged for 10 
mins at 3,000 x g at 4 «C. The bacterial pellet was resuspended in 25 mis of ice-cold 50 
mM CaCH. Cells were incubated on ice for 10 mins and centrifuged at 3,000 x g for 10 
mins. The supernatant was discarded and the cells were very gently resuspended in 3.33 
mis of ice cold 50 mM CaCH and kept on ice (or in the fridge) until needed. 
Competence of the cells increased 10-fold after 24 hours and the cells were used for up 
to 48 hours post-preparation.
3.9 Transformation of competent bacterial cells
100 pi of competent E. coli cells (3.8) were added to a 10 pi ligation reaction (3.6) and 
incubated on ice for at least 1 hour. Cells were then heat shocked at 42 °C for 90 
seconds and placed back on ice for 1 min. Then 1 ml of LB (without antibiotics) was 
added to the cells which were subsequently incubated at 37 “C for 1 hour. 10 pi, 100 pi 
and 500 pi aliquots of the cell culture were then plated onto 3 agar plates containing the 
appropriate antibiotic for selection of positive transformants. Both a positive control, to 
check the competence of the cells, and a negative control, to ensure the untransformed 
bacteria could not grow in the presence of the antibiotic, were included each time. The
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added to the cells which were subsequently incubated at 37 °C for 1 hour. 10 pi, 100 pi 
and 500 pi aliquots of the cell culture were then plated onto 3 agar plates containing the 
appropriate antibiotic for selection of positive transformants. Both a positive control, to 
check the competence of the cells, and a negative control, to ensure the untransformed 
bacteria could not grow in the presence of the antibiotic, were included each time. The 
positive control contained 10 ng of pUC19 control DNA. The plates were incubated at 
37 °C O/N and colonies were picked the following day for analysis of small scale DNA 
preparations (3.2). Transformation efficiencies were calculated by counting the number 
of transformant colonies on each control plate and was routinely found to be 1x10^ 
colonies per pg of pUC19 DNA.
3.10 Preparation of oligonucleotides
The phosphoramide method was used to generate synthetic oligonucleotides which 
were supplied in ammonium hydroxide. The base protecting groups were removed by 
heat treatment for 5 hours at 55 °C and the ammonia was subsequently removed by 
lyophilisation. The oligonucleotide pellet was dissolved in 200 pi sterile distilled water 
(dH2 0 ) and impurities which had not dissolved were pelleted by centrifugation at 
14,000 rpm in a cold benchtop microfuge. The supernatant was decanted into a fresh 
tube where 20 pi of 3 M NaAc (pH5.2), 2.2 pi of 1 M MgCl2 and 600 pi of 100 % 
ethanol were added. The DNA was then precipitated at -20 °C for 30 mins and pelleted 
by high speed centrifugation in a cold benchtop microfuge for a fuither 30 mins. The 
supernatant was carefully aspirated off and the pellet was dried briefly under vacuum 
and resuspended in 100 pi of dH20. The oligonucleotide concentration was determined 
by OD at 260 nm where an OD reading of 1 is equal to 25 pg/ml of oligonucleotide. 
From the concentration, the molarity of the solution could be calculated using 329 
daltons as the mass of 1 base.
3.11 7» vitro transcription reactions
Negative sense RNA transcripts were generated from in vitro transcription reactions for 
transfection and CAT rescue attempts. Typically the CAT plasmid DNA template was
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linearised using an appropriate blunt-cutting restriction enzyme (3.3), phenol / 
chlorofoi-m extracted, ethanol precipitated, dried and resuspended at a final 
concentration of 1 |ig/p.l in d H2O. Transcription reactions contained 1 |0,g of linearised 
DNA, T7 RNA polymerase buffer supplied by the manufacturer diluted to the required 
concentration (40 mM Tris-HCl pH7.9, 6mM MgCl2,2mM  spermidine, 10 mM 
NaCl)(Promega), 0.4 mM NTPs, 4 mM DTT, 20-40 units of placental ribonuclease 
inhibitor RNasin® (Promega), 10-20 units of T7 DNA dependent RNA polymerase 
(Promega) in a total volume of 50 |0,1. Reactions weæ incubated at 37 °C for 2 hours 
whereupon 1 unit of RQl RNase-Free DNase (Promega) was added and incubated for 
15 mins. After DNase treatment, 5 |al of the reaction mix was run on a 0.8% agarose gel
(3.4) to estimate RNA concentrations. RNA was then snap frozen in an ethanol-dry ice 
bath and kept there until needed for transfection.
3.12 Preparation of total RNA from SV5 infected cells
A confluent monolayer of Vero cells were grown in a 150mm x 20mm tissue culture 
dish and infected with SV5 W3 strain at an m.o.i. of 1. At 48 hours post infection, the 
medium was aspirated off and the cells were scraped into 5 mis of PBS and gently 
pelleted by centrifugation at 3,000 x g for 2 mins. Once the supernatant was discarded, 
the resuspension and centrifugation was repeated twice more to wash the cells 
thoroughly. After the final centrifugation step, the cell pellet was resuspended in 0.5 
mis of RNA lysis buffer (10 mM Tris-HCl pH 7.8,10 mM NaCl, 2mM MgCW and 50 
|il of 10% NP40. The lysed cells were transfened to an Eppendorf tube for 
centrifugation at high speed in a cold benchtop microfuge for 5 mins. The supernatant 
was decanted into a fresh tube containing 180 p.1 STB (100 mM NaCl, 10 mM Tris-HCl 
pH 8.0,1 mM EDTA) and 20 jil of 20% SDS. The cell extract was then split into 100 |il 
aliquots and extracted twice with phenol and twice with chloroform. 10 jil of 3M NaAc 
pH5.3 and 250 }il of 100% ethanol was added to each aliquot. The aliquots were mixed 
and stored at -20 °C until needed whereupon the RNA was pelleted by centrifugation 
for 15 mins at high speed in a cold benchtop microfuge. The supernatant was gently
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aspirated off, the pellet was dried briefly under vacuum and resuspended in 10 jil of 
sterile dH2 0 .
3.13 Reverse transcription of cDNA from viral RNA
The reverse transcription reaction utilised total cell RNA extracted from SV5 infected 
cells as outlined in 3.11. 1 jil of RNA was used in a 10 jil reaction which contained Ix 
Taq DNA polymerase buffer (supplied by Appligene), 400 jiM of each of the dNTPs,
2.5 jiM primer, 0.5 jil of RNasin® (Promega) and 200 units of Moloney Murine 
Leukaemia Virus (MMLY) reverse transcriptase (Gibco-BRL). Two negative controls 
were also included; one without RNA and one without reverse transcriptase. Each 
reaction was incubated at 37 for 30 mins and the resultant cDNA strand from the 
reverse transcription step was amplified by polymerase chain reaction (PCR).
3.14 Polymerase chain reaction (PCR) amplification of 
DNA
Typically 1-10 ng of plasmid DNA (or 10 jil o f a reverse transcription reaction) was 
used as the template for polymerase chain reaction (PCR) amplification of a specific 
cDNA. The PCR reaction contained 1 jiM each of a forward and reverse primer, 200 
jiM of each of the dNTPs, IxTaq DNA polymerase buffer (supplied by Appligene) and 
2 units of Taq DNA polymerase (Appligene) in a 100 jil total volume. The PCR 
reaction mix was overlaid with around 50 jil of mineral oil to prevent evaporation of the 
reaction components during the thermal cycling. PCR amplification was carried out in a 
Techne DNA thermal cycler programmed to cycle at 94 °C for 1.5 mins (DNA 
dénaturation), 55 °C for 1.5 mins (primers anneal to template DNA), 72 °C for 2.0 mins 
(primer extension by Taq DNA polymerase), for 30 cycles with a 10 min extension at 
72 °C  at the end. After 30 cycles, the mineral oil was removed and 10 jil was loaded 
onto an 0.8% (w/v) agarose gel to check that the product was of the expected molecular 
weight. Once this had been confirmed, the PCR product was phenol / chloroform 
extracted, ethanol precipitated, dried and resuspended in 50 jil of dH20. The PCR 
product was now ready for restriction digestion and cloning into the appropriate vector.
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3.15 Preparation of plasmid DNA for dideoxynucleotide 
sequencing
Large scale plasmid preps (3.1) were used in DNA sequencing reactions. The plasmid 
DNA first had to be denatured before starting the sequencing reaction. For each 
reaction, 5 |ig of pure plasmid DNA (OD260-280 = 1.65-1.85) was denatured by adding 
equal volumes of 0.4M NaOH / 4mM EDTA (i.e. 0.2M NaOH /  2mM EDTA final 
concentration) in an Eppendorf tube and incubating at 37 °C for 30 mins. Then one 
tenth (1/10) volume of 3M NaAc pH5.2 and 2.5 volumes of 100% ethanol were added 
and the DNA was precipitated by incubating at -20 °C for 15 mins. The DNA was 
pelleted by centrifugation at high speed in a cold benchtop microfuge for 15 mins. The 
supernatant was aspirated off and the pellet was washed in 70% (v/v) ethanol and dried 
under vacuum. The dried, denatured DNA pellet was stored at -70 °C until needed for 
the sequencing reactions. Typically 5 aliquots of a given plasmid were denatured 
simultaneously to allow more than one sequencing reaction at a time to be performed.
3.16 Dideoxynucleotide sequencing reactions
Sequencing reactions were carried out using a Sequenase ™  Version 2.0 DNA  
sequencing kit (United States Biochemical) which used the method of Sanger et al 
(1977). An aliquot of denatured plasmid DNA (3.15) was resuspended in 7 jil of dHaO, 
2 jil of Sequenase buffer (40 mM Tris-HCl pH7.5,20 mM MgCh, 50 mM NaCl) and 1 
jil of primer pre-düuted to 3 ng/jil. The primer was annealed to the DNA by heating at 
65 °C for 2 mins and cooling slowly to 35 °C. The primer extension step utilised 
Sequenase V2 T7 DNA polymerase to incorporate p5S]-dATP into the nascent DNA. 
To the cooled DNA, 1 jil of O.IM DTT, 2jti of labelling mix (1.5 jiM dGTP, 1.5 jiM 
dCTP, 1.5 JiM  dTTP), 0.5 jil (5 jiCi) of P^Sj-dATP (Amersham International) and 2 jil 
of Sequenase V2 T7 DNA polymerase diluted one in eight in enzyme dilution buffer 
(10 mM Tris-HCl pH 7 .5 ,5  mM DTT, 0.5 mg/ml BSA) were added. The reactions were 
mixed and incubated at RT for 5 mins. The extension reactions were stopped by adding
3.5 jil of the labelled mix to each of four termination tubes containing 2 jil of the
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whereupon 3 pi of each sample was loaded onto 7 M urea, 6% (w/v) polyacrylamide gel 
for electrophoresis.
3.17 Electrophoresis of sequencing reactions
Sequencing gels consisted of IxTBE, 7M urea and 6% (w/v) acrylamide in a total 
volume of 75 mis. To this a few grains of bromophenol blue were added and dissolved 
to enable bubbles in the gel to be easily visualised while pouring. The solution was 
filtered through a 0.45 pm disposable filter and polymerised by the addition of 75 pi of 
25% (w/v) ammonium persulphate and 75 pi of TEMED (BioRad). The gel solution 
was poured into a Sequi-Gen® nucleic acid sequencing cell (BioRad) which had been 
assembled according to the manufacturers' instructions and had been sealed at the 
bottom with 1% (w/v) agarose. Once poured, the comb was inserted into the top of the 
gel such that the flat edge of the comb created an even surface to the top of the gel when 
polymerised. After polymerisation, the comb was removed, the gel was submerged in 
IxT-BE and pre-run at 2,000 volts until it had warmed to 50 '^C. Once the gel was warm, 
the comb was inserted such that the fine sharks teeth points of the comb rested on the 
gel surface. The spaces between the teeth created the wells where the samples were 
loaded so a tight fit was essential to prevent leakage of sample from well to well. The 
samples were boiled for 3 mins and 3 pi of each sample was loaded onto the gel for 
electrophoresis. The gel was routinely run at 2,000 volts until the bromophenol blue 
reached the bottom but it was sometimes necessary to run the gel for longer to analyse 
sequences further from the primer. Once run, the gels were transferred onto 3mm 
Whatman filter paper and dried at 80 °C under vacuum. Once dry the gels were put 
against X-ray film for autoradiography at room temperature. The DNA sequence was 
read from bottom to top of the gel / autoradiogram which represented sequence in the 3' 
to 5' orientation.
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sequence was read from bottom to top of the gel / autoradiogram which represented 
sequence in the 3' to 5' orientation.
4. Generation of inducible cell lines 
expressing SV5 proteins
4.1 Transfection of BalbC cell for the generation of 
inducible cell lines
75 cm^ tissue culture flasks were seeded with BalbC cells and grown to 80% 
confluency in GMEM+10% NBCS. The cells were then transfected with the driver 
fusion plasmid pMRlOl/tTA, and the appropriate responder plasmid(s) at a 1:10 driver 
fusion:responder plasmid ratio. For the cell lines inducibly expressing NP, P or V this 
was 200 jig of responder plasmid (pTET-pGlobinNP, pTET-P or pTET-V) and 20 jig 
of driver fusion plasmid (pMRlOl/tTA). Transfection cocktails contained DNA diluted 
to a total volume of 500 jll in OPTIMEM®. For each transfection mix 100 jil of 
liposomes was added to 400 jil of OPTIMEM® and mixed. The diluted liposomes were 
added to the DNA and incubated at RT for 20 mins. During this time, cell monolayers 
were washed in 5 mis of OPTIMEM®. Then 4 mis of OPTIMEM® was added to the 
DNA-lipid mixture which was mixed and added to the washed cells. Cells were 
incubated O/N at 37 °C under 5% CO2 whereupon the transfection mixture was 
replaced with 20 mis of GMEM+10% NBCS and incubated for a further 24 hours. At 
48 hours post-transfection, cells were trypsinised and resuspended in 10 mis of 
GMEM+10% NBCS. 35 mis of GMEM+10% NBCS supplemented with 500 jlg/ml 
Geneticin (Gibco-BRL) and 2 jlg/ml tetracycline (Sigma) was added to two 150 mm 
diameter tissue culture plates per transfection. Then 6 mis of transfected cells were 
added to the first dish and 2 mis to the second. (Two dilutions were used for isolation of 
well separated single transfectant colonies.) The rest of the cells were used in 
immunofluorescence (IF), (5.7) and western blotting (5.6) to monitor transient 
expression of the protein of interest. The medium was changed every 2 days on the 150
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mm dishes to remove dead cell debris and allow the formation of geneticin resistant 
colonies.
4.2 Isolation of Geneticin resistant colonies.
Resistant colonies were harvested when easily visible to the naked eye. Each colony 
was scraped off the plastic with a sterile pasteur pipette in 200 jil of medium and 
transfeiTed into a well of a 24 well tissue culture dish containing 1 ml of GMEM+10% 
NBCS supplemented with geneticin and tetracycline. Typically 48 clones per new cell 
line were harvested.
4.3 Screening of new cell line clones
Once the clones had grown to cover around one third of the well, they were tiypsinised 
and resuspended in 500 jll medium. 50jil of each clone was dotted onto a well of a 
multispot slide and cells were allowed to settle on the slide O/N. Slides were washed 
three times in PBS to remove all traces of tetracycline and incubated in GMEM+10% 
NBCS for 48 hours for analysis of protein expression by immunofluorescence 
microscopy (5.7). Clones exhibiting positive fluorescence for the protein(s) of interest 
were then subcloned to increase the percentage of expressing cells (4.4).
4.4 Subcloning of positive clones
Clones exhibiting positive fluorescence for the protein(s) of interest usually had around 
30-40% of positive cells but this was as low as 5% for some clones. The best clone 
from each cell line was therefore subcloned to generate colonies from single ceils. The 
rationale was to expand a colony from a single cell which expressed the protein of 
interest, thus, theoretically, a subclone from each cell line would express the required 
protein of interest. Cells from the appropriate positive clone were trypsinised from the 
well of a 24 well dish and resuspended in 1 ml of medium. The cells were then counted 
in an Improved Neubauer counting chamber (Hawksley Cristalite) and cells were plated 
on three 90 mm diameter tissue culture dishes (100,10 and 1 cell per dish) in 
GMEM+10% NBCS supplemented with geneticin and tetracycline. Colonies began to
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remaining after the counting procedure were used to seed a 25 cm^ tissue culture flat 
per clone and grown to contluency for storage in liquid nitrogen (4.6).
4.5 Ring cloning of single cell colonies
24 subclones, each derived from a single cell, were picked for screening by ring- 
cloning. A 1 cm diameter, sterile, metal ring was dipped in sterile vaseline and the 
vaseline coated base was placed around a clone without touching any neighbouring 
clones. Once secure, the vaseline seal prevented any leakage of medium outwards or 
inwards. The medium surrounding the clone was aspirated off and the subclone was 
trypsinised in 100 pi of trypsin and added to 400 pi of GMEM+10% NBCS 
supplemented with geneticin and tetracycline. 50 pi was then dotted onto a multispot 
slide for screening by immunofiuorescence (5.7). 24 subclones per cell line were 
isolated in this way and expression from all positive subclones was verified by western 
blot analysis (5.6). Once positive subclones had been identified they were grown to 
contluency in 25 cm^ tissue culture flats and frozen for storage in liquid nitrogen.
4.6 Freezing down of tissue culture cells
Cell monolayers were grown to confluency in 25 cm^ tissue culture flasks and 
trypsinised. Cells were resuspended in 5 mis of ice-cold freezing mix (60% (v/v) 
GMEM, 30% (v/v) NBCS, 10% (v/v) DMSG) on ice and aliquotted into 1 ml amounts 
in cryotubes. Aliquots were frozen at -70 °C in a polystyrene box O/N and transfeiTed 
into liquid nitrogen for long term storage.
5 Protein Analysis
5.1 Antibodies
The panel of monoclonal antibodies (mAbs) used in the course of this study were raised 
against SV5 proteins as described in Randall et al (1987), and are detailed at the front of 
the thesis. NP and P proteins were detected using specific mAbs while V was detected
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of the thesis. NP and P proteins were detected using specific mAbs while V was 
detected using a niAb which also detected the P protein. L was detected in 
immunoprécipitation reactions (5.4) using an N-terminal peptide antiserum. This was 
raised against E-I-L-L-P-E-V-H-L-N-S-P-TV-K-H-K peptide found in the hydrophilic 
N-terminal regions of SV5 and hPIV2 and was generously supplied by Dr.Y. Ito, Dept 
of Microbiology, Mie School of Medicine, Mie-Prefecture, Japan.
5.2 35 S labelling of proteins
Cells were seeded in 6 well dishes, infected with VacT7 and transfected with the 
appropriate vector encoding an SV5 gene under T7 control as described elsewhere. At 
17 hours post-vaccinia virus infection, cells were starved for 30 mins in methionine and 
glutamine free medium ((Gibco-BRL) supplemented with 1% NBCS. Cells were then 
labelled in 500 pi of labelling solution (50-100 pCi /  ml of protein labelling (^^S- 
methionineP^S-cysteine) mix (NEN), 2mM glutamine, 1% NBCS in methionine and 
glutamine free medium) for 2 hours at 37 °C. Cells were then washed twice in ice-cold 
PBS and prepared for immunoprecipitaion (5.4).
5 3  In vitro Transcription / Translation
In vitro transcription / translation reactions were performed using the TNT® Coupled 
Transcription / Translation System (Promega) according to the manufacturers’ 
instructions. A typical 50 pi reaction contained 1 pg of template DNA, 20-40 units of 
RNasin®, 1 mM of Amino acid mix minus methionine, 40 pCi of [3^S]-methionine 
(Amersham), TNT® Reaction buffer, 1 pi of TNT® T7 RNA polymerase and 25 pi of 
TNT® Reticulocyte Lysate. The reactions were incubated at 30 °C for 120 mins and 
labelled polypeptides were analysed by SDS-PAGE (5.5). The gel was then dried on 3 
mm Whatman filter paper at 80 °C under vacuum and exposed to X-ray film for 
autoradiography.
66
5.4 Immunoprécipitation
After 35S-labelling, the cells were washed twice in ice-cold PBS and prepared following 
a protocol adapted from Harlow and Lane (1988). Cells from each well were scraped 
into 100 pi immunoprécipitation (IP) buffer (0.65M NaCl, 20 mM Tris-HCl pH7.8. 1 
mM EDTA, 0.5% (v/v) NP40, 0.1% (v/v) NaAz, 0.1% (v/v) SDS) and transferred into
1.5 ml Eppendorf tubes. The cell lysates were sonicated using an ultrasonic probe and 
centrifuged at 14,000 rpm in a cold benchtop microfuge for 1 hour. The supernatants 
containing soluble antigens were decanted into fresh tubes and incubated with the 
appropriate mAbs for 1 hour on ice. Then 30 pi of Protein A sepharose beads 
(Pharmacia) was added to each tube, flicked to mix and incubated on ice for 1 hour. 
Beads were gently pelleted by low speed centrifugation for 5 mins on a benchtop 
microfuge and the supernatant discarded. The beads were washed five times in 1 ml of 
IP buffer. The final pellet was resuspended in 50 pi of SDS-lysis buffer (50 mM Tris- 
HCl pH 7.0, 2% (v/v) SDS, 5% (v/v) [3-mercaptoethanol, 3% (v/v) glycerol, 0.1% (w/v) 
bromophenol blue), boiled for 3 mins and labelled polypeptides were separated by 
electrophoresis through and SDS-polyacrylamide slab gel (5.5). After electrophoresis, 
the gel was dried on 3 mm Whatman filter paper at 80 "C under vacuum and 
subsequently exposed to X-ray film at room temperature (RT).
5.5 SDS-Polyacrylamide Gel Electrophoresis
Proteins were denatured in SDS-lysis buffer (50 mM Tris-HCl pH 7.0, 2% (v/v) SDS, 
5% (v/v) p-mercaptoethanol, 3% (v/v) glycerol, 0.1% (w/v) bromophenol blue) and 
boiled before loading onto a polyacrylamide gel containing SDS for polypeptide 
separation by electrophoresis (Laemmli, 1970). Mini Protean System gel rigs (BioRad) 
were assembled according to the manufacturers' instructions. The resolving gel 
consisted of 0.375M Tris-HCl pH 8.3, 10% (v/v) acrylamide-bisacrylamide (29:1 
acrylamide:bisacrylamide)(NBL Gene Sciences Ltd), 0.375% (v/v) ammonium 
persulphate, 0.1% (v/v) SDS and 4.5 pi of TEMED (BioRad) per 10 mis of gel solution. 
Once prepared, the gel solution was poured into pre-assembled rigs and covered with
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0.5 mis of isopropanol until the gel had polymerised. Once the resolving gel had 
polymerised, the isopropanol was removed and replaced with stacking gel solution 
which consisted of 0.125M Tris-HCl pH 7.0,0.1% (v/v) SDS, 3.75% (v/v) acrylamide- 
bisacrylamide (29:1), 0.056% (v/v) ammonium persulphate and 6 pi of TEMED per 4 
mis of gel. Once poured, a 10 well plastic comb was inserted to create wells and the 
stacker was polymerised for 10 mins. Once polymerised,the comb was removed and the 
wells were rinsed in d H2O before assembling into the electrophoresis tank. Gels were 
loaded and run at 150V in SDS-running buffer (0.025M Tris, 0.19M glycine, 0.1%
SDS) until the bromophenol blue from the samples had reached the bottom of the gel.
5.6 Western Blotting
Once the polypeptides had been separated by SDS-PAGE (5.5), they were transferred to 
nitrocellulose membrane by western blot using a Trans-Blot Cell (BioRad) assembled 
according to the manufacturers* instructions. The transfer unit was submerged in 
transfer buffer (0.025M Tris, 0.19M glycine, 20% (v/v) methanol) in a gel tank 
containing an ice cooling chamber and run at 200 mA for 1 hour. After transfer to 
nitrocellulose, the polypeptides were detected using mAbs described in 5.1. Non­
specific protein binding sites on the nitrocellulose filter were blocked by incubating the 
filter in Blotto (10% (w/v) skimmed mük powder, 0.2% (v/v) Tween20 in PBS) for 1 
hour. Specific viral polypeptides were detected by incubating the filter with a dilution 
(1/100 or 1/1000) of the appropriate mAbs in Blotto for 30 mins and unbound mAb was 
removed by four 15 min washes in Blotto. The bound mAb was detected by incubating 
the filter in a 1/1000 dilution of anti-mouse Ig conjugated to horseradish peroxidase 
(Amersham International) in Blotto for 30 mins. The filter was washed by two 15 min 
washes in Blotto, a 15 min wash in PBS+0.2% (v/v) Tween 20 and a 15 min wash in 
PBS. Secondary antibody was detected in an enhanced chemiluminescence (ECL) 
reaction (Amersham) followed by autoradiography.
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5.7 Caesium chloride (CsCl) gradients
Attempts were made to analyse the solubility of NP-P and NP-V complexes by their 
mobility through a CsCl gradient by density centrifugation, following the protocol of 
Buchholz et al, 1993. Four 25 cm^ tissue culture flasks containing BalbC cells 
expressing SV5 NP, NP+P, NP+V or naive BalbC cells respectively, were induced for 
48 hours by incubating the cells in the absence of tetracycline. Cells were harvested in 
500 jll of a hypotonic buffer (lOmM Tris-HCl, pH 8.0, O.IM EDTA) and transferred to 
Eppendorf tubes. Cells were then vortexed and centrifugated at 10,000 rpm in a 
benchtop microfuge at 4 °C. Supernatants were decanted for loading onto the CsCl 
gradients.
20%, 30% and 40% CsCl solutions (w/w), and a 30% gycerol (w/w) solution were 
prepared in TNE (Tris-HCl, pH7.4, 50 mM NaCl, 2 mM EDTA). A 4 ml step gradient 
(1 ml of 40%, 30% then 20% CsCl followed by 1 ml of 30% glycerol) was assembled 
in centrifuge tubes suitable for the Beckman SW 50.1 rotor. The samples were layered 
onto the glycerol cushion and the tubes were centrifuged at 36,000 x g at 16 °C for 16 
hours.
Samples were harvested by carefully inserting a capillary tube through the gradient 
until it almost reached the bottom. A peristaltic pump was then used to extract seven 
0.5 ml fractions. The polypeptides within each fraction were seperated on a 10% SDS- 
polyacrylamide slab gel and analysed by western blot (See 5.6).
5.8 SPOTS analysis
A series of C-terminal overlapping peptides covering the unique region of the P protein 
were generated on a cellulose membrane by GENOSYS (Cambridge, UK). This 
membrane was then reacted sequentially with the available P specific mAbs (Randall et 
at, 1986) to determine their specific sequence binding motif(s). First, the non-specific 
binding sites on the membrane were blocked by overnight incubation at 4 °C in a 
casein-based blocking reagent supplied by the manufacturer. (Blocking buffer was 
supplied as xlO concentrated and was therefore diluted 10 fold in Tris buffered saline
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blocking bulTer to approximately 0.1 mg / ml and incubated with the membrane at RT 
for 30 mins with shaking. The membrane was then washed five times in PBS containing 
0.05% Tween 20 (PBS-T), for 10 mins per wash. The secondary antibody (HRP- 
conjugated sheep anti-mouse Ig) was then reacted with the membrane at RT with 
shaking. The membrane was washed five times in PBS-T as described above. Bound 
antibody was then detected in an ECL reaction as for western blots (See 5.6).
Each P mAb was tested individually and the membrane was regenerated before the next 
assay. Membrane regeneration involved incubation of the membrane in a solution of 
5M urea / 1% SDS (v/v) / 0.1% (v/v) |3 mercaptoethanol for 30 mins at RT. The 
membrane was then washed in a solution of Ethanol / water / acetic acid (5:5:1 v/v/v) 
for 30 mins. The membrane was finally rinsed in PBS-T and stored in blocking buffer at 
4 °C in preparation for the next assay.
5.9 Immunofluorescence microscopy
Cells were plated on multispot slides and grown until around 70% confluent in 
GMEM+10% NBCS. Slides were carefully washed twice in PBS and fixed in a PBS 
solution containing 5% (v/v) formaldehyde and 2% (w/v) sucrose for 10 mins. Cells 
were then permeabilized for 5 mins in a PBS solution containing 10% (w/v) sucrose, 
0.1% (v/v) NaAz and 0.5% (v/v) NP40. The slides were washed three times in PBS and 
incubated with the appropriate mAb - NP was detected with SV5 NP-d conjugated to 
the fluor Texas Red, both the P and V proteins were detected with SV5 P-k conjugated 
to fluorescein isothiocyanate (FITC). Both antibodies contained DAPI (1.4) at 10 jlg/ml 
as an indication of cell density and also monitored mycoplasma contamination. 50 jil of 
a 1/100 dilution of the mAb was added per well to the multispot slide and incubated for 
1 hour at 37 °C in a humid atmosphere. If two proteins expressed simultaneously were 
to be detected by double staining, the mAbs were mixed before incubation with the 
cells. When the incubations were complete, the slides were washed three times in PBS 
and fixed for a further 5 mins. The slides were washed again in PBS and air dried 
briefly before adding 2-3 pi Citifuor mounting fluid (Citifluor Ltd) per well, covering
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briefly before adding 2-3 pi Citifuor mounting fluid (Citifluor Ltd) per well, covering 
the slide with a clean coverslip and examined using the immonofluorescence 
microscope.
5.10 Chloramphenicol Acetyl-Transferase (CAT) Assays
This CAT assay method was adapted from that of Gorman et al, (1982). Transfected 
cell monolayers in 6 well dishes were washed with 3 mis of ice-cold PBS and scraped 
into 1 ml of harvesting buffer (40 mM Tris-HCl pH7.4, ImM EDTA, 150mM NaCl). 
Cells were transfeiTed into 1.5 ml Eppendorf tubes and pelleted by centrifugation at 
1,5(X) rpm in a cold benchtop microfuge for 5 mins. The supernatants were poured off 
and pellets were resuspended in 50 pi of 0.25M Tris-HCl pH 7.5 by vortexing briefly. 
The cells were lysed by repeated freeze / thaw cycles in an ethanol / dry ice bath and 37 
°C water bath. Cell debris was pelleted by high speed centrifugation in a benchtop 
microfuge at 4 °C for 5 mins. During this time, a bulk CAT reaction mix was prepared. 
Each reaction contained 70 pi Tris-HCl pH 7 .5 ,24  pi dH20,2 p l  of 40 mM Acetyl 
Coenzyme A and 4pl (0.1 pCi) of ^^-chloramphenicol (Amersham). Once the bulk 
mix was prepared, it was aliquotted in 100 pi amounts into a set of tubes on ice. The 
supernatant from the lysed cells was added to the reaction mix and incubated in a 37 °C 
water bath for 2-24 hours. After incubation, the reactions were extracted with 1 ml of 
ethyl acetate by vortexing and spinning at 14,000 rpm in a cold benchtop microfuge for 
10 mins. The top layer containing chloramphenicol and the acetylated products was 
decanted into a fresh tube. The lid of each tube was pierced and the samples were dried 
under vacuum for 1 hour at 37 °C. Once dry the samples were resuspended in 20 pi 
ethyl acetate and dotted onto a silica gel plate for thin layer chromatography (TLC). 
The plate was then placed in a TLC tank with a saturated atmosphere 95 chloroform : 5 
methanol until the solvent front was approximately 1 cm from the top of the plate. The 
plates were removed from the tank, air dried and put against X-ray film for 
autoradiography at RT.
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5.11 p-Galactosidase Assays
To determine the translection efficiency of a particular cell line or a new batch of home­
made cationic liposones (2.3.2), cells were seeded at 1x10^ cells per well in 6 well 
tissue culture dishes. When the cells were around 80% continent, they were transfected 
with a known amount of pPEpOal plasmid DNA which contained the bacterial /acZ 
gene encoding the p-Galactosidase enzyme under the control of the human 
cytomegalovirus (hCMV) immediate early promoter. The cells which had been 
transfected, expressed p-Galactosidase and therefore stained blue in the presence of the 
chromogenic substrate X-Gal (5-bromo-4-chloro-3-indolyl-p-galactopyranisode). By 
counting the number of blue cells the percentage of transfected cells was determined. 36 
hours post transfection the cells were washed in PBS and fixed for 5 mins at room 
temperature in 1 ml of a PBS solution containing 2% (v/v) formaldehyde and 0.2%
(v/v) gluteraldehyde. The fixing solution was aspirated off and replaced with 1 ml of a 
staining solution (PBS containing 5 mM potassium leiTocyanide, 5mM potassium 
feii'icyanide, 2mM M gC^ and 0.5 mg/ml of X-Gal in DMF) and incubated in the dark 
until the colour appeared. Typically the blue colour was visible to the naked eye after 2 
hours. The reaction was stopped by washing the monolayers in PBS and the percentage 
of transfected cells was determined by light microscopy.
5.12 Preparation of an Infected Cell Extract (ICE)
During the preparation of SV5 W3 virus stock (1,2.1), 4 confluent roller bottles of Vero 
cells were infected with virus. Once the medium containing the virus had been 
harvested, the infected cells were also harvested to prepare an infected cell extract (ICE) 
for western blot analysis. The migration of the viral polypeptides in a polyacrylamide 
gel acted as a control for the migration of those from recombinant proteins. The cells 
were harvested by the addition of 10 mis of ice-cold PBS to one roller bottle whereupon 
around 100 sterile glass beads were added and the bottle was shaken to dislodge the 
monolayer. Once dislodged, the PBS containing the cells was decanted into a 50 ml 
screw-capped tube and the cells were pelleted by centrifugation at 4,000 x g for 5 mins.
72
The supernatant was carefully poured off and the cell pellet was resuspended in 5 mis of 
SDS-lysis buffer (5.5) and sonicated with an ultrasonic probe for 30 secs at high power 
three times. The cell lysate was aliquotted in 1 ml amounts and stored at -20 "C. Before 
loading onto an SDS-polyacrylamide slab gel for electrophoresis and western blotting, 
the ICE was diluted 1/20 in SDS-lysis buffer, boiled and 10 jil was typically loaded 
onto a gel.
5.13 Capture Assays
5.13.1 Initial Capture Assay Protocol
To look at viral protein;protein interactions, a novel solid phase panning assay was 
developed by Dr.R.E. Randall. This involved flooding a 96 well microtitre plate with a 
0.2% (v/v) suspension of fixed and killed Staphylococcus aureus Cowan Strain A in 
PBS for at least 4 hours at 4 "C. The unbound material was removed by washing three 
times in PBS and the remaining S. aureus was cross-linked to the plastic by incubating 
in fixing solution (5.6) for 10 mins at RT. Once fixed, the plate was washed again 
whereupon 50 j.il of a 1/100 dilution (in PBS) of an appropriate mAb was added to each 
well and incubated for 2-3 hours at 4 "C with rocking. Unbound mAb was removed by 
washing three times in PBS and non-specific protein binding sites were blocked by 
flooding the plate with 10% (w/v) bovine serum albumin (in PBS) or Blotto (5.6) and 
incubating for 1 hour at 4 °C. The plate was again washed in PBS whereupon 100 jil of 
P or V containing cell extract (See below) per well was added and incubated for 1-2 
hours on a rocker at 4 °C. Unbound material was removed by washing the plate four 
times in PBS. To examine the binding of NP to captured P or V proteins, 100 jil of NP 
extract was added to the appropriate wells and bound for 1-2 hours at 4 °C on a rocker. 
Any unbound material was again removed by washing in PBS. Bound polypeptides 
were harvested by adding 30 ql of SDS-lysis buffer (5.5) per well. The plate was boiled 
for 5 mins and samples were loaded onto a 10% SDS-PAGE (5.5) for western blotting 
(5.6).
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5.13.2 Amended Capture Assay Protocol
The original capture assay protocol described formaldehyde cross-linking of the 
S.aureus to the microti ire plate followed by the addition of a mAb of interest. When the 
proteins on each well were analysed by western blot, the heavy and light chains of the 
immobilising antibody were visualised and sometimes obscured the the band of interest. 
To circumvent this problem, formaldehyde was used to cross-link the immobilising 
mAb to the S. aureus on the plate.
A 96 well plate was flooded and incubated with S.aureus as described above. The plate 
was washed and then 50 ql of a 1/100 dilution (in PBS) of an appropriate mAh was 
added per well. The plate was incubated at 4 °C for 2-3 hours on a rocker. Unbound 
mAb was removed by washing the plate in PBS whereupon the mAb was cross-linked 
to S.aureus by flooding the plate with fixing solution (5.7) for at least 3 hours at RT. 
Once fixed, tlie plate was washed in PBS and non-specific protein binding sites were 
blocked by the addition of Blotto (5.6) for 1 hour at RT. The plate was again washed 
three times in PBS before adding cell extracts as described in 5.11.1.
5.14 Preparation of cell extracts for capture assay
5.14,1 Preparation of extracts from cell lines inducibly expressing P or 
V proteins
BalbC cells which expressed P of V proteins were seeded onto five 150 mm diameter 
tissue culture dishes per cell line and grown to 60% confluency in GMEM+10% NBCS 
supplemented with geneticin and tetracycline (4.2). The P or V proteins were induced 
for 48 hours in the absence of tetracycline. Cells were harvested by scraping into 5 mis 
of ice-cold PBS per plate and pelleted by centrifugation at 4,000 x g for 5 mins in 50 ml 
screw-capped tubes. The supernatant was carefully poured off and the cell pellet was 
resuspended in 10 mis of PBS. Cells were stored at -70 °C in 1 ml aliquots until 
required. When required, cell extracts were thawed, sonicated for 30 secs and cell debris 
was pelleted by centrifugation at 14,000 rpm in a benchtop microfuge at 4 '^C for 15
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15 mins. The supernatant was decanted into a fresh tube and 100 ql of the P or V 
extract was used per well on a capture assay plate.
5.14.2 Preparation of extract from cell line inducibly expressing NP 
protein
BalbC cells were seeded, induced for 48 hours and haiwested as described in 5.12.1.
Cell extracts were made by sonicationg the thawed NP aliquot for 30 secs and spinning 
at 6,500 rpm on a benchtop microfuge for 10 mins. The supernatant was decanted into a 
fresh tube and called "Low Speed Supernatant" (LSS). The LSS was further 
fractionated by centrifugation at 400,000 x g i n  a Beckman benchtop ultracentrifuge. 
The supernatant was decanted and called "High Speed Supernatant" (HSS), and the 
pellet was resuspended in its original volume of PBS by sonication and was called 
"High Speed Pellet" (HSP). 100 ql of each extract was used per well on a capture assay 
plate.
5.14.3 Preparation of P-deietion mutant extracts from VacT7 infected 
cells
A 90 mm diameter tissue culture dish per construct was seeded with 293 cells and 
grown in GMEM+10% PCS until 80% confluent. The cells were infected with VacT7 
at a m.o.i. of 1 (1.3.3) and at 1 hour post-infection, were transfected (2.3.2) with 10 qg 
of pTM-P or the deletion mutant derivatives. Cells were harvested at 18 hours post­
infection by washing the monolayers in PBS and scraping into 10 mis of PBS per plate. 
The cells were gently pelleted by centrifugation at 4,000 x g for 5 mins and the pellets 
were resuspended in 1 ml of PBS. Cells were aliquotted in 100 ql amounts and stored at 
-70 °C until needed. When required, the aliquots were thawed, sonicated and 
centrifuged at 14,000 rpm in a cold benchtop microfuge for 15 mins. The supernatants 
were decanted and diluted 1/100 in PBS, 100 ql per well was added to to capture assay 
plates.
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5.14.4 Preparation of P extract from bacterial ceils
The pET (jilasmid for Expression by T7 polymerase) vector expression system, first 
developed by Studier and Moffat (1986), is one of the most effective ways of 
expressing high levels of protein in E.coli. Here pETl Ic was used as the vector into 
which both the P and V open reading frames were cloned. pETl Ic contains the la d  
gene encoding the Lac repressor which prevented expression of T7 RNA polymerase 
encoded by a 1  prophage in the bacterial genome. (Bacterial strain (3.7) used was 
BL21(DE3) ). Expression of T7 RNA polymerase was induced (or de-repressed) by the 
addition of isopropyl-p-D-thiogalactoside (IPTG) which inactivated the Lac repressor. 
The T7-RNA polymerase, in turn, bound to the T7 promoter and induced expression of 
the P or V proteins. Bacterial cells containing the pET-P plasmid were grown O/N from 
a single bacterial colony in 5 mis of LB (3.7) supplemented with 100 qg/ml of 
amplicillin. The O/N culture was used to seed 50 mis LB+Ampicillin (Amp) at a 1/100 
dilution and the culture was grown until the OD^oo was equal to 0.3. P protein was 
induced for 3 hours by the addition of IPTG to a final concentration of 1 mM. Cells 
were pelleted by centrifugation in 50 ml screw-capped tubes at 4,000 x g for 15 mins. 
The cell pellet was resuspended in 5 mis of PBS and aliquotted into 500 ql amounts to 
be stored at -70 until needed.
When needed, an aliquot was thawed and the cells lysed by the addition of 100 qg/ml 
lysozyme and incubated at RT for 5 mins. Then 500 ql of IP buffer (5.3) without SDS 
was added and lysate was sonicated at full power for 30 secs. Cell debris was pelleted 
by centrifugation at 400,000 x g in a benchtop ultracentrifuge (Beckman) at 4 °C for 30 
mins. The supernatant was decanted into a fresh tube, diluted 1/1000 in PBS and 100 ql 
was used per well on capture assay plates.
5.14.5 Preparation of V extract from bacterial cells.
Supernatant from bacterial cells expressing V protein were contaminated by a 
significant amount of P, which had to be removed before carrying out the capture assay. 
The V extract was prepared as described in 5.12.3 and the clarified supernatant was 
again diluted 1/1000 in PBS. To remove the contaminating P protein, the diluted extract
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was incubated with 500 ql of P specific mAb (SV5 P-e) bound to S.aut'eus. (1ml of a 
10% suspension of fixed and killed S.aureus Cowan strain A was incubated with 20 
mis of hybridoma cell tissue culture fluid containing expressed SV5 P-e for 1 hour on a 
tumbler. S.aureus-mAb complexes were pelleted by centrifugation at 4,000 x g for 5 
mins and pellet was gently resuspended in 20 mis of PBS. S.aureus-mAb complexes 
were pelleted again and resuspended in 500 ql of PBS and added to diluted V extract) 
for 1 hour on a tubler at 4 °C. The &awrgw^-mAb-P complexes were pelleted by 
centrifugation at 4,000 x g for 15 mins at 4 °C and the supernatant was carefully 
decanted into a fresh tube. 100 ql of this V extract was added per well of a capture 
assay plate.
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Chapter 3 : Results
The 'Results' chapter has been broken down into 3 main sections with appropriate 
introductions to each section. The first documents early attempts made to characterise 
conditions which supported the transcription and replication of a synthetic negative 
sense RNA mini-genome using reverse genetics techniques. The rationale for this 
approach is explained and the generation of the necessary components for the reverse 
genetics system described in detail. Section 2 utilises some of the clones constructed in 
Section 1 for the generation, isolation and characterisation of BalbC cell lines which 
inducibly express SV5 proteins. The cell lines had a dual purpose; to supply SV5 
proteins in trans for the rescue of synthetic mini-genomes (from Section I) and to 
examine viral protein iprotein interactions taking place within the replication complex. 
Immunofluorescence data are presented from tliese cell lines which suggest direct 
interactions between NP and both the P and V proteins. These interactions are examined 
more closely in Section 3 using a solid phase panning assay (Capture Assay) developed 
for this purpose and suggest possible roles for the protein interactions during virus 
replication.
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Appendix 1
The following constructs were made by Mr. B.L. Precious in this laboratory and used 
by me in the experiments described in this thesis.
1) Reverse genetics experiments
2) Expression of SV5 proteins
3) Generation of inducible cell lines
4) Bacterial expression of P and V
pUCSV5TKCAT 
pGEM-P, pGEM-V 
pM RllO/tTA, pTET-P, pTET-V 
pET-P, pET-V
The inducible cell lines expressing NP, P and V, NP+P and NP+V were isolated by Mr. 
D. Young in this laborotory and used by me in the experiments described in this thesis. 
(Note that a second, more stable NP+V cell line was isolated by me, as described 
herein.)
78a
1 Reverse Genetics of SV5
This section documents early attempts made to develop a defined system for the study 
of transcription / replication mechanisms of the Rubulavirtis, SV5, using reverse 
genetics techniques. This work was carried out as pai t of an ongoing project started in 
1991 by Mr. B. L. Precious in this lab and continued by me, in collaboration with 
Mr, Precious. Preceeding my arrival in the lab in 1992, Mr. Precious had constructed a 
cDNA clone encoding a genomic sense RNA analogue under the control of the 
bacteriophage T7 promoter. This clone was used by me in the rescue experiments 
presented in this section, and for completeness, details on the construction of this initial 
clone are included.
As discussed in the introduction, (Chapter 1, Section 2), viral RNA can only function as 
a template for tr anscription and / or replication when in a correctly assembled 
nucleocapsid structure. Therefore, five different approaches were taken which aimed to 
encapsidate our synthetic RNA transcript into a form recognisable to the viral 
polymerase complex. This first involved intracellular generation of the genome 
analogue in SV5 infected cells, where the encapsidation / replication proteins were 
supplied by the SV5 helper virus. In the second approach, the in vitro generated 
genome analogue was transfected into cells containing SV5 helper virus. In the next 
approach, the in vitiv  generated genome analogue was transfected into cells expressing 
plasmid-encoded proteins for encapsidation and transcription. The fourth approach 
involved the in vitro generation and subsequent transfection of a synthetic copyback 
defective interfering (DI; pan-handle) structure, into cells expressing the viral plasmid- 
encoded proteins. The fifth, and last, approach involved transfecting in vitro 
synthesised genome analogues into cell lines induced to express SV5 proteins (The 
latter is included in Section 2).
The results presented here demonstrate the problems faced in attempting to rescue 
mimi-genomes by supplying the proteins necessary for encapsidation, transcription and 
replication from SV5 helper virus or in trans from cDNA clones.
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cDNA clone containing 
CAT reporter gene 
under T7 control
TRANSFECTION
Proteins for encapsidation 
and transcription of synthetii 
RNAsupplied by SV5 helpCT 
virus
T7 polymerase 
supplied bt vTF7-3
Synthetic -VE sense CAT RNA
Encapsidation of CAT transcript
Transcription of synthetic RNA 
into mRNA
mRNA
Y Translation to CAT enzyme
CAT ENZYME
Enzyzme activity 
detected in CAT assay
Fig.l2:Transfection strategy for CAT rescue
Overview of transfection strategy for rescue o f synthetic CAT transcripts 
from cDNA clone. Transfected plasmid DNA contains the SV5 leader and 
trailer sequences flanking the CAT reporter gene under the control of the T7 
promoter. T7 polymerase supplied by recombinant vaccinia virus (vTF7-3) 
transcribes the synthetic negative sense CAT RNA. Proteins necessary for 
encapsidation and transcription of the synthetic transcript are supplied by SV5. 
The resultant mRNA is translated into CAT enzyme, the activity o f which is 
detected by CAT assay.
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1.1 Overview of mini-genome rescue system
1.1.1 Transfection strategy for CAT rescue system
The original strategy of amplification of a synthetic RNA was adapted from that of 
Luytjes et al (1989) where they expressed recombinant RNA from plasmid DNA. They 
replaced the coding sequence of the influenza A virus NS gene with the bacterial 
chloramphenicol acetyl-transferase (CAT) gene and genomic sense transcripts were 
generated which contained authentic terminal sequences from the influenza virus 
segment, flanking the CAT reporter gene. This transcript was encapsidated in vitro by 
purified virus NP and polymerase proteins (PA, PB 1 and PB2) and transfected into 
influenza virus infected cells. In the presence of the helper virus, the recombinant RNA 
was amplified, expressed and packaged into virus particles which could be passaged 
several times. This strategy was adapted for the SV5 system as shown in Fig. 12.
A plasmid was constructed which contained the SV5 leader and trailer sequences 
flanking 2 reporter genes all under the control of the bacteriophage T7 promoter (See 
Section 1.1.2 for details on construction). The reporter genes, thymidine kinase (TK) 
from heipes simplex virus and CAT, were separated by the intergenic region between 
the SV5 NP and P/V genes. It was hoped that analysis of the role(s) played by the 
intergenic regions in viral transcription / replication would be possible by comparing 
the relative activities of the two reporter genes. A recombinant vaccinia virus (vTF7-3), 
(Fuerst et al, 1986), was used to supply T7 DNA-dependent RNA polymerase which 
bound to the T7 promoter and generated a negative sense RNA transcript. The synthetic 
RNA transcript aimed to mimic the SV5 genome allowing encapsidation by SV5 
proteins into a synthetic nucleocapsid structure. It was hoped that the synthetic 
nucleocapsid would be recognised by the viral RNA-dependent RNA polymerase 
complex leading to synthesis of reporter gene mRNA. Once translated, CAT or TK 
enzyme activity could be detected in biochemical assays. (Note that the BHK cells used 
in these experiments had been treated with the thymidine analog 2'-bromo-deoxyuridine 
(BDU), (Sigma), to generate a TK-deficient cell line.
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1.1.2 Construction of a cDNA clone for CAT rescue
The rationale for the construction of the double reporter gene construct is outlined 
above and depicted in Fig. 13 which shows the relationship between the SV5 genome 
and the subsequent plasmid. As mentioned previously, it was constructed and 
generously provided by B.L. Precious from this lab. The NP and PA  ^genes of SV5 
were replaced by the TK and CAT reporter genes respectively, by a series of PCR 
reactions and cloning steps in the pUC19 cloning vector. The SV5 leader, trailer and 
intergenic sequences were amplified from viral RNA by reverse transcription / 
polymerase chain reaction (RT/PCR) amplification and verified by dideoxy-nucleotide 
sequencing (See Materials and Methods, Chapter 2, Section 3.13 and 3.14 for details on 
RT/PCR and Sections 3.15-3.17 for DNA sequencing). The CAT gene and T7 promoter 
were also PCR amplified but the TK gene was subcloned directly into pUC19 from 
pX l, a plasmid containing HSVl macroplaque TK. (pXl was kindly supplied by Dr. C. 
Preston, MRC Virology Unit, Church Street, Glasgow, UK). The resultant cDNA  
construct, pUCSV5TKCAT, gave rise to a negative sense RNA containing the SV5 
leader and trailer sequences flanking the TK and CAT genes which were separated by 
the NP-P/V intergenic region, all under the control of the T7 promoter. 
pUCSV5TKCAT was the initial clone used in the CAT rescue experiments and the 
negative sense RNA transcript obeyed the rule of six (Calain and Roux, 1993; Chapter 
1, Section 2.2.2).
1.1.3 Comparison of transfection methods by CAT assay
Before embarking on the CAT rescue experiments, a reliable method for DNA delivery 
had to be chosen. The efficiency of DNA delivery into Baby Hamster Kidney (BHK) 
cells was examined using three transfection methods, calcium phosphate, DEAE- 
Dextran and lipofection, as detailed in Material and Methods (Chapter 2, Section 2).
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TRAILER SEQLEADER SEQ
SV5 RNA 
GENOME
INTERGENIC REGIONS
TRAILER SEQLEADER SEQ
TK CAT
INTERGENIC REGION
-VE SENSE 
RNA
3'- TK —  CAT 5' T 7 cDNACONSTRUCT
(pUCTKNPCAT)
Fig. 13 ; Construction of pUCSVSTKCAT
Diagrammatic representation of the SV5 genome where the NP and P/V 
genes are represented as genes 1 and 2 respectively. The NP and P/V genes 
were replaced by the reporter genes thymidine kinase (TK) and 
chloramphenicol acetyl-transferase (CAT) respectively, to generate 
pUCSV5TKCAT which was subsequently used in CAT rescue experiments.
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The transfection efficiency using each method was determined by introducing 
pSV2CAT plasmid DNA encoding the CAT reporter gene under the control of the 
SV40 early promoter region (Gorman et al, 1982) into the cells and assaying for CAT 
expression. CAT enzyme inactivates chloramphenicol by the formation of mono- and 
diacetylated derivatives (Shaw, 1967) which can be easily separated by silica gel thin 
layer chromatography (Cohen et al, 1980). Fig. 14 demonstiated that little or no 
difference was found between the transfection methods at the 100 ng and 1 |ig level of 
input DNA. However, with calcium phosphate mediated transfection using HBS, CAT 
activity could be detected from 10 ng of input DNA and so this was deemed to be the 
most efficient method for DNA delivery (Compare Lane 5 with Lanes 2 ,8 ,11  and 14). 
The effect of transfection upon cell morphology was also noted, as future experiments 
were to involve transfecting virus infected cells and so the ’mildest’, or 'least toxic’ 
method was required. Although calcium phosphate mediated transfection using HBS 
was the most efficient transfection method for BHK cells, a cytopathic effect was 
observed. (Around 1% of the cells died and around 20% of the surviving cells had a 
round morphology.) This effect was seen with all the transfection methods except 
lipofection. Based on this observation, lipofection was used as the transfection method 
in future experiments since it gave a comparable level of transfection efficiency to the 
other methods tested but was much less toxic to the cells.
1.1.4 Monitoring transfection efficiencies by p-Galactosidase assay
Lipofection was the transfection method of choice but the commercially available 
Lipofectin ™  (Gibco-BRL) proved to be prohibitively expensive. Cationic liposomes, 
equivalent to Gibco-BRL TransfectACE were subsequently prepared in the lab by 
the method of Rose et al, 1991 and used in all transfection experiments (See Chapter 2, 
Section 2.3.1 for liposome preparation). Due to the potential liposome batch variability, 
the transfection efficiency of each new batch was tested by p-Galactosidase assay (See 
Chapter 2, Section 5.11 for details ).
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Fig.l4: Comparison of transfection methods by CAT assay
Different transfection methods were used to determine which gave the highest 
transfection efficiency for BHK cells as judged by CAT assay. 10 ng, 100 ng 
and 1 p,g of pSV2CAT was transfected using BBS (Lanes 2, 3 and 4 
respectively); HBS (Lanes 5, 6 and 7 ); Lipofectin (Lanes 8 ,9  and 10 ); Old 
DEAE-Dextran (Lanes 11,12 and 13 ) and New DEAE-Dextran (Lanes 14,
15 and 16). A 'No DNA' control was in Lane 1 illustrating the migration of 
-chloramphenicol. Lane 17 (control) contained 5 units of CAT enzyme 
illustrating the acetylated forms of ^"Hü-chloramphenicol. These are ( in order 
of increasing mobility) 1-acetate chloramphenicol, 3-acetate chloramphenicol 
and 1,3-diacetate chloramphenicol. Each of the transfection methods tested 
contained readily detectable amounts of CAT activity at the 100 ng and 1 p-g 
level of pSV2CAT input DNA. Only HBS-mediated transfection gave 
detectable amounts of CAT activity from 10 ng of input DNA.
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Fig. 15 shows an experiment where pPEpGal, a plasmid containing the (3-gaIactosidase 
gene under the control of the human cytomegalovirus (hCMV) immediate early 
promoter, was transfected into 293 cells with the cationic liposomes. Cells were then 
fixed and stained at 36 hours post-transfection. The cells which had been transfected, 
expressed active (3-galactosidase and therefore stained blue in the presence of the 
chromogenic substrate X-Gal. By counting the number of blue cells, a percentage of 
transfected cells was determined and was typically found to be around 20% when using 
293 cells. When comparing the transfection efficiency between cell types, BHK and 
BalbC cells were found to have a 40-fold lower transfection efficiency than 293 cells. 
This observation became important in future experiments.
1.2 Rescue of mini-genomes by SV5 helper virus
1.2^1 VacTT derived CAT activity from input pUCSVSTKCAT
The strategy described in 1.1.1 and depicted in Fig. 12 was used to rescue SV5-TK-CAT 
mRNA transcripts. It was known that an exact 3' genomic RNA end was necessary for 
encapsidation of a synthetic transcript (e.g. Park et aL 1991; Pattnaik et aL 1992), 
therefore pUCSV5TKCAT DNA was linearised by digestion with E arl restriction 
enzyme. Increasing amounts of the linearised DNA were subsequently transfected into 
BHK cells which had been infected with vTF7-3 (VacT7) to generate a negative sense 
RNA transcript (from the T7 transcription reaction) with an exact 3’ end of the SV5 
genome. These cells were also infected with SV5 to supply the proteins necessary for 
transcription and replication of the mini-genome.
No CAT activity was detectable in the test lanes containing linearised pUCSVSTKCAT 
(Fig. 16 Lanes 1-3). One reason which could account for this was found in a subsequent 
experiment which showed linearised plasmid DNA had very low transfection 
efficiency compared to uncut (circular) plasmid. (The transfection efficiency of BHK
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Fig. 15 : Transfection efficiency by B-Galactosidase assay
B-Galactosidase assays were used to monitor transfection efficiency of 293 
cells using each new batch of liposomes. Increasing amounts (0, lOng and 
100 ng) pf pPEBGai plasmid DNA was transfected into 293 cells. At 36 hours 
post-transfction the cells were fixed in a PBS solution contai ni n 2% (v/v) 
formaldehyde and 0.2% (v/v) gluteraldehyde for 5 mins. The cells which had 
been transfected, exhibited B-Galactosidase activity and therefore stained blue 
in the presence of the chromogenic substrate X-Gal. Panel A shows a negative 
control where no DNA had been transfected. 10 ng and 100 ng of DNA were added 
to Panels B and C respectively. Panels D is a x40 magnification of the cells 
transfected with 100 ng of DNA. (Panels A, B and C were x20 magnification).
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Fig.l6:Transfection of BHK cells with pUCSVSTKCAT after infection 
with VacTT and SYS.
BHK cells were transfected with 500 ng, 1 |ig and 2 }ig of linearised 
pUCSV5TKCAT after infection by both VacT7 and SV5 (Lanes 1, 2 and 3 
respectively). Lane 4 contains cells tranfected with 2 jig of linearised 
pUCSVSTKCAT after infection with VacT7 alone. Cells were transfected 
with 2 pg circular (uncut) pUCSV5TKCAT after infection with SV5 and 
VacT7 (Lane 5) or VacT7 alone (Lane 6). Lane 7 contains an extract of cells 
which were transfected with 100 ng of pSV2CAT control DNA and Lane 8 
contained 5 units of CAT enzyme control.
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cells using circular (uncui) plasmid DNA was found lo be around 1%, estimated by (3- 
Galactosidase staining, but this fell to less than 0.1% when the plasmid was lineaiised. 
(Data not shown). To increase the percentage of cells being transfected, circular (uncut) 
plasmid was used.
The necessity of the exact SV5 3' end of the synthetic RNA was examined by 
transfecting 2 pg circular (uncut) plasmid DNA into cells infected with both SV5 and 
VacT7 (Lane 5) or VacT7 alone (Lane 6). If the encapsidation process did not require 
an exact 3' end then encapsidation of the transcript would begin elsewhere resulting in a 
viable synthetic nucleocapsid, recognisable to the viral polymerase and could therefore 
give rise to CAT mRNA and CAT enzyme. CAT activity was detected at a veiy low 
level in the cell extracts in Lanes 5 and 6. This was a curious finding as Lane 6 had 
been designed as a negative control due to the absence of SV5 helper virus. Without 
helper virus, the synthetic transcript generated by VacT7 could not have been 
encapsidated by SV5 proteins to form a synthetic nucleocapsid which, in turn, could not 
have been transcribed by SV5 RNA-dependent RNA polymerase to CAT mRNA for 
translation. Since this low level CAT activity was found when pUCSVSTKCAT was 
transfected into VacT7 infected cells, with or without SV5, one explanation was that 
the vaccinia virus itself was transcribing CAT mRNA directly from the DNA template. 
Although an unexpected problem, it did demonstrate that pUCSVSTKCAT had the 
capability of giving rise to active CAT enzyme.
1.2.2 Construction of pUCSVSCAT
To simplify the system and increase the possibility of synthetic negative (-VE) sense 
CAT RNA being encapsidated and transcribed into CAT mRNA, a smaller construct 
was made. It was anticipated that once the system was established using the smaller 
CAT construct, the double reporter construct could again be used to analyse the role of 
the intergenic regions in modulating viral transcription.
Fig. 17 shows a schematic diagram of the construction of pUCSVSCAT from 
pUCSVSTKCAT. A fragment containing the TK gene, SV5 leader sequence (3' end),
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Fig.l7:Construction of pUCSVSCAT
To shorten the synthetic transcript being used in transfections and CAT assays, 
pUCSVSTKCAT was modified to pUCSVSCAT. The TK gene, flanked by 
SVS 3’ leader region and NP-P intergenic region, was excised by digesting 
with Sacl and Bstl 107 1 restriction enzymes. Bstl 107 cut between bases 23 
and 24 of CAT ORF. The SVS 3’ leader region was replaced by PCR 
amplification from pUCSVSTKCAT in which the forward primer included the 
first 64 bases of the 3' leader sequence and the reverse primer included the first 
34 bases of CAT ORF. The PCR product was also digested with Sacl and 
Bstl 107 1 and ligated to the digested vector to create pUCSVSCAT.
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NP-P iniergenic region and the first 34 bases of the CAT ORF was excised from 
pUCSVSTKCAT by digestion with Sacl and Bst 1107 1 restriction enzymes. This 
fragment was used as a PCR template to amplify the SV5 leader sequence. A forward 
primer was designed which included the first 64 bases of the SV5 leader sequence and a 
reverse primer was designed to include the first 34 bases of the CAT ORF. The 
resultant PCR product was digested with Sacl and Bst 1107 1, gel purified and ligated 
to the Sacl/Bst 1107 1 fragment from pUCSVSTKCAT which contained the CAT ORF 
and SVS trailer sequences. The resultant construct, pUCSVSCAT, was used in 
subsequent CAT rescue experiments. The negative sense RNA transcript from 
pUCSVSCAT containing the CAT gene flanked by SVS leader (le), and trailer (tr), 
sequences, is referred to as a 'le-CAT-tr' transcript.
1.2.3 Input DNA versus RNA from pUCSVSCAT
The strategy described previously (1.1.1) was used to rescue pUCSVSCAT mRNA 
from pUCSVSCAT DNA and the resultant CAT assay is shown in Fig. 18. Panel A 
contained extracts of BHK cells which had been infected with VacT7 and SVS, and 
transfected with increasing amounts of pUCSVSCAT DNA (Lanes 2, 3 and 4 
respectively) illustrating detectable CAT enzyme activity. Lane S contained a control 
where 2 |ig of pUCSVSCAT DNA was transfected into BHK cells infected with SVS 
alone and, as expected, shows no CAT activity. Without VacT7, there would be no -VE 
sense CAT RNA generated to encapsidate, and from which CAT mRNA could be 
transcribed. In Lane 6, however, the negative control had detectable CAT enzyme 
activity from cells transfected with 2 |ig of pUCSVSCAT DNA but infected with 
VacT7 alone. Therefore in the absence of SVS proteins, CAT enzyme was still 
generated demonstrating again that VacT7 had the ability to transciibe mRNA from the 
cDNA construct. This also confirmed that VacT? was responsible for the CAT activity 
seen in Lanes 2, 3 and 4.
In an attempt to circumvent the use of VacT7, pUCSVSCAT RNA was transfected in a 
parallel experiment. The pUCSVSCAT plasmid was linearised with Earl and used as 
the template for an in vitro T7 transcription reaction (See Materials and Methods, 
Chapter 2, Section 3.11 for details). The resultant negative sense RNA transcript was
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Fig.l8:Transfection of pUCSVSCAT DNA or RNA into BHK TK(-) Cells
In Panel A, 500 ng, 1 |ig or 2 |ig of pUCSVSCAT DNA was transfected into 
BHK TK(-) cells ^ter infection with SVS and VacT7 (Panel A; Lanes 2, 3 and 
4 respectively). Lanes 5 and 6 contained extracts from cells which had been 
transfected with 2 fig of pUCSVSCAT DNA after infection with SVS alone 
(Lane 5) or VacT7 alone (Lane 6 ). Lane 1 represents a 'No DNA' control and 
Lane 7 represents a background control.
In Panel B, SOO ng, 1 fig  or 2 fig  of pUCSVSCAT RNA was transfected into 
BHK TK(-) cells after infection with SVS alone. (Panel B; Lanes 2, 3 and 4 
respectively). 2 fig  of pUCSVSCAT RNA was transfected into naive BHK 
TK(-) cells (Panel B; Lane S) and Lane 1 represents a 'No RNA' control. Lane 
6 contained an extract from cells which had been transfected with 100 ng of 
pSV2CAT control DNA and Lane 8 contained S units of CAT enzyme control.
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Lransi'ected into BHK cells which had been infected with SV5 (Panel B; Lanes 2, 3 and
4), but no CAT activity could be detected (Panel B; Lanes 1 to 5). Lane 6 contained a 
transfection control demonstrating that the cells had been successfully transfected. 
Although successful with other similar systems (Luytjes et al (1989),.Collins et al 
(1991), Park et aL {1991), Pattniak et al. (1992) ), the rescue of CAT from 
pUCSVSTKCAT and pUCSVSCAT was unsuccessful using SVS alone to supply the 
proteins necessary for encapsidation and transcription of the synthetic transciipt. The 
reason for this is, undoubtedly, multifactorial but one explanation could be due to the 
synthetic transcript being in direct, and very unfavourable competition with nascent 
virus genomes and anti-genomes for encapsidation and replication. To overcome this 
potential problem, the transfection rationale was changed so that SVS proteins would be 
generated from cDNA clones and supplied in trans, which would remove the necessity 
for SVS helper virus.
1.3 Cloning of SV5 NP, P, V and L
An overview of the amended transfection rationale is given in Fig. 19, where the 
proteins thought necessary for encapsidation and subsequent transcription of a synthetic 
negative sense CAT RNA were to be supplied in trans from cDNA clones of the 
respective genes. The results presented in this section document the construction of an 
NP clone in the pGEM3Zf(+) vector (Promega), which contained a T7 promoter 
upstream of the multiple cloning site, facilitating NP protein expression from the 
VacT7 system.
1.3.1 Construction and expression of pGEM-BLNP
pBR322NP (Paterson et aL 1984), was generously provided by Prof. R. A. Lamb 
(Northwestern University, Evanston, Illinois, USA), where the NP gene had been 
cloned into the p-lactamase gene of the vector pBR322. This plasmid was used as the 
template for amplification of the NP ORF by PCR as outlined in Fig.20. (The forward
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Fig.l9:Amended transfection strategy for CAT rescue
Overview o f amended transfection strategy for rescue o f synthetic CAT 
transcripts. Negative sense CAT RNA was generated in an in vitro T7 
transcription reaction from linearised pUCSVSCAT and transfected into cells. 
Proteins necessary for encapsidation and transcription o f the synthetic CAT 
transcript wa*e supplied by transfecting plasmids encoding SVS NP, P, V 
and L genes under the control o f the T7 promoter. After encapsidation (formation 
of a synthetic nucleocapsid) CAT mRNA was to be generated by viral 
polymerase (P/L) supplied in trans, and subsequently translated into CAT 
enzyme for detection by CAT assay.
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PCR primer contained the first 21 bases of the NP ORF and encoded the recognition 
sequence for the restriction enzyme BamHl. The reverse primer contained the last 24 
bases of the NP ORF and the recognition sequence for the restriction enzyme Hindi 11.) 
Once the NP gene was amplified, the PCR product was digested with BamHl and 
Hindi 11 restriction enzymes and run on a 1% agarose gel for band purification. (See 
Materials and Methods, Chapter 2, Section 3.5) The purified NP ORF was ligated to the 
BamHl /  Hindi 11 sites of pGEM3Zf(+) which had been digested and purified in 
parallel to the NP ORF. The resultant construct was called pGEM-BLNP.
It should be added here that there were veiy few transformants from this ligation step 
which was repeated many times before 4 clones were generated. These transformants 
grew very slowly on agar plates and in liquid culture, and gave poor plasmid yield if  
grown for less than 48 hours.
Expression of NP protein from pGEM-BLNP was tested by transfecting 4 clones into 
293 cells infected with VacT7. (Note that 293 cells were used here, as the transfection 
efficiency of this cell line had been shown to be much higher than BHK cells.) At 18 
hours post-infection cells were harvested for western blot analysis shown in Fig.21. 
Lanes 1 ,2 , 3 and 4 contained the pGEM-BLNP clones and aU expressed a truncated NP 
protein of around the same size as SV5 P protein (Compare Lanes 1-4 with ICE). Lanes 
5 and 6 contained negative controls of extracts from 293 cells infected with VacTT 
(Lane 5), or naive 293 cells (Lane 6), demonstrating that the major band in each lane 
which ran with approximately the same mobility as NP was due to a non-specific cross­
reaction of the mAbs with host cell protein. However, there did seem to be some low 
level expression of full-length NP from the clone in Lane 3. This clone also produced a 
protein of around the same mobility as P protein, (43 kDa), suggesting that there may 
have been some internal initiation of translation. It was calculated that if the ninth AUG 
codon was used as the initiation codon, then a protein of 42 kDa would be generated. 
The small amount of full-length NP being generated could be explained by there being 
a low frequency of correct initiation at the first AUG. A second explanation for the 
generation of a truncated NP protein from pGEM-BLNP was much simpler. If the clone 
contained a mutation which led to a premature termination codon, then a tinncated
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protein would be inevitable. To distinguish between tliese possibilities, the entire NP 
ORF was sequenced.
1.3.2 Sequencing of pGEM-BLNP
The NP ORF was sequenced and apait from 2 silent mutations at positions 732 and 
1074 of NP ORF (both C-T transitions), the NP sequence was found to be identical to 
that published by Parks et al, (1992), until base 1232 of the ORF. Fig.22 shows that 
after base 1232 of the NP ORF, there were a number of C residues followed by an anti­
sense sequence from the p-lactamase gene. The original template used to PCR amplify 
the NP ORF was pBR322NP (Paterson et al, 1984), in which the NP gene had been 
cloned into the p-lactamase gene of pBR322. The reason for amplification of P- 
lactaniase sequence as part of the NP ORF remains unclear. When initially amplified, 
the resultant PCR product was the expected molecular weight of the entire NP ORF and 
no complementary region to the NP reverse primer was found whilst sequencing this 
clone. Due to the difficulty in initially generating this clone and that 1232 nucleotides 
(from a total of 1532) had been sequenced demonstratmg no coding changes to the 
published sequence, it was clear that a C-terrainal repair of the existing clone was more 
appropriate than the generation of an entirely new NP clone.
1.3.3 Carboxy-terminal repair of pGEM-BLNP
A schematic diagram of the cloning strategy employed to repair the carboxy-terminus 
of NP is shown in Fig.23. The NP ORF was amplified by RT/PCR from NP mRNA in 
total RNA prepared from SV5 infected Yero cells using the same oligonucleotide 
primers used in the amplification from pBR322NP. The resultant PCR product was 
digested with Muni and Hindi 11 restriction enzymes. The C-terminal Muni-Hindi 11 
fragment (450 base pairs) was purified from tlie rest of the NP ORF by running on a 1%
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Fig.21 lExpression of NP protein from pGEM vectors
293 cells were infected with VacT7 and transfected with NP clones and protein 
expression was analysed by western blot. 293 cells were plated in 6 well 
dishes and infected with VacT7 at m.o.i. of 1. At 1 hour post-infection, cells 
were transfected with 1 pg of DNA from 4 pGEM-BLNP clones and harvested 
18 hours post infection for analysis by western blot. Lanes I, 2, 3 and 4 show 
the expression from the pGEM-BLNP clones. Lane 5 and 6 were negative 
controls containing cell extracts from unnansfected VacT7 infected 293 cells 
and uninfected 293 cells respectively. An SV5 infected cell extract (ICE) 
indicated the migration of the polypeptides in the polyacrylamide gel. NP 
protein was detected on the western blot with the polyclonal anti-NP antibody 
while the P and V proteins were detected with the mAh SV5-P-k. Bound 
antibodies were detected in an ECL reaction using HRP-conjugated sheep anti­
mouse Is.
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Fig.22: Sequencing of pGEMBLNP
Sequence of pGEMBLNP is shown to base 1232 of NP ORF. A stretch of C 
residues indicate the end of NP sequence and the beginning of the p- 
Lactamase gene sequence corresponding to base 1617 on the anti-parallel 
strand of pGEM3Zf(4-).
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Flg.23 : C-terminal repair of pGEMBLNP
The C-terminus o f the NP clone was found to be incomplete and needed 
to be replaced. The whole of the NP ORF was amplified from viral mRNA 
from SV5 infected Vero cells in an RT/PCR reaction. Both pGEMBLNP and 
the resultant cDNA encoding the NP ORF were digested with Muni and Hindlll 
and ligated together to form pGEMBLNP(Repaired).
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agarose gel and excising the band of interest for gel purification, pGEM-BLNP was 
also digested with Muni and Hind 111 and purified away from the small C-terminal 
fragment as above. The C-terminus generated by PCR, was ligated to pGEM-BLNP and 
and the resultant plasmid was called pGEM-BLNP(Repaired). The clone was sequenced 
and it was confirmed that no point mutations in the new C-teiminus had been 
introduced by PCR. Fig.24 shows the sequence from pGEM-BLNP(repaired) using an 
oligonucleotide primer which bound at bases 1015-1029 of NP ORF. The sequence 
shown corresponds to bases 1119 -1260 of the NP ORF and covers the region where the 
stretch of C residues (position 1232) led into the P-lactamase gene before the repair. 
Protein expression from the repaired clone was then examined.
1.3.4 Increase in NP expression after the addition of the p-Globin 
leader sequence
During the initial expression of the NP clones in in vitf'o transcription /  translation 
reactions, it was noted that protein expression levels were low (Data not shown). 
Analysis of in vitro synthesised proteins is frequently hampered by inefficient 
translation, especially of large proteins. It had been demonstiated that replacement of 
the GC-rich leader of human serum response factor (SRF) by an in frame fusion to the 
human p-globin leader sequence including the AUG initiation codon, strongly 
stimulated translation in a reticulocyte lysate (Norman et al, 1988). This observation 
was expanded to show that the region homologous to the 5' end of the rabbit P-globin 
RNA, but lacking the initiation AUG, could enhance translation efficiencies in both 
rabbit reticulocyte lysates and in wheatgerm extracts (Annweiler et at, 1991).
In an attempt to increase the amount of NP expressed from pGEM-BLNP, the rabbit p- 
globin leader sequence was added as shown in Fig.25. Complementaiy oligonucleotide 
primers were designed which encoded the entire rabbit P-globin leader sequence, the 
first 30 bases of the NP ORF and restriction enzyme recognition sequences for EcoRl 
(foi'wai'd primer) and N del (reverse primer). Tliese primers were used to amplify the p- 
globin leader region by PCR in a 'primer dimer' reaction due to complementarity of the
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Fig.24: Sequencing of pGEMBLNP-end repaired
Sequence from bases 1120-1260 of NP ORF from C-terminally repaired 
pGEMBLNP. Arrow indicates bases 1232 onwards where p-lactamase 
sequence was replaced by new NP C-terminal region.
102
f3 Globin Forward primer + EcoRl restriction site 5’ TACATA GAA TTC ACA CTT GCT TTT GAC ACA ACT GTG 
ITT ACT TGC AAT CCC CCA AAA CAO ACA QAA 3'
P Globin Reverse primer + Ndel restriction site
3'ooT nnr o t c  t o t  c t t  a c  a  g t a  g g c  a c g  a a t  t t c  g taTACTCGCTATCA 5'
PCR ‘Primer dimers 
to form pGlobin start
EcoRl pGlobm leader
EcoRl
H iodlllBamHl
I
mm
NPORF
IN pGEMBLNP
Fig.25:Construction of pGEMpGlobinNP
To ensure translational initiation at the first AUG of the NP ORF, the rabbit 
pGlobin untranslated leader region was added to the start of the NP ORF of 
pGEMBLNP. The pGlobin leader region was amplified by using 
complementatry primers encoding the entire region including the first 30 bases 
of the NP ORF in PCR 'primer dimer' reaction. Complementary regions of the 
primers are outlined, restriction enzyme sites are in bold and sequence in the 
NP ORF is underlined. The resultant PCR product and pGEMBLNP were 
digested with EcoRl and Ndel and ligated together to form pGEMPGlobinNP.
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primers. The resultant PCR product, along with pGEM-BLNP, were digested with 
EcoRl and N del. (Note that the cloning procedure took advantage of a unique Ndel 
site at base number 30 of the NP ORF allowing fusion of the P-globin leader region to 
the initiating ATG of the NP ORF.) Once digested, DNA fragments were separated by 
running on a 1% agarose gel whereupon the bands of interest were excised, purified and 
ligated. The resultant plasmid was called pGEM- polobinNP and NP expression from 
this clone was analysed by in vitro transcription/translation (See Materials and 
Methods, Chapter 2, Section 5.3 for details).
pGEM-PGlobinNP was lineaiised by digestion with Hindi 11 restriction enzyme and 1 
jig of linearised plasmid was used as the template for in vitro transcription/translation. 
An mRNA transcript was first generated by T7 DNA-dependent RNA polymerase and 
subsequently translated by rabbit reticulocyte lysate which utilised ^^S- methionine to 
generate radiolabelled translation products which were separated by SDS-PAGE. The 
gel was dried and put against X-ray film for autoradiography. Fig.26 Lane 3, 
demonstrated that the migration of the truncated NP protein before C-terminal repair, 
was slightly higher than that of the P protein (Lane 4), but after C-terminal repair 
pGEM-BLNP(Repaired) expressed full length NP (Lane 2). The effect on translation of 
the P-globin enhancer region was seen in Lane 1 which contained pGEM-pGlobinNP 
and demonstrated an increased level of translated product compared to pGEM-BLNP 
(Lane 2). Therefore, pGEM-PGlobinNP was used in all future experiments and was 
used as the parental plasmid for all future cloning steps.
1.3.5 Cloning of other SV5 proteins
As part of the reverse genetics project, the cloning of the SV5 genes was carried out in 
collaboration with Mr*. B.L. Precious who constructed and generously provided pGEM- 
P and pGEM-V where the P and V ORFs had been cloned into pGEM3Zf(+). Once 
constructed, pGEM-P and pGEM-V ORFs were completely sequenced by me. Two 
changes to the published sequence of Thomas et aU (1988) were found in the P ORF 
(A-C substitution at position 207 of ORF, and A-G substitution at position 993 of
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Fig.26:Expression of NP protein after C-terminal repair and addition 
of pGlobin leader sequence
NP protein expression from pGEM vectors was analysed by in vitro 
transcription/translation after C-terminal repair and addition of the pGlobin 
leader sequence. 1 jig of linearized plasmid DNA was used as the template for 
methionine labelled in vitro transcription / translation reactions. From a 25 
|il reaction, 5 pi was added to 15 pi lysis buffer, boiled and 10 pi (equivalent 
of 10% of translation mix) loaded on a 10 % gel for elecU'ophoresis. Gel was 
dried and put against film for autoradiography. Lanes 1 and 2 show full length 
NP expressed from pGEMpGlobinNP and pGEMBLNP after C-terminal 
repair. Lane 3 shows NP expression from pGEMBLNP before the C-terminal 
repair. A comparison of Lanes 1 and 2 demonstrates the effect of the PGlobin 
enhancer region on NP expression levels from pGEMpGlobinNP and 
pGEMBLNP respectively.
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ORF), neither of which led to an amino acid change. One change from the published 
sequence was found in the V ORF (A-G substitution at position 466 of ORF) which led 
to a change in amino acid number 156 from a Serine to a Glycine residue (AGT (Ser)- 
GGT (Gly)).
Although many attempts at constructing a pGEM-L clone were made, a full length 
clone proved elusive and therefore the clone pGEM3-L was kindly provided by Prof. 
R.A. Lamb (Northwestern University, Evanston, Illinois, USA). The construction of the 
L clone into pGEM3 (Promega) is documented in Parks et aL (1992), where 2 
independent clones were completely sequenced without finding an amino-acid 
difference. However, duiing the course of the rescue expeiiments, there remained a 
doubt over the ability of the polymerase clone to generate mRNA since at the time 
these experiments were carried out, the L clone had not been shown to be functional.
1.4 Addition of SV5 proteins in trans
The pGEM constructs containing the SV5 genes to be used for CAT rescue were found 
to be incompatible for co-transfection experiments. This was due to NP, P and V having 
been cloned into pGEM3Zf(+) vector, whereas L (having been supplied by Prof. R.A. 
Lamb), had been cloned into the pGEM3 vector. The fundamental difference between 
vectors was the orientation of the T7 promoter with respect to the multiple cloning 
sites. The position of the T7 promoter in pGEM3Zf(+) gave rise to a "clockwise" 
mRNA species whereas pGEM3 gave rise to an "anti-clockwise" mRNA species. Since 
this was the only difference between the vectors, mRNAs generated from co-transfected 
vectors had complementary mRNA tails which could inhibit translation. This was 
overcome by subcloning the individual genes into another vector which gave rise to 
mRNA transcription in one direction. The vector system chosen also increased protein 
production from the VacT7 system.
1Ü6
1.4.1 Cloning of SV5 genes in pTM-1
Recombinant vaccinia vims (VacT7), as with all poxvimses, encodes its own capping, 
methylating and polyadenylating enzymes, so it was anticipated that that the transcripts 
made by the T7 polymerase would be properly modified for stability and translation. 
Fuerst and Moss (1989) found that although the amounts of RNA generated by VacTT 
were very high, (30% of total RNA in the cytoplasm), analysis of the RNA indicated 
that only 5% was capped and methylated. Since the cap structure is required for 
efficient translation in eukaryotic cells, only moderate levels of protein synthesis were 
achieved: Moss et al (1990) utilised the untranslated region of the picomavims, 
encephalomyocarditis virus (EMCV), to generate T7 transcripts which were cap- 
independent for translation. Unlike cellular mRNA or mRNA from other viruses, 
picomavims RNAs do not contain cap-stmctures but instead, have a long untranslated 
region (UTR) that facilitates ribosome binding (Jang et at, 1988). Elroy-Stein et at 
(1989) placed the EMCV UTR just downstream of the T7 promoter and fbtmd protein 
expression levels increased 5-10 fold.
The plasmid pTM-1 was constructed by Moss et al (1990) to express genes under the 
control of the T7 promoter / EMCV UTR. The gene of interest was inserted into the 
multiple cloning site such that the N col site provided the translation initiation codon. 
This plasmid was utilised to increase the level of NP, P and V being expressed in the 
VacTT system for CAT rescue. The SV5 P and V genes were sub-cloned from pGEM-P 
and pGEM-V as outlined in Fig.2T. Both pGEM-P and pGEM-V had been generated by 
RT/PCR using the same oligonucleotide primers. The design of the forward primer 
fortuitously created a N col site at the initiating ATG of each ORF allowing direct sub­
cloning into pTM-1. Both parental plasmids (pGEM-P and pGEM-V) were digested 
with N col and Sail restriction enzymes. The P and V ORFs were separated from the 
parental vector by mnning on a 1% agarose gel and excising the bands of interest for 
purification. The recipient vector, pTMl, was digested with N col and Xhol restriction 
enzymes, purified as before, and ligated to either P or V ORFs. (Note that Sail and 
X hol digested DNA have compatible ends which ligate to form a Taql restriction site.) 
The resultant plasmids were called pTM-P and pTM-V respectively. Similarly, a pTM
lOT
pGEMP/V(44kb)
PUCIS
pGEMP and pGEMV digested with Nool and Sail
pTMl digested with Ncol and 
Xhol
(6504)
■pUCI*
pTMl 
(5357 W)
Fig^7:Construction of pTM-P and pTM-V
To increase the translation properties of T7 transcripts, the SV5 P and V ORFs 
were cloned into pTMl which adds the EMCV UTR at the initiating AUG. 
pGEM-P and pGEM-V(represented as pGEM P/V) were digested with N col 
and Sail restriction enzymes to isolate the P and V ORFs and ligate them into 
pTMl which had been digested with N col and X hol. The restriction enzymes 
Sail and Xhol have compatible ends which ligate together to form a Taql site. 
The resultant plasmids were called pTM-P and pTM-V (represented as pTM- 
P/V)
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clone expressing NP was obtained but a full length pTM-L clone proved elusive and so 
the pGEM-L clone (compatible with the pTM system) was used.
1*4.2 Co-transfection of NP, P, V and L
Fig.28 shows the expression of NP, P, V and L (from pTM-NP, pTM-P, pTM-V and 
pGEM-L) in 293 cells infected with VacT7 and immunoprecipitated (See Materials and 
Methods, Chapter 2, Section 5.4 for details) with mAbs SV5 P-k (P and V proteins), 
SV5 NPa (NP protein) ^ d  anti-L (N-teiminal) peptide serum. Labelled polypeptides 
were separated by elecrophoresis through a 10% SDS-polyacrylamide slab gel which 
was subsequently dried and put against X-ray film for autoradiography.
Lanes 2 ,3 ,4  and 5 show NP, P, V and L expression from their respective cDNA  
constructs. Lane 6 demonstrated NP+P co-expression from co-transfection o f pTM-P 
and pTM-NP. However, when NP+P+V were cotransfected, there was a decrease in the 
amount of NP and P expressed, and the V protein itself was not detected (Compare 
Lanes 6 and 7). This observation was repeated in Lane 8 where NP+P+V+L were 
cotransfected. L was expressed at similar levels when co-expressed as it had been when 
expressed alone (Lanes 5 and 8), but levels of NP and P were still decreased (Compare 
lanes 6 with Lanes 7 and 8) and V was again not detected.
This result, although somewhat curious, was reproducible. Therefore, the experiment 
was repeated and the (unlabelled) immunoprecipitated samples were analysed by 
western blot to increase sensitivity of detection (Fig.29). NP, P, V and L were 
expressed alone in Lanes 4 ,5 , 6 and 7 respectively. (Note that anti-L peptide serum 
worked extremely poorly in western blot and so was omitted from the detection step. L 
was therefore not detected in this figure and so Lane 7 merely shows sample spilled 
from Lane 8.) This experiment showed that V was indeed being made when co­
expressed with NP and P but to a lesser degree than when expressed alone. The 
decrease in NP and P expression on the addition of V was again seen (Compare Lane 8 
with Lanes 11 and 12) suggesting that V may have been having a negative effect on the 
ability of the
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Fig.28:Transient SV5 protein expression in VacTT system
IP demonstrating co-expression of SV5 proteins from co-transfection of pTM- 
NP, pTM-P, pTM-V and pGEM-L in 293 cells infected with VacT7. 1 pg of 
each plasmid DNA was transfected into 293 cells either singly or in 
combination 1 hour post VacTT infection. Cells were labelled with 
methionine (17 hours post VacTT infection) for 1 hour prior to 
immunoprécipitation. Extracts were precipitated with mAbs SV5-NPa, SV5- 
Pk (for both P and V proteins) and anti-L (N-terminal) peptide antiserum. 
Samples were loaded onto 10% polyacrylamide gel for electrophoresis.and 
subsequently dried and put against film for autoradiography. Lanes 2, 3, 4 and 
5 represent NP, P, V and L expressed alone. Lane 6 ,7  and 8 represent 
NP+P+V, NP+P and NP+P+V+L respectively. Lane 1 was a negative control 
of VacTT infected cell extract which was incubated with a pool of the 
antibodies mentioned above.
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Fig.29:Western Blot of SV5 protein co-expression
Western blot ot' immunoprecipitated SV5 proteins in co-expression experiment 
trom co-transfected 293 cells. Repeat of transfection shown in Fig.28, where 
samples were immunoprecipitated and western blotted. Lanes 4. 5, 6 and 7 
represent NP, P, V and L expression from pTM-NP, pTM-P, pTM-V and 
pGEM-L respectively. NP+P were co-expressed in Lane 8, NP+V in Lane 9, 
NP+L in Lane 10, NP+P+V in Lane 11 and NP+P+V+L in Lane 12. Negative 
controls were run in Lanes 1, 2 and 3 from uninfected 293cells, VacT7 
infected 293 cells and VacTT infected 293 cells and transfected with pTMl 
vector respectively. The polypeptides were detected with mAbs SV5-NP-d, 
and SV5-P-k (which detects both P and V proteins). Bound antibody was 
detected in an ECL reaction using HRP-conjugated sheep anti-mouse Ig.
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proteins to be immunoprecipitated. These findings were not examined more closely at 
this stage. Co-expression of NP, P, V and L had been demonstrated in the VacTT 
system but functionality of the recombinant proteins had not been examined. This was 
tested by their ability to encapsidate and transcribe pUCSV5CAT negative sense RNA 
into inRNA.
1.4.3 Construction of pPanHan for rescue
SV5 proteins necessary for encapsidation and transcription of le-CAT-tr RNA were 
supplied in trcms from co-transfection of pTM-NP, pTM-P, pTM-V and pGEM-L into 
VacTT infected 293 cells as demonstrated in Section 1.4.2. The le-CAT-tr RNA was 
generated by an in vitro TT transcription reaction from pUCSVSCAT linearised by 
digestion with Earl (as in Section 1.2.3). No CAT activity was detected in attempts to 
rescue CAT mRNA from input le-CAT-tr RNA (Data not shown).
The focus of the rescue project was then transferred to the laboratory of Prof. R. A. 
Lamb, Northwestern University, Evanston, Illinois, USA, where, in collaboration with 
Prof. Lamb and Dr. Carol Ward, a fresh approach was taken. Dr. Ward had performed 
experiments similar to those described above, independently to me, and also without 
success. In discussion with both Dr. Ward and Prof. Lamb, it was agreed that a 'pan­
handle' construct should be constructed to aid transciption initiation of the genome 
analogue.
It had been reported that initiation of influenza virus transciiption from genomic RNA 
relied on the formation of panhandle structures from the the 3' and 5' terminal 
nucleotides of virion RNA segments (Fodor et a i  (1994), Pritlove et al, (1995) ). The 
"panhandle" or "fork" regions were shown to contain highly conserved non-coding 
nucleotides which were important for the transcriptional activity of the viral 
polymerase. This strategy was employed for CAT rescue by generating a cDNA 
construct which would give rise to a CAT RNA species with complementary 3' and 5' 
termini which formed pan-handle structures. Fig.30 shows a schematic diagram of the 
construction of cDNA clone encoding such a panhandle, pPanHan. This was
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Fig30:Construction of pPanHan
To increase potential for replication of the synthetic CAT transcript, 
modifications were made to the cDNA clone resulting in a pan-handle 
structure for the synthetic transcript. pT7.1 tr-TAC-le contsruct (provided by 
Dr. C. Ward, Northwestern University, Illinois, USA) was used as a PGR 
template to amplify the SV5 trailer region. The primers used encoded H indi 11 
and Sail restriction enzyme sites which allowed the PGR product to replace 
the leader region from pT7.1. Both the PGR product and pT7.1 were digested 
with Hindi 11 and Sail, ligated together and the resultant plasmid was called 
pPanHan.
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construcied from pT7.1. a le-CAT-tr construct provided by Dr. Ward which also obeyed 
the rule of six (Chapter I. Section 2.2.2). Oligonucleotide primers were designed to 
amplify the SV5 trailer region by PCR. The primers used contained H indi 11 and Sail 
restriction enzyme sites which allowed the PCR product to replace the existing leader 
sequence in pT7.1. Following digestion of both the PCR product and pT7.1 with 
H indi 11 and Sail restriction enzymes, fragments were separated by running on a 1% 
agarose gel, excised and purified. The fragments were then ligated together and the 
resultant plasmid was called pPanHan.
In Fig.31, large scale lithium chloride DNA preparations (See Materials and Methods 
Chapter 2, Section 3.1 for details), of four pPaiiHan clones were digested with H indi 11 
and Sail restriction enzymes to confirm the leader sequence (le) had been replaced by 
the trailer sequence (tr). Due to the small sizes of the le (89 base pairs) and tr (47 base 
pairs) regions, digests, including one of the parental pT7.1 digested in parallel, were run 
on an 8 % polyacrylamide slab gel and stained with ethidium bromide. Lane 6  contained 
the parental pT7.1 plasmid digest where the 89 base pair le sequence was visible. Lanes 
2, 3 and 5 clearly showed a 47 base pair fragment had been excised from clones 1, 2 
and 4 indicating the tr region had indeed replaced the le region. Lane 4 showed that the 
remaining clone was a religated plasmid which did not contain either the original le or 
the new tr region. Clone 1 (Lane2) seemed also to have a slight band corresponding the 
original parental le as well as the newly added tr and so was discarded. Clone 4 (Lane 
5) was chosen as pPanHan and sequenced, confirming no PCR errors had been 
introduced.
pPanHan was linearised by digestion with Sail and used as a template for the 
generation of negative sense tr-CAT-tr RNA by in vitro transcription. The tr-CAT-tr 
RNA was transfected into 293 cells along with plasmids encoding the SV5 proteins 
necessary for encapsidation and transcription of the synthetic RNA and assayed for 
CAT activity as before. No CAT activity was detected using pPanHan, pT7.1 or 
pUCSV5CAT RNA as the input RNA for these assays.
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Fig.31 :Digestion of pPANHAN constructs
Diagnostic restricion digests to confirm construction of pPANHAN before 
sequencing. DNA from clones 1-4 were prepared by the LiCl method and 
digested with Hindi 1 and Sail restriction enzymes (Lanes 2-5 respectively) 
Lane 6  contained parental pT7.1 DNA digested with the same enzymes. Lane 
1 contained H infl digested pM45 as a molecular weight ladder. All samples 
were run on an 8 % acrylamide gel and stained with ethidium brimide. SV5 le 
(89 bases) and tr (47 bases) are indicated.
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Although levels of SV5 proteins expressed by the VacT7 system were manipulated to 
mimic molar ratios of proteins seen in an SV5 infection, no effect was seen in the 
results of the CAT rescue expeiimenis which all showed no detectable CAT enzyme 
activity. Supplying the SV5 proteins by SV5 infection or in trans from cDNA clones 
driven by VacT7, proved unsuccessful in attempts to rescue CAT mRNA transcripts. In 
parallel to the CAT enzyme assays, cell extracts from the transfected cells were 
subjected to Northern Blot analysis which also failed to detect CAT mRNA (Data not 
shown). One possible explanation could have been that the template RNA had not been 
successfully transfected into the 293 cells. However, in control experiments, in vitro 
transcribed luciferase mRNA was successfully transfected as judged by the detection of 
luciferase enzyme activity 18 hours post-transfection (Data not shown). This indicated 
that the transfection method used (cationic liposomes) was also a successful RNA 
delivery system.
There could be two possible explanations for the failure of the le-CAT-tr rescue system. 
Firstly, the SV5 proteins may have failed to encapsidate the transfected RNA. If 
nascent vRNA (genomic and antigenomic) is nonnally held in a conformation 
favourable for initiation of encapsidation, maybe such a confoimation was not achieved 
by the synthetic transcript. Secondly, the synthetic transcript may have been 
encapsidated, but perhaps failed to generate a synthetic nucleocapsid stmcture which 
was recognisable to the viral polymerase. At the lime of these studies, functional 
analyses of the cloned viral polymerase had yet to be performed so even if the synthetic 
transcript had been encapsidated and formed a synthetic nucleocapsid structure, there 
remained a doubt over the ability of the polymerase clone to generate mRNA.
Since the rescue system had been unsuccessful to this point, an added avenue of 
investigation was neccessary to allow expansion of the overall focus of the project. 
Development of inducible mammalian cell lines expresssing viral proteins was 
investigated as this would give added flexibility to the CAT rescue system by 
regulating the levels of SV5 proteins being expressed, but would also allow the 
development of a parallel project on the examination of molecular interactions between 
viral proteins.
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2 Inducible expression of SV5 proteins in mammalian cell lines
This section deals with the generation, isolation and characterisation of BalbC cell lines 
which inducibly express SV5 proteins. A modification to the tetracycline 
Transcriptional Activator (iTA) system is desciibed and subsequently utilised to 
generate the inducible cell lines. This was work carried out in collaboration with Mr. 
B.L. Precious (DNA cloning) and Mr. D. Young from this lab. Mr. Young isolated the 
initial cell lines which were used by me to generate further cell lines which co­
expressed 2 or 3 SV5 proteins.
2.1 Overview of expression from tTA system
2.1.1 How does tTA work?
Fig.32 shows a schematic overview of the control of transcription by the tetracycline 
Transcriptional Activator (tTA) first published by Gossen and Bujard (1992). The 
tetracycline transcriptional activator is activated and inactivated by the absence or 
presence of tetracycline repectively, based on the regulatory elements of the 
tetracycline resistance operon of E.coli. tTA was generated by fusion of the Tn-10- 
derived teracycliiie repressor {tet R) with die activation domain of VP16 from herpes 
simplex virus (HSV). This binds specifically to its heptamerized operator {tet O) which 
is placed upstream of the human cytomegalovirus (hCMV) minimal promoter and this, 
in turn, is upstream of the gene of interest. In the absence of tetracycline, tet R binds tet 
O and through VP 16 interaction with host cell transcription factors and RNA 
polymerases, the gene of interest is transactivated. In the presence of tetracycline, 
however, tet R binding to tet O is blocked and transactivation of the gene of interest is 
prevented.
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Fig32:Overview of tTA transcriptional control
Schematic representing the activation and inactivation of tTA by tetracycline 
based on the regulatory elements of the tetracycline resistance operon of 
E.coli. Fusion of the Tn-lO  -derived tetracycline repressor (tetR) with the 
activation domain of VP 16 from HSV generated a transactivator (tTA) which 
bound specifically to its heptamerized operator (tetO). tetO was placed 
upstream of a human cytomegalovirus (hCMV) minimal promoter which in 
turn was upstream of a gene of interest. In the absence of tetracycline, tTA 
bound to tetO and fm/ijactivated the gene of interest via VP 16 interactions 
with host cell transcription machinery represented as transcription factors 
(TFs) and RNA polymerases (RNA pols). The binding of tetR  to tetO is 
blocked by the addition of tetracycline which itself binds tetR  thus preventing 
rroMjactivation of the gene of interest. Adapted from Didcock (1996).
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To establish cell lines which constitutively expressed tTA in the initial study (Gossen 
and Bujard, 1992), two plasmids had to be transfected, one encoding tTA and the other 
conferring resistance by expression of a gene such as neomycin aminoglycoside 
phosphotransferase (neo), which results in resistance to the neomycin analogue 
Geneticin (G418; Gibco-BRL). Alternatively, a gene which expressed a resistance 
phenotype could be cloned into the plasmid encoding tTA (Gossen et al, 1994). The 
level of success with these approaches was found to be variable and many cell lines had 
to be screened before one which expressed useful levels of tTA was obtained.
Here, an alternative approach was tried in which the gene encoding tTA was fused, via 
a sequence encoding the Foot-and-Mouth-Disease Virus (FMDV) 2A cleavage peptide 
(Ryan and Drew, 1994), to the neo gene in a single long ORF. Ryan and Drew (1994) 
demonstrated that cleavage of fusion proteins at the 2A cleavage domain resulted in the 
addition of 19 amino acids to the C-terminus of the N-terminal domain of a fusion 
protein (in this case tTA) and a single proline residue to the N-terminus of the C- 
terminal domain of a fusion protein (neo).
tTA 2A neo
Cleavage of fusion protein
tTA neo
19 aa
Pro
The original tTA driver plasmid, pUHD15.1, contained the hCMV promoter and tTA 
region but had no selectable marker for the isolation of mammalian transfectants. 
tTA/neo driver fusion was constructed to increase expression levels of tTA during 
isolation of transfected cells and introduce a selectable marker (neo) at the same time. 
The resultant plasmid was called pM RlOl/tTA and contained a single ORF of 
tTA/FMDV 2A/neo. Once transfected, cells containing the driver fusion plasmid, 
pM RlOl/tTA, were selected by resistance to the neomycin analogue Geneticin (G148). 
This demonstrated that cleavage of the fusion protein had occurred at the 2A site to
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Fig.33:Construction of pTET-pGlobinNP (pTET-NP)
SV5 NP ORF cloned into pUHD-10.3 for inducible expression via the 
tetracycline-controlled transactivator in mammalian cell lines. The NP ORF 
including the pGlobin leader sequence was excised from pGEMpGlobinNP by 
digesting with EcoRl and Xbal restriction enzymes. The purified fragment 
was ligated to pUHDlO.3 which had also been digested with EcoRl and X bal. 
The resultant plasmid was called pTET-PGlobinNP.
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produce fully functional neo. Therefore, the addition of the proline residue at the N- 
terminus of neo did not interfere with its function. It was subsequently shown that the 
19 amino acid addition at the C-terminus of tTA did not affect its ability to transactivate 
transcription of the SV5 gene(s) of interest (Precious et al, 1995).
2.1.2 Construction of responder plasmids for tTA system
Once tTA is activated (i.e. in the absence of tetracycline), it binds to tet O on tlie 
responder plasmid(s), thus transactivating the gene(s) of interest (Fig.32). The 
construction of the pTET responder plasmids was carried out in collaboration with Mr. 
B.L. Precious who made pTET-P and pTET-V. Fig.33 shows a schematic diagram of 
the construction of pTET-pGlobiiiNP (or pTET-NP) from pGEM-pGlobinNP. The NP 
ORF, including tlie p-globin enhancer region, was excised from pGEM-pGlobinNP by 
digestion with EcoRl and X bal restriction enzymes and purified by gel extraction. The 
NP fragment was cloned into tlie EcoR l/X bal sites of pUHDlO.3 and the resultant 
plasmid was called pTBT-NP. All 3 plamids, pTET-NP, pTET-P and pTET-V, were 
used as the responder plasmids for activation by tTA.
2.2 Generation of cell lines expressing SV5 proteins
BalbC cells were transfected with the tTA/neo driver fusion plasmid and the 
appropriate responder plasmid (pTET-NP, pTET-P or pTET-V), to generate the cell line 
clones as described in Materials and Methods, Chapter 2, Section 4. Once positive 
clones had been identified by immunofluorescence and verified by western blot, the 
clones with the highest number of positive cells were sub-cloned. This aimed to enrich 
for cells expressing high levels of the protein of interest by expanding colonies from 
single cells (Described in Materials and Methods, Chapter 2, Section 4.4). A subclone 
from each cell type showing the highest level of protein expression, as judged by 
immunofluorescence, was chosen for further analysis. The cell lines expressing NP, P
121
Fig34 : Western blot of NP, P and V cell line extracts.
Cell lines expressing NP, P or V proteins were induced for 36 hours by 
incubating the cell lines in the absence of tetracycline. The cells were 
washed in PBS and harvested by scraping into ice-cold PBS and stored in 1 
ml aliquots (See Materials and Methods, Chapter 2, Section 5.14 for details). 
A sample of each extract was added to SDS-lysis buffer and boiled for 2 
mins before loading onto a 10% SDS-slab gel for separation of the 
polypeptides by electrophoresis. In the resultant western blot, NP (Lane 1), P 
(Lane 2) and V (Lane 3) cell extracts demonstrated that full-length authentic 
viral proteins were expressed since the proteins of interest were similar in 
size to the native proteins from and infected cell extract (ICE). The P and V 
proteins were detected with mAh SV5 P-k and the NP protein was detected 
with SV5 P-d.
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or V were generated and isolated by Mr. D. Young from this lab and are included here 
for completeness.
2.2.1 BalbC cell lines expressing NP, F or V
Once isolated, the protein expression from each cell line was assayed by western blot to 
verify full length authentic proteins were being expressed. This was demonstrated in 
Fig.34 Lanes 1, 2 and 3 where NP, P and V proteins from the respective cell lines were 
shown to be similar in size to the native viral proteins from an infected cell extract 
(ICE). Protein expression from all 3 cell lines was subsequently shown to be under tTA 
control since the levels of protein expression were seen to increase significantly upon 
induction (Precious et al, 1995).
Intracellular localization of the NP, P and V proteins was then examined by 
immunofluorescence and confocal microscopy, revealing distinct differences in the 
distribution patterns of NP, P and V proteins when expressed individually. P protein 
had a generally diffuse cytoplasmic distribution but some fine filamentous structures 
could be seen. In addition, the majority of cells contained a single focal point 
(occasionally two) of accumulated P fluorescence close to or on the nuclear membrane 
(Fig.35, Panel a). In contrast to this, V protein had a diffuse, primarily nuclear 
distribution, but could be visualised in the cytoplasm when expressed at high levels 
(Fig.35, Panel b). The NP protein was distributed throughout the cytoplasm where it 
was visualised as punctate and granular- fluorescent loci (Fig.35, Panel c).
2.2.2 Isolation of cell lines expressing P+NP and V+NP
To examine (potential) vkal proteimprotein interactions, cell lines co-expressing NP-hP 
and NP+V were generated by co-transfecting the driver fusion plasmid with the 
appropriate pTET responder plasmids. The resultant colonies were screened for protein 
expression as described above and a clone from each cell type with the highest level of 
protein expression, was analysed further.
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Fig.35 : Immunofluorescence of NP, P, V and NP+P cell lines.
Photgraphs illustrating the intracellular distibition of P, V and NP in cells 
which had been released from a tetracycline block for 24 hours and were 
expressing the P, V, NP or NP+P proteins, as visualised by confocal 
microscopy. Monolayers were fixed and stained by direct fluorescence using 
FITC-labelled SV5 P-k, which detects both P and V proteins, and 
rhodamine-labelled SV5 NP-a, which detects NP. Cells expressing both NP 
+ P were stained simultaneously with both antibodies.
Figure taken from Precious et al, 1995.
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Fig.36 : Immunofluorescence of NP+V and NP cell lines.
Photographs comparing the distributions of the NP protein in NP and NP+V 
expressing cell lines. Monolayers were released forom the tetracycline block 
for 24 hours, fixed and stained by direct fluorescence with FITC-labelled 
SV5- P-k to detect V, and rhodamine-labelled SV5 NP-a to detect NP. 
Figure taken from Precious et al, 1995.
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The inti'acellular distribution of the co-expressed proteins was examined by 
immunofluorescence. Fig.35-d shows that co-expression of the NP and P proteins led to 
the formation of large cytoplasmic aggregates. These consisted of co-localised NP+P 
proteins in inclusion bodies similar to those seen at late times in an SV5 infection. This 
was very different to the fluorescence patterns seen when the proteins were expressed 
alone. (Compare Panels a and c with d and e in Fig 35)
However, when co-expressed with V, NP was partially redistributed from the punctate 
granular* fluorescent loci, seen when it was expressed alone, (Fig 35 panel c and Fig 36, 
bottom right panel), to diffuse cytoplasmic and nuclear fluorescence (Fig 36, top right). 
Furthermore, no NP-V inclusion body-type aggregates could be detected.
2.2.3 Further isolation of NP+V cell lines
In the initial NP+V cell line, the number of cells co-expressing NP and V proteins was 
ver*y low and this number was not substantially increased by subcloning. Therefore, a 
new NP+V cell line was generated by transfecting the V expressing cell line with 
pTET-NP and a plasmid containing a selectable mar*ker. The V ceU line had been 
shown to produce high levels of tTA which could be utilised to drive NP simultaneous 
to V expression. The V expressing cell hne was therefore co-transfected with pTET-NP 
and pREP4 (Invitrogen) which contained the hygromycin resistance gene, and 
subsequently selected by resistance to Hygromycin B. From 48 initial clones screened, 
4 were positive for NP expression and were all subcloned to enrich for NP expressing 
cells. From a total of 96 subclones, only 1 expressed NP but, unfortunately, in this 
clone, V expression had been lost (Data not shown).
A second attempt at generating NP+V cell lines was then made by transfecting naive 
BalbC cells with the driver fusion plasmid and the responder plasmids as described 
previously. From 48 clones, 3 were positive for NP and V expression and the one 
expressing highest levels of protein was analysed further.
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Fig.37 : Immunofluorescence of NP+V and NP+P+V cell lines.
Photographs illustrating the distribution patterns of NP and V proteins in the 
new NP+V cell line (Panels la, b, c and d) and the distribution of NP and P 
proteins in the NP+P+V cell line (Panels 2a and 2b). Both cell lines were 
released from a tetracycline block for 36 hours, then fixed and 
simultaneously stained with DAPI (Panel 1) and by direct fluorescence with 
FITC-labelled SV5 P-k to detect V (in NP+V cell line. Panels la  and Ic), 
FITC-labelled SV5 P-e to detect P (in NP+P+V cell line. Panel 2a) and 
rhodamine-labelled SV5 NP-a to detect NP (Panels lb. Id and 2b).
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Fig.37 Panels la, b, c and d show that the intracellular distributions of the NP and V 
proteins were identical to that seen with the original NP+V cell line (compare to Fig.36) 
but the percentage of expressing cells had increased. Therefore, when NP and V 
proteins were co-expressed, NP was again redistributed to give diffuse cytoplasmic and 
nuclear fluorescence.
Fig.38 shows a time course of release from the tetracycline block (induction of protein 
expression) from cell lines expressing NP, NP+V and NP+P proteins, and analysed by 
western blot. This demonstrated that each cell line expressed full length authentic 
proteins with optimum protein accumulation at 60 hours post-tetracycline release.
2.2.4 BalbC ceil lines co-expressing V+P and V+NP+P
To investigate potential P+V interactions, a cell line expressing both proteins was 
generated and examined by immunofluorescence for any change in P or V distribution 
compared to when expressed alone. The cell line was generated by transfecting the V 
cell line with pTET-P plus pREP4 as described in 2.2.3. From 24 initial colonies of the 
V+P cell line, there were 5 positive clones, the best of which was subcloned and 
screened by western blot. Fig.39 shows a western blot of the first 8 subclones. As 
expected, the majority of the subclones expressed V protein but only subclone number 
2 (Lane 2) was positive for the prescence of P.
The P+V cell line was then examined by immunofluorescence where no change in the 
distribution of either protein was seen, suggesting there was no discernible P: V 
interaction detected by this method.
A cell line expressing V+NP+P was generated as described in 2.2.3, the aim being to 
supply SV5 proteins necessary to encapsidate a le-CAT-tr negative sense RNA 
transcript for CAT rescue. pTET-NP and pTET-P were transfected into the V 
expressing cell line as described in 2.2.3. The resultant clones were initially screened 
for NP and P expression by IF. From 24 initial clones of the V+NP+P cell line, 4 were 
positive for NP and P fluorescence, the best of which is shown in Fig.37 Panels 2a and
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Fig.38:Time course of induction for BalbC NP+V, NP and NP+P cell lines
Western blot of time course of induction from BalbC NP+V, NP (Panel A) and 
NP+P cell lines (Panel B). Cells were plated into 6 well dishes and induced for 
between 12 and 72 hours, harvested in 500 pi PBS, sonicated and spun at 
14,000 rpm in a cold benchtop microfuge. 30 pi of the resultant supernatant 
was added to 30 pi of lysis buffer, boiled and 20 pi loaded on a 10% gel for 
SDS-PAGE and western blotting. Panel A, Lanes 1-7 represent BalbC NP+V 
cells induced for 0, 12,24, 36,48, 60 and 72 hours respectively. Lanes 8-13 
represent BalbC NP cells induced for 0, 12, 24, 48, 60 and 72 hours 
respectively. Panel B Lanes 14-20 represent BalbC NP+P cells induced for 0, 
12, 24, 36, 48, 60 and 72 hours respectively. The polypeptides were detected 
with mAbs SV5-NPd and SV5-Pk and the antibodies were detected in an ECL 
reaction using HRP-conjugated sheep anti-mouse Ig. An SV5 infected cell 
extract (ICE) was also included to show where the NP, P and V polypeptides 
migrated in the polyacrylamide gel.
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Fig.39:Protein expression from BalbC V+P sub-clones
BalbC cell line sub-clones were screened by western blot for SV5 V+P protein 
expression. Each sub-clone was grown in one well of a 24 well dish and 
induced for 48 hours. Cells were lysed in 1 ml of lysis buffer, sonicated and 20 
pi loaded onto a 10% polyacrylamide gel for SDS-PAGE and western blotting. 
BalbC V+P sub-clones 1-8 are presented here as indicated above each lane. 
Polypeptides were detected using mAbs SV5-Pk and SV5-NPd The bound 
antibody was detected in an ECL reaction using HRP-conjugated sheep anti­
mouse Ig. An SV5 infected cell extract (ICE) was also included to show where 
the NP, P and V polypeptides migrated in the polyacrylamide gel.
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Fig.40:Protein expression from BalbC NP+P+V cell line sub-clones
BalbC cell line sub-clones were screened by western blot for SV5 NP+P+V 
protein expression. Each sub-clone was grown in one well of a 24 well tissue 
culture dish, induced for 36 hours and harvested in 400 pi of lysis buffer. Cells 
were sonicated, boiled and 20 pi of each sample was loaded onto a 10% 
polyacrylamide gel for SDS-PAGE and western blotting. The numbers above 
each lane correspond to the clone number analysed (i.e. BalbC NP+P+V sub­
clones 2, 3 ,7 , 8, 10, 11, 12 and 15 are presented here) The polypeptides were 
detected with mAbs SV5-NPd and SV5-Pk. Bound antibody was detected in 
an ECL reaction using HRP-conjugated sheep anti-mouse Ig. An SV5 infected 
cell extract (ICE) was also included to show where the NP, P and V 
polypeptides migrated in the polyacrylamide gel.
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2b where NP+P cytoplasmic aggregates were clearly visible. This clone was subcloned 
and screened by western blot to assay for the presence of all three proteins. Fig.40 
shows a western blot from V+NP+P subclones. Although 3 subclones clearly expressed 
both NP and P proteins (Lanes 8, 10 and 15) they had lost their ability to express V. 
Since previous fluorescence data from NP+V cells had suggested a role for V in 
keeping NP from self-aggregating, and that NP+P formed large inclusion body-type 
aggregates, one could predict that the absence of V in a V+NP+P cell line would lead to 
formation of cytoplasmic aggregates similar to those seen in NP+P cells. This could 
account for the NP+P aggregates seen in the fluorescence of the initial clone. However, 
some diffuse NP fluorescence was seen suggesting that significantly more soluble NP 
was produced in the V+NP+P cell line than in the NP+P cell line. Therefore, the 
V+NP+P cell line was used to supply the encapsidation proteins for the CAT rescue 
system, with any auxiliary proteins necessary for transcription and replication being 
supplied by SV5 helper virus.
2.3 Uses for the inducible cell lines
2.3.1 CAT rescue in V+NP+P cells
The V+NP+P cell line was used as a noncytocidal alternative to the VacT7 system for 
providing the viral proteins necessaiy for the reverse genetics experiments. As 
previously indicated, the V+NP+P cell line produced very little V protein but did 
contain a significant amount of soluble NP, as judged by a diffuse immunofluorescence 
pattern. It was therefore hoped that this cell line would be able to supply the proteins 
necessary to encapsidate a synthetic negative sense transcript for CAT rescue. The 
auxiliary proteins necessary for transcription and replication of the encapsidated 
transcript were supplied by SV5 helper virus.
At 24 hours post-tetracycline release, the cells were transfected with RNA from pT7.1 
and pPanHan, as described in 1.4.3. The cells were infected with SV5 at 12 hours post­
transfection and harvested for CAT assay 24 hours post-infection. No CAT activity was 
detected using RNA from either pT7.1 or pPaiiHan (Data not shown).
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Although the results from the reverse genetics system were disappointing, a number of 
valuble reagents were generated, with the inducible cell lines being the most useful.
2.3.2 Analysis of NP-P and NP-V complexes by CsCl gradients
Immunofluorescence data from NP+P and NP+V cell lines had demonstrated a 
difference in NP distribution from that seen when NP was expressed alone and 
suggested that NP+P complexes were insoluble while NP+V complexes were soluble. 
An attempt was made to demonstiate the differences in density of the NP:P and NP:V 
complexes by caesium chloride (CsCl) density centrifugation. It was hoped that soluble 
NP: V complexes would be found at the top of the gradient, while insoluble complexes 
would be found at the bottom. Unfortunately, both the NP+P and NP+V complexes 
completely dissociated in the presence of CsCl (Data not shown), and so another way of 
examining these interactions was necessary.
2.4 Conclusions from the Generation of Inducible Cell 
Lines
The results using the cell lines for the reverse genetics system were again disappointing, 
but not altogether suiprising. The cell lines proved to be good reagents with which to 
examine the the interactions of the SV5 proteins involved in the control of viral 
encapsidation, transcription and replication.
When co-expressed with NP, P seems to bind to NP aggregates resulting in laiger 
cytoplasmic aggregates than those seen when NP is expressed alone. However, the 
change of the intr acellular distribution of NP when co-expressed with V (compared to 
when expressed alone), suggests a possible role for V in keeping NP soluble prior to an 
ordered encapsidation process. Therefore, the focus of the project moved towards 
elucidating the viral protein : protein interactions within the replication complex, and 
thereby understand more clearly the the roles played by these proteins in the viral 
transcription / replication mechanism.
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3 SV5 Protein : Protein Interactions
Generation of the cell lines had demonstrated by immunofluorescence that NP could 
bind both P and V proteins. However, since examination of the NP:P and NPiV 
interactions had been unsuccessful using CsCl density centrifugation, another approach 
for the investigation of these interactions was devised.
This section describes the development of a solid phase panning assay (Capture Assay) 
which utilised extracts from the NP, P and V expressing cell lines. The assay was used 
to examine direct NP;P and NP:V interactions. The differences between NP:P and 
NP:V interactions were investigated and the binding site on P for polymeric NP was 
examined by C-terminal deletion mutant analysis. Therefore, the results presented in 
this section give some insight into the protein : protein interactions taking place within 
the replication complex and suggest possible roles for these proteins in SV5 
transcription / replication mechanisms.
3.1 NP-P and NP-V interactions examined by capture 
assay
NP:V interactions had been shown to be sensitive to both ionic and non-ionic 
detergents (Precious erciL 1995) and as a consequence, simple co-immunoprecipitations 
of mixed supernatant extracts from cells expresing NP, P or V proteins were not 
successful. In an alternative approach, a novel protein : protein capture assay was 
developed by Dr. R.E. Randall in this laboratory, and used by me to investigate direct 
NP:P and NP:V interactions.
3.1.1 Overview of capture assay
It had been previously shown that fixed and killed Staphylococcus aureus bound 
strongly to certain kinds of plastic (Randall, 1983), and this property was used as the 
basis for the solid phase panning assay. Full details are given in Materials and Methods
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Protein : Protein Capture Assay
1) Coat 96 well dish with killed fixed 
Staphylococcus aureus Cowan strainA. 2) Bind mAh to Staph A plate
3) Bind specific protein to mAh 
(SV5 P or V proteins)
4) 'Capture' protein of interest via 
protein: protein interactions 
(SV5 NP protein) 
and analyse via Western blot
Fig.41:Protein : protein capture assay.
96 well microtitre plate flooded with 0.2% suspension of fixed and killed 
Staphylococcus aureus Cowan strain A {S.aureus) in PBS and left for a 
minimum of 4 hours at 4 ^C. Unbound material was removed by washing 
with PBS, leaving a confluent monolayer of S.aureus bound to the plate. This 
monolayer was cross-linked to the surface of the plastic by incubating the plate 
in a PBS solution containing 5% (v/v) formaldehyde and 2% (w/v) sucrose for 
10 mins at RT. The plate was washed extensively in PBS whereupon 
monoclonal antibodies (mAbs) were bound to the monolayers by adding 50 |il 
of mAb per well and incubating at 4 for 2 hours. Unbound mAb was 
removed by washing with PBS and any non-specific protein binding sites 
were blocked by addition of 10% bovine serum albumin (BSA) for 1 hour at 4 
The P and V proteins were captured by the mAbs by adding 100 |il (per 
well) of extracts from the cells expressing these proteins, and incubated at 4 
for 2 hours with continuous rocking. Unbound material was removed by 
washing 4 times with PBS. To examine the binding of the NP protein to the 
captured P or V proteins, 100 |il of extract from cells expressing the NP 
protein were incubated with the appropriate wells for 2 hours at 4 with 
continuous agitation. Unbound material was removed by washing 4 times with 
PBS. 30 pi of disruption buffer added to each well, the plate was heated to 
100 C c for 5 mins and samples run on SDS-PAGE and analysed by Western 
blot.
135
Chapter 2, Section 5.13 but briefly, a 96 well micotitre plate was coated with a fixed 
killed suspension of S. aureus . A mAh specific to the amino-cotermini of the P and V 
proteins was then bound to the immuno-absorbant coating on each well. Extracts from 
the P and V cell lines were then 'captured' by the mAh and the ability of the captured 
proteins to bind NP was examined by western blot analysis. A schematic diagram of the 
capture assay is given in Fig.41.
3.1.2 Direct interaction of NP with both F and V
The mAh, SV5 P-k, which recognises an amino-terminal epitope common to both P and 
V proteins, was added to S. aureus coated wells of a 96 well microtitre plate (StaphA 
plate)and incubated for 2 hours at 4 °C with shaking. Non-specific protein binding sites 
were blocked by the addition of blotto (10% (w/v) skimmed milk powder in PBS) for 1 
hour at 4 °C with shaking. Extracts from the BalbC P and V expressing cell lines were 
prepared by harvesting tlie cells in PBS whereupon the cells were then sonicated and 
the cell debris pelleted by centrifugation (See Materials and Methods, Chapter 2,
Section 5.14 for details). The supernatants were decanted in preparation for addition to 
the Staph A plates . 100 pi of either P or V extract was added to a well for 
immobilisation by incubating the plate at 4 °C with shaking for 1-2 hours. Any unbound 
material was removed by washing extensively in PBS.
A low speed supernatant (LSS) extract was then prepared from NP cells by harvesting 
the cells in PBS, sonicating them and then removing cell debris by centrifugation at 
6,500 rpm on a benchtop microfuge (See Materials and Methods, Chapter 2, Section 
5.14 for details). 100 pi of the NP LSS was added to the wells containing immobilised 
or 'captured' P or V proteins. NP was incubated with P or V for 2 hours at 4 °C with 
shaking and unbound material was again removed by washing extensivly in PBS.
Direct protein : protein interactions were analysed by adding 30 pi of SDS-lysis buffer 
to each well whereupon the plate was boiled for 5 mins. Each sample was
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Fig.42 : NP can bind to both P and V proteins.
Protein'.protein capture assay demonstrating NP:P and NP:V interactions. 
The mAh SV5 P-k was bound to wells of a S.aureus microtitre plate (Lanes 
1-6). Low speed supernatant extracts of cells expressing P, V or NP were 
made. The P extract was added to wells 3 and 4, while the V extract was 
added to wells 5 and 6, and PBS was added to wells 1 and 2. Following 
binding of P and V to the mAh SV5 P-k, the wells were thoroughly washed 
with PBS and the NP extract was added to wells 2, 4 and 6. The NP extract 
was incubated with P or V for 2 hours at +4 °C, whereupon the wells were 
washed again in PBS. The residual polypeptides were seperated by 
electrophoresis on a 10% SDS-polyacrylamide slab gel and visualised by 
western blot analysis. P and V proteins were detected with the mAh SV5 P-k 
and NP was detected with the mAh SV5 NP-d. Bound antibody was detected 
in an ECL reaction using HRP-conjugated sheep-anti-mouse Ig. The anti­
mouse Ig also detected the heavy chain (IgH) of the immobilising antibody 
(SV5 P-K) which was bound to the S.aureus and was thus visualised in the 
western blot. An infected cell extract (ICE) was also western blotted to show 
the positions to which the NP, P and V proteins migrated in the 
polyacrylamide gel.
Figure taken from Randall and Bermingham, 1996.
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electrophoresed through a 10% SDS-polyacrylamide gel for western blot anaiysis(See 
Materials and Methods, Chapter 2, Section 5.5 and 5.6 for details).
A direct interaction between NP and both P and V proteins is shown in Fig.42 (Lanes 4 
and 6). This interaction was only seen in wells containing P or V protein (Lanes 4 and 
6) and not in the control well containing mAb alone (Lane 2). Furthermore, the amount 
of NP bound by V was significantly less than that bound by P (Compare Lanes 4 and 
6), suggesting that V could only bind a subset of the NP recognised by P.
3.1.3 V binds a subset of the available NP
The results described above suggested that V could only bind a subset of the NP 
available for binding and which is recognised by P. This was further tested in an 
absorption experiment on a Staph A plate coated with SV5 P-k. A series of wells 
containing either P or V proteins was prepared as described above. 100 p.1 of a LSS 
extract from the NP expressing cells was added to the first well containing V and 
incubated for I hour at 4 "C with shaking. The unbound material from the V containing 
well was then transferred to the adjacent V-containing well and incubated for a further 
hour. (The bound polypeptides from the first well were harvested in SDS-lysis buffer 
for electrophoresis and western blot analysis.) The absorption step ( serial passage of 
NP extract across V-containing wells) was repeated 5 times and the residual fraction 
was tested for its ability to bind P by adding it to a well containing P protein. The serial 
passage of NP extiact across V wells is shown in Fig.43 Panel b, Lanes 10-15. NP 
binding to V could be seen in Lane 10 but in none of the subsequent wells, 
demonstrating the small amount of NP initially bound by V had been absorbed out of 
the NP extract. The unbound material from Panel b. Lane 15, was then added to a well 
containing P (Panel a. Lane 8) and showed that the pre-absorbed extract still contained 
NP which had the ability to be bound by P.
The experiment was also done in reverse where NP was bound to a series of P wells 
(Panel a. Lanes 2-7) whereupon the residual material was assayed for its ability to bind
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Fig.43 : V binds a subpopulation of the available NP.
Western blot analysis demonstrating that preabsorption of NP with P 
removed the fraction of NP that bound V, but preabsorption of NP with V, 
did not remove all the NP that bound to P. The mAh SV5 P-k, attached to 
S.aureus microtitre plates, was used to capture P (Panel a) or V (Panel b) 
from low speed supernatant extracts of cells expressing these proteins. A low 
speed supernatant extract of NP-expressing cells was added for 2 hours at 4 
°C, to wells 2 and 10. The unbound material from these wells was collected 
and incubated with P and V present in 3 and 11 respectively. Similar 
absorptions of the NP protein continued until wells 7 and 15 respectively. 
Following this final absorption, the unbound material which had been 
incubated with P was added to a well containing V (Well 16), and the 
unbound material which had been incubated with V was added to a P 
containing well (Well 8). Polypeptides in all the wells were seperated by 
electrophoresis through a 10% SDS-polyacrylamide gel and analysed by 
western blot. The Pand V proteins were detected with the mAh SV5 P-k and 
the NP protein with the mAh SV5 NP-d. An infected cell extract (ICE) was 
included to show the positions to which the native NP, P and V polypeptides 
migrated in the polyacrylamide gel.
Figure taken from Randall and Bermingham, 1996.
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V. However, after NP was preabsorbed with P, there was no NP available to bind V 
(Panel b, Lane 16).
These results were consistant with the hypothesis that V could only bind a 
subpopulation of NP recognised by P. After a series of preincubation steps with V, a 
substantial amount of NP remained in the unbound material, which could be 
subsequently bound by P. (Panel a. Lane 8) This, however, was not the case in reverse. 
After preincubation with P, there was no NP available to be bound by V. Furthermore, 
the results suggested there was a difference in NP populations; one recognised by P 
alone and the other recognised by both P and V.
3.1.4 P binds soluble and polymeric NP while V binds only soluble NP
To further elucidate the differences in NP populations, the low speed supernatant (LSS) 
from NP expressing cells was further fractionated by centrifugation at 400,000 x ^ in a 
benchtop ultracentrifuge (Beckman) for 1 hour at 4 °C. The supernatant was decanted 
and called "high speed supernatant" (HSS), and the pellet was resuspended in its 
original volume of PBS by sonication and called "high speed pellet" (HSP). Analysis of 
these fractions by western blot is shown in Fig.44, Panel a. The majority of the NP from 
the LSS (Lane 1) was pelleted upon centrifugation (Lane 3) demonstrating that it was 
polymeric. However, a small fraction remained soluble and was detected in the HSS 
(Lane 2).
The ability of both P and V to bind to the fractionated NP extracts was then tested. A 
Staph A plate, containing P or V proteins bound by SV5 P-k, was prepared as described 
previously. 100 |al of the NP LSS, HSS or HSP extracts were then incubated with the 
appropriate P or V wells, and assayed by western blot as shown in Fig.44. Panel c 
(Lanes 7 and 8) clearly demonstrated that P could bind both soluble and polymeric 
forms of NP. However, Panel d, (Lanes 11 and 12) demonstrated that V could only bind 
soluble NP (Lane 11) and not polymeric NP (Lane 12).
Again, V bound much less NP from the LSS extract than did P (Compare Lane 7 with 
Lane 10), but this could now be explained. The LSS extract was a combination of
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Fig.44 : P binds both soluble and polymeric NP while V binds only 
soluble NP.
Western blot analysis demonstrating the interaction of the P and V proteins 
with soluble and polymeric forms of NP. The mAh SV5 P-k was bound to all 
wells of a S.aureus microtitre plate (b, c and d). PBS, P or V proteins were 
incubated with all the wells of b, c and d respectively. Low speed supernatant 
(LSS), high speed supernatant (HSS) and high speed pellet (HSP) extracts of 
cells expressing the NP protein (Panel a, Lanes 1, 2 and 3 rspectively) were 
then added to wells 1, 2 and 3 respectively to each of b, c and d. Unbound 
material was removed and the residual polypeptides were seperated by 
electrophoresis through a 10% SDS-polyacrylamide slab gel, and analysed 
by western blot as described previously.
Figure taken from Randall and Bermingham, 1996.
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soluble and polymeric NP which could all be bound by P. Since V could only bind 
soluble NP, the small amount of NP bound by V from the LSS, corresponded to the 
amount of soluble NP in this fraction.
3.1.5 niAb SV5 P-e blocks P binding to polymeric NP
Since the P and V proteins are amino-cotenninal, and only P could bind polymeric NP, 
this suggested that the unique C-terminus of P was site of interaction with polymeric 
NP. A panel of mAbs had been generated to the P unique region (Randall et al, 1987) 
and were used to determine whether any could block the P interaction with NP.
StaphA plates were prepared and coated with each of the mAbs specific to the C- 
terminus of the P protein. LSS extracts of P expressing cells was bound to the various 
mAbs and then incubated with LSS, HSS and HSP extracts from NP expressing cells as 
described above. The bound polypeptides were electrophoresed through a 10% SDS- 
polyacrylamide gel and analysed by western blot.
Most of the mAbs gave the same binding pattern to that seen with SV5 P-k (Fig.44) 
indicating that the binding of P to polymeric NP had not been blocked. However, when 
P was immobilised by mAb SV5 P-e, a change in the binding pattern was observed 
(Fig.45, Panel b). P could now only bind a small proportion of NP from the LSS as 
compared to when immobilised by SV5 P-k (Compare Lanes 2 in Panels a and b) and 
this small amount of NP bound by P corresponded to the soluble NP fraction (Panel b. 
Lane 3). P could no longer bind polymeric NP (Panel b. Lane 4) and therefore gave a 
similar binding profile to that seen with V. This suggested that the site of interaction 
between P and polymeric NP lay, at least in part, within the SV5 P-e recognition 
sequence.
3 .2  M ap p in g  o f  the m A b  S V 5  P -e  ep ito p e
The binding sites of the P unique mAbs had never been identified and so it was hoped 
that by mapping the epitope coiTesponding to the SV5 P-e, the site of interaction
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Fig.45 : mAb SV5 P-e blocks P binding to polymeric NP.
Western blot analysis demonstrating the ability of the mAb SV5 P-e to 
prevent P binding to polymeric NP. The mAbs SV5 P-k (Panel a) or SV5 P-e 
(Panel b) were immobilised on a S.aureus micro titre plate. A low speed 
supernatant extract of cells expressing the P protein or PBS was added to 
wells 1-4 and 5-8 respectively. Unbound material was removed by extensive 
washing in PBS. LSS, HSS and HSP extracts of NP-expressing cells were 
prepared. LSS was added to wells 2 and 6, HSS was added to wells 3 and 7, 
and HSP was added to wells 4 and 8 of Panels a and h respectively. PBS was 
added to wells 1 and 5. Polypeptides, including those of an infected cell 
extract (ICE) were separated by electrophoresis through a 10% SDS 
polyacrylamide slab gel for western blot analysis as described previously. 
Note that the multiple bands visualised with molecular weights lower that P, 
were degredation products of P as they were recognised by SV5 P-k when 
the blot was stripped and reprobed using SV5 P-k alone
Figure taken from Randall and Bermingham. 1996.
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between polymeric NP and P could be identified. Two approaches were taken to 
identify the SV5 P-e epitope. These examined the ability of SV5 P-e to recognise either 
a series of C-lerminal peptides immobilised on a nitrocellulose filter or a series of C- 
terminal deletion mutants.
3.2.1 mAb epitope mapping using SPOTS membrane
To identify the epitopes of the P unique mAbs, including SV5 P-e, a series of peptide 
spots, each of 13 amino acids, and with 8 amino acid overlaps, covering the whole of 
the P unique C-terminal region (amino acids 163-393), were generated on a 
nitrocellulose filter (Genosys), (See Materials and Methods Chapter 2, Section 5.8).
This 'SPOTS' membrane was then incubated with each of the P unique mAbs 
individually to define the individual binding sites within the C-terminal region of P. 
First, the 'SPOTS' membrane was blocked 0 /N  at 4 °C in a casein based blocking buffer 
supplied by the manufacturer. This prevented non-specific binding of the test mAh with 
the membrane (c.f. western blot). The mAh of interest (approximately 0.1 fig/ml in 
blocking buffer) was then incubated with the membrane for 30 mins at room 
temperature with shaking. Unbound mAb was then removed by washing the filter 
extensilvely in PBS containing 0.05% Tween 20 (PBS-T). Any mAh bound to the 
peptide spots was reacted with HRP conjugated sheep anti-mouse IgG. This secondaiy 
antibody was detected in an ECL reaction as with a western blot. The membrane was 
regenerated after incubation with one mAh to allow the mapping of each mAh binding 
site(s) individually (See M+M for details on membrane regeneration).
Fig.46 shows an outline of the SPOTS membrane when probed with sheep anti-mouse 
HRP alone and demonstrates that there was no non-specific interaction between the 
secondary antibody (sheep anti-mouse HRP) and the bound peptides. It also shows the 
relative positions of the peptide dots on the membrane. SV5 P-d bound to peptide spot 
number 4 which corresponded to amino acids 178-190 and SV5 P-a bound to spot 
number 6 which corresponded to amino acids 188-200, both in the C-terminal region of 
the P protein, as expected. Although successful for 2 of the 8 mAbs tested, the binding
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Fig.46:Mapping of mAb binding sites in C-terminus of P
SPOTS membrane containing overlapping peptides from the unique C- 
terminal region of P was probed with a panel of mAbs (individually) which 
had been raised against this region in order to map their epitopes. Panel A 
shows the membrane probed with anti-mouse Ig conjugated to HRP and 
detected in an ECL reaction. The positions of the peptide spots can be seen as 
clear patches on the darker background and demonstrated that there was no 
cross-reaction between the anti-mouse Ig conjugated HRP and the bound 
peptides. Only 2 of the 8 mAbs tested bound to the membrane. Panel B shows 
the binding site of SV5 P-d coiresponded to spot 4 (amino acids 178-190 
SDGWEMKSRSLSG) and Panel C shows the binding site of SV5 P-a 
corresponded to spot 6 (amino acids 188-200 LSGAIHPVLQSPL). Once 
bound to the membrane, the mAbs were detected with anti-mouse Ig 
conjugated HRP and detected in an ECL reaction as with western blots.
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sites of the other mAbs, including SV5 P-e, could not be determined using the SPOTS 
membrane.
3.2.2 Cloning of C-terminally deleted mutants
An alternative strategy was employed to elucidate the SV5 P-e binding site using a 
series of C-terminal deletion mutants. Three unique restriction enzyme sites found in 
the C-terminal region of P were used to create truncated ORFs which were then cloned 
into pTMl for protein expression from the VacT7 system.
The cloning of the P deletion mutants is outlined in Fig.47. The P ORF was initially 
isolated from pGEM-P by digestion with EcoRl and Sail restriction enzymes. Once 
purified, the P ORF was digested again with either Earl, Smal or Seal restriction 
enzymes and subsequently digested with Ncol. The fragments of interest were gel 
purified and ligated to pTMl which had been digested with Ncol and Stul restriction 
enzymes. The resultant plasmids were called pTMP-Earl, pTMP-Smal and pTMP- 
Scal respectively. (Note that Earl, Smal, Seal and Stul are blunt cutters and blunt 
ends of the insert were ligated to the vector.)
3.2.3 Modification to the original capture assay
The C-terminal deletion mutants had been constructed for expression in the VacT7 
system and subsequent examination by capture assay. Before these assays were 
performed, a modification to the capture assay protocol was made and used in all 
subsequent capture assays.
The original capture assay methodology described formaldehyde cross-linking of the 
S.aureus to the microtitre plate followed by addition of the mAb of interest. When the 
proteins in each well were analysed by western blot, the heavy and the light chains from 
the immobilising antibody were visualised, and in some cases, obstructed the band of 
interest from being seen clearly, (e.g. Fig. 44 Panel d. Lanes 1, 2 and 3, where
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g  a a  163
P/V shared 
N-tenninus P - unique region
WT P 393 a a  (43K)
P-Earl 364 a a  (40K)
P-Smal 2 7 8 aa  (30.5K)
P-Scal 174aa(19.1K )
Fig.47: Construction of P deletion mutants
p ORF was excised from pGEM-P by digestion with EcoRl and Sail 
restriction enzymes. Once purified, the ORF was further digested with Ncol 
and either Seal, Smal or Earl and purified again for ligating to pTMl which 
had been digested with Ncol and Stul. The resultant plasmids were called 
pTMP-Scal, pTMP-Smal and pTMP-Earl. Panel A shows the positions of 
the restriction sites within the P ORF and Panel B show the relative sizes of 
the resulting mutant P proteins. The P/V shareN-terminus is shown as a 
shaded box and the P-unique region is also indicated.
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migration of V is masked by the detection of light chain from the immobilising 
antibody, SV5 P-k.) To circumvent this problem, formaldehyde was used to cross-link 
the mAh of interest to the S.aureus on the plate. It was found from a time course 
experiment that 3 hours was the minimum incubation time which gave effective cross- 
linking of the mAh to S.aureus (Data not shown). Once the mAh was cross-linked to 
S.aureus, the capture assay proceeded as described previously. It should be noted that 
the cross linking of the mAh to S.aureus merely cut down on background signal from 
the immobilising antibody but did not completely erase it.
3.2.4 Expression of P deletion mutants
Once cloned, pTM-P, pTMP-EaiT, pTMP-Sraal and pTMP-Scal were transfected into 
VacT7 infected 293 cells for protein expression. The cell extracts were prepared as 
described in Materials and Methods, Chapter 2, Section 5.14.4 and 5.24.5. The 
migration of the C-terminally deleted proteins and their ability to be recognised by SV5 
P-k, was examined by capture assay. A StaphA plate, containing SV5 P-k, was 
prepared as described previously and the VacT7 generated protein extracts were diluted 
1/100 in PBS before addition to the plate. The extracts were incubated and harvested as 
described previously with the resultant western blot shown in Fig.48. All of the P 
proteins were recognised by the N-terminal mAh SV5 P-k. Full-length P protein was 
expressed from pTM-P and is referred to as wild-type P (WT-P) in Panel A, Lane 3. 
The deletion mutants, pTMP-Earl, pTMP-Smal and pTMP-Scal are shown in Lanes 3 
of Panels B, C and D respectively. The relative mobilities of all the recombinant P 
proteins were compared to the authentic viral protein from an SV5 infected cell extract 
(Lane labelled ICE in Panels A, B, C and D.).
3.2.4 Mapping of SV5 P-e binding site with deletion m utants
The ability of the C-terminal deletion mutants to be recognised by SV5 P-e was then 
tested, with the aim of identifying the location of the mAh binding site. This method
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Fig.48: VacT7 expression of P deletion mutants in capture assay
Western blot demonstrating the ability of VacT7 driven expression of P 
deletion mutants from pTM vectors to bind SV5 P-k in capture assay. The 
mAb SV5 P-k was added to S. aureus coated 96 well microtitre plates. (Lanes
2 and 3 Panels A, B, C and D respectively) Lane 1 in each panel represents 5. 
aureus alone and Lane 2 represents mAh SV5 P-k bound to S. aureus . Cell 
extracts from 293 cells infected with VacT7 and transfected with pTM-P (and 
derived P deletion mutants) were prepared as described in the text. These cell 
extracts (or PBS. Lane 2 in each panel) were added to the capture plates (Lane
3 in each panel) and incubated for 3 hours at 4 °C with rocking. Unbound 
material was removed by extensively washing with PBS and polypeptides 
present in the wells, and those from an SV5 infected cell extract (ICE) were 
electrophoresed through 10% SDS-PAGE and western blotted. The P protein 
was detected with mAb SV5-P-k and NP protein was detected with the mAb 
SV5 NP-d. Bound antibody was detected in an ECL reaction using HRP- 
conjugated sheep anti-mouse Ig.
The 393 amino acid wild-type or full length SV5 P protein expressed from a 
VacT7 driven pTM-P clone is indicated by WT-P(393). P proteins from the 
deletion mutants expressed in the same way are indicated by capital P (P) with 
protein length (in amino acids) given in brackets.
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was les led by l'irsi using the mAh, SV5 P-a where the binding site had already been 
determined using the SPOTS membrane. This mAb was used to coat a StaphA plate 
whereupon extracts containing the (ull-length or C-terminally truncated P proteins were 
added. Bound polypeptides were harvested as described previously and the resultant 
western blot is shown in Fig.49, Panel C. Full length P (393 amino acids) was bound by 
SV5 P-a (Lane 3) as were P-Earl (364 amino acids) and P-Smal (278 amino acids) in 
lanes 9 and 7 respectively. However, P-Scal (174 amino acids) was not bound by SV5 
P-a (Lane 5) indicating that the binding of the mAh lay between amino acids 174 and 
278. This is consistant with the SPOTS analysis where the binding site had been shown 
to be amino acids 188-20() in the C-terminus of P.
Since this method had been shown to work, the experiment was repeated with SV5 P-e 
bound to a StaphA plate. The extracts were incubated as described previously and the 
resultant western blot is shown in Fig.49, Panel B. Full length P was bound by SV5 P-e 
(Lane 3) but none of the mutants were recognised by the mAh (Lanes 5, 7 and 9). This 
demonstrated that deleting the extreme C-terminal 29 amino acids, abolished the ability 
of the P protein to be recognised by SV5 P-e, indicative of the binding site being in this 
region. Therefore the putative binding site on P for interactions with polymeric NP lies, 
at least in part, within the extreme C-ierminal 29 amino acids.
3.3 NP interactions with bacterially expressed P and V
For future examination of structure / function relationships in both P and V proteins, it 
was necessary to generate large amounts of protein for X-ray crystallographic studies. 
Neither the inducible cell lines nor the VacT7 system could generate sufficient amounts 
of protein for this purpose and so bacterial expression of both P and V proteins was 
investigated. The pET (plasmid for Expression by T7 polymerase) system was chosen 
since it is one of the most efficient ways of expressing high levels of protein in E.coli 
(See Materials and Methods, Chapter 2, Section 5.14.4 for details on the pET system) 
and would facilitate the generation of both clones and protein for future mutational 
analysis. Before any X-ray crystallographic studies were undertaken, some indication of
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Fig.49 : Mapping of SV5 P-e binding site by deletion mutant analysis.
S.aureus microtitre plate was prepared and the mAh SV5 P-k was added to 
wells 2-9 of Panel A, mAh SV5 P-e was added to wells 2-9 of Panel B and 
mAh SV5 P-a was added to wells 2-9 on Panel C. Extracts from VacT7 
generated pTM-P and P deletion proteins were prepared as described in the 
text. An extract containing full-length P (393 amino acids) was added to 
Lane 3 in Panels A, B and C respectively. P-Scal (174 amino acids) was 
added to Lane 5 in Panels A, B and C respectively. P-Smal (278 amino 
acids) was added to Lane 7 of Panels A, B and C respectively. P-Earl (364 
amino acids) was added to Lane 9 of Panels A, B and C respectively. (PBS 
was added to wells 1, 2, 4, 6 and 8 of Panels A, B and C respectively. 
Unbound material was removed by washing extensively in PBS whereupon 
the residual poypeptides (including those of an infected cell extract) were 
seperated by electrophoresis through a 10% SDS-polyacrylamide slab gel 
and analysed by western blot as described previously.
Note that Lane 1 of Panel A contained S.aureus alone and therefore the 
bands seen in this lane are 'spill-over' from the infected cell extract (ICE) 
control lane.
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the ability of the bacterially expressed protein to behave as native protein was 
necessary. The ability of the bacterially expressed proteins to be recognised by both N- 
lerminal and C-terminal mAbs would suggest that the proteins had folded corectly. This 
would be further strengthened if the proteins could form complexes with NP similar to 
those made by cell line expressed P and V proteins.
3.3.1 Construction and Expression of pET-P and pET-V
Both pET-P and pET-V were constructed by Mr. B.L. Precious and used by me in the 
experiments described below. The P and V ORFs were directly subcloned from pGEM- 
P and pGEM-V into the bacterial expression vector, pE T lic , for IPTG inducible 
expression in Escherichia coii. Bacterial cells containing the pET-P or pET-V plasmids 
were grown and induced with 1 mM IPTG as described in Materials and Methods, 
Chapter 2, Sections 5.14.4 and 5.14.5. Bacterial cell extracts were prepared by treating 
the Tells with lysozyme and then diluting the lysates in IP buffer (without SDS).
Lysates were sonicated and cell debris was pelleted, whereupon the supernatant was 
decanted into a fresh tube. The resulting supernatant was diluted 1/1000 in PBS for 
addition to StaphA plates.
3.3.2 Bacterially expressed P and V bind NP
Bacterially expressed P and V were initially assayed for their ability to be recognised 
by the N-terminal mAb, SV5 P-k, on a StaphA plate. A StaphA plate was therefore 
prepared and coated with SV5 P-k as described previously. 100 ql of bacterially 
expressed P or V protein, or 100 \i\ of cell expressed P or V protein was added to the 
appropriate wells and incubated for 2 hours at 4 with rocking. The plate was 
extensively washed with PBS to remove unbound material. The bound polypeptides 
were harvested as described previously for electrophoresis and western blot analysis. 
Fig.50 demonstrated that both bacterially expressed P (Panel B, Lane 3) and V (Panel
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Fig.50: Bacterially expressed P and V can bind NP.
Western blol comparing bacterially expressed P and V proteins with BalbC 
cell line extracts containing P and V proteins for their ability to bind NP by 
capture assay. The mAb SV5-P-k was bound to S. aureus coated wells of a 96 
well microti ire plate. Cell extracts from BalbC cell lines expressing P (Panel 
A, Lanes 3-6), or V (Panel C. Lanes 3-6) were added to the plate. Bacterial 
lysates were prepared as described in the text and bacterially expressed P 
(Panel B, Lanes 3-6) or V (Panel D, Lanes 3-6) was added to the plate and 
incubated at 4 "C for at least 2 hours on a rocker. After washing extensively 
with PBS. low speed supernatant, high speed supernatant and high speed pellet 
extracts of cells expressing NP protein were added to lanes 4, 5 and 6 
respectively of Panels A, B, C, D and E and incubated for 3 hours on a rocker 
at 4 "C . Lanes 1, 2 and 3 in panels A, B, C and D contained 5. aureus alone, 
S.aureus plus mAb SV5 P-k, and S. aureus plus mAb SV5 P-k plus 
appropriate P or V extract respectively. Panel E represents a negative control 
for non-specific interaction between the NP extracts and mAb SV5 P-k bound 
to the plate. Lanes 1 and 2 contained S. aureus, S. aureus plus mAb SV5 P-k 
respectively. Following removal of the unbound material by washing 
extensively with PBS, the polypeptides present in the wells, and those from an 
SV5 infected cell extract (ICE),were electrophoresed through a 10% SDS- 
PAGE and western blotted. The P and V proteins were detected with mAb 
SV5-P-k and NP protein was detected with the mAb SV5 NP-d. Bound 
antibody was detected in an ECL reaction using HRP-conjugated sheep anti- 
mouse lii.
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D, Lane 3) were recognised to the same degree as their cell line counterparts (Lanes 3 
of Panels A and C, respectively). This suggested that at least the N-terminal region of 
the bacterially expressed proteins had folded sufficiently for recognition by the N- 
term inal mAb, SV5 P-k.
The bacteiially expressed proteins were subsequently assayed for their ability to form 
complexes with NP, in a repeat of the experiment in 3.1.4. A StaphA plate containing 
SV5 P-k was prepared as described previously. 100 p.1 of the bacterially expressed P or 
V proteins was added to the appropriate wells (Cell line expressed P and V were 
included as positive controls).The plate was incubated for 1 hour with shaking at 4 °C, 
and the unbound material was removed by washing extensively with PBS. 100 |il of 
LSS, HSS and HSP extract from NP expressing cells were added to the plate and 
incubated for a further hour at 4 °C, with shaking. Again the unbound material was 
removed by washing in PBS and the bound polypeptides were harvested as decribed 
previously, for electrophoresis and western blot analysis.
The bacterially expressed proteins displayed binding profiles identical to those of the 
cell line expressed proteins. Bacterially expressed P bound both soluble and polymeric 
NP (Fig.50, Panel A, Lanes 4, 5 and 6), while bacterially expressed V bound only the 
soluble form of NP (Panel C, Lanes 4, 5 and 6), thus mirroring the result obtained with 
the cell line expressed P and V proteins (respectively Panels B and D, Lanes 4, 5 and 6, 
and section 3.1.4). Furthermore, the P and V proteins had been shown to be 
phosphorylated when expressed in their respective BalbC cell lines (Precious et al,
1995). When expressed in bacteria, however, no post-translational modification 
associated with the mammalian expression system would have taken place. Therefore, 
the results above, demonstrate that the phosphorylation states of either P or V proteins, 
did not influence their ability to bind NP.
3.3.3 SV5 P-e blocks bacterially expressed P binding to polymeric NP
To further strengthen the findings that bacterially expressed P behaved in an identical 
fashion to its cell line expressed counteipart, the ability of the protein to be recognised
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by the C-lerminul mAb. SV5 P-e, was tes led. A StaphA plate containing either SV5 P-e 
or SV5 P-k (as a positive control for P binding), was prepared. Bacterially expressed P 
was added to the plate and the bound polypeptides were assayed by western blot. F ig.51 
confirms that bacterially expressed P is recognised by the SV5 P-k (Panel A, Lane 3) 
but also demonstrates that SV5 P-e recognises the bacterially expressed protein (Panel 
B, Lane 3).
The ability of the C-terminally captured P protein to bind NP was then assayed. For 
this, LSS, HSS and HSP extracts of NP expressing cells were added to a StaphA plate 
containing bacterially expressed P protein captured by SV5 P-k or SV5 P-e. NP-P 
interactions were analysed by western blot as described previously. Once again, the 
bacterially expressed P captured by SV5 P-k bound both soluble and polymeric forms 
of NP (Fig.51, Panel A, Lanes 4, 5 and 6) and SV5 P-e blocked the interaction between 
bacterially expressed P and polymeric NP (Panel B, Lanes 4, 5 and 6). This result once 
more mirrored that seen with P expressed im mammalian cells (3.1.5).
Both P and V proteins expressed in E.coli had NP binding profiles in capture assays 
indistinguishable from their mammalian cell line counterparts. They were recognised by 
both N-terminal and C-terminal mAbs, suggesting that, even though they were without 
the normal post-translational modifications, they had not taken up a totally abenant 
structure. Therefore, the bacterially expressed P and V proteins were deemed suitable 
for X-ray crystallography and future structure/function analysis.
3.4 Summary and Conclusions from Capture Assays
Fractionation of extracts from the NP expressing cell line demonstrated that there were 
two separable populations of NP expressed in the cells; one soluble and the other 
polymeric. Both P and V proteins bind soluble NP suggesting that the site of interaction 
between P or V and soluble NP lies in the N-terminus of the protein as P and V are 
amino-coterminal. For SeV, P protein has been shown to act as a chaperone for NP by 
forming a soluble NP:P complex. This prevents NP from self-aggregating and also acts 
as the encapsidation substrate during both genomic and anti-genomic RNA synthesis
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Fig.51:Binding of bacterially expressed P to polymeric NP can be 
blocked by mAb SV5 P-e.
Western blot demonstrating the ability of mAb SV5 P-e to prevent the binding 
of bacterially expressed P to the polymeric form of NP. The mAbs SV5 P-k 
and SV5 P-e were added to S. aureus coated 96 well m icrotitre plates. (Lanes 
2-6 Panels A and B respectively) A bacterial cell extract was prepared as 
described in the text and added to wells 3-6 for 3 hours at 4 °C on a rocker. 
Unbound material was removed by washing extensively in PBS before 
addition of low speed supernatant, high speed supernatant and high speed 
pellet extracts of NP cell line to lanes 4, 5 and 6 respectively. Lanes 1 and 2 in 
Panels A and B contained S. aureus alone and S. aureus plus mAb 
respectively. Following reomoval of the unbound material by washing 
extensively with PBS, 3ie polypeptides present in the wells, and those from an 
SV5 infected cell extract (ICE), were electrophoresed through a 10% SDS- 
PAGE and western blotted. The P protein was detected with mAb SV5-P-k 
and NP protein was detected with the mAb SV5 NP-d. Bound antibody was 
detected in an ECL reaction using HRP-conjugated sheep anti-mouse Ig.
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(i.e. virus replication).The data presented in this section support this finding by 
demonstrating that SV5 P can interact with soluble NP. Furthermore, V can also 
interact with soluble NP, suggesting that V could fulfil a similar chaperone role in SV5, 
to that seen with P for SeV, This possibility is discussed further in Chapter 4.
P also binds polymeric NP, suggesting that this site of interaction lies within the unique 
C-terminus of P. This site was subsequently predicted to reside, at least in part, within 
the extreme C-terminal 29 amino acids. These results also support findings for SeV P 
protein, which has been shown to interact with the viral nucleocapsid (assembled NP). 
This interaction is thought to occur when P is in the P-L polymerase complex and 
thereby anchors the polymerase to the template for either transcription or replication. 
This is again discussed in more detail in Chapter 4.
Therefore, the protein : protein interactions demonstrated in this section give some 
insight into the roles played by these proteins within the replication complex.
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Chapter 4 : Discussion
As described in Chapter 1, a number of methods are now available to study the 
transcription / replication mechanisms in negative strand RNA viruses. Most, if  not all, 
involve the use of a reverse genetics system of one kind or another. Unfortunately, the 
reverse genetics approaches described here proved unsuccessful for the investigation of 
SV5 biology. However, the results presented in this thesis provide evidence for protein 
: protein interactions within the replication complex and possible roles for these 
interactions during virus replication are examined.
This discussion is therefore divided into 4 sections. The first deals with the problems 
associated with our reverse genetics experiments and discusses approaches taken in 
more successful systems. The second discusses viral protein : protein interactions 
within the replication complex. Thirdly, a model for SV5 replication is proposed, with 
respect to the protein : protein interactions presented in Section 2. Finally, section 4 
outlines future applications of genetically engineered negative-strand RNA viruses.
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1 Reverse Genetics of Negative Strand RNA viruses
1.1 Problems associated with our SV5 rescue system
During the course of this study, the generation of a reverse genetics system to study 
SV5 biology proved unsuccessful. Initial experiments utilized a le-CAT-lr genomic 
(negaiive-sense) RNA analogue which was transcribed intracellulaiiy from a transfected 
cDNA clone under T7 promoter control. Synthesis of the synthetic analogue was driven 
by T7 DNA-dependent RNA polymerase, supplied by a recombinant vaccinia virus 
expressing the polymerase (Chapter 3, Section 1.2). However, it was found that the 
recombinant vaccinia virus (VacT7) could generate CAT mRNA directly from the 
cDNA template. Although the reason(s) for this were never determined, similar results 
were found in other laboratories (Dr. C. Ward, Northwestern University; Dr. E. Dunn, 
Glasgow University; personal communication), and can perhaps be attributed to the 
promiscuity of the vaccinia virus DNA-dependent RNA polymerase. The polymerase is 
known to have a consensus core recognition region with no apparent sequence 
requirements upstream of the core or downstream of the initiation site (Reviewed in 
Moss, 1996). It is possible that a sequence similar to this core recognition region had 
been serendipitously encoded within the le-CAT-tr cDNA clone thus allowing CAT 
mRNA transcription directly from the cDNA template.
Alternative methods of generating (and delivering) synthetic CAT transcripts were also 
investigated but irrespective of the method employed for the generation of an SV5 
genome analogue, no CAT activity was detected, suggesting that the input CAT RNA 
had not been transcribed.
It was possible to mimic the molar ratios of the encapsidation proteins (NP, P, V and L) 
seen in an SV5 infection by co-transfecting their respective cDNA clones. Ratios of 
input plasmid DNA were adjusted until target levels of protein expression, driven by 
VacT7, were achieved. This strategy was used to supply viral proteins in tm ns for the 
encapsidation and transcription of the le-CAT-tr RNA transcript, but was unsuccessful.
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Possibly the synthetic nucleocapsid structure was not recognised by the viral 
polymerase, regardless of whether it was supplied by a cDNA clone or by infectious 
vims. However, RNAse protection assays provide some evidence to suggest that the 
CAT transciipt may not have been encapsidated (Dr. C. Ward, personal 
communication) leading to the possibility that the necessary encapsidation substrate had 
not been formed. The protein : protein interactions directing encapsidation,and 
replication were therefore examined using inducible cell lines expressing SV5 proteins. 
The distribution of the encapsidation proteins (NP, P and V) when expressed alone or in 
combination was examined by IF and extracts from these cell lines were subsequently 
used in capture assays to study the interactions in more detail, as discussed in section 2.
1.1 Rescue of infectious recombinant viruses
A successful reverse genetics system has now been developed for SV5 using a cDNA 
clone of the complete genome, which was constructed such that an anti-genome 
(positive sense) RNA could be ti*anscribed by T7 RNA polymerase. This plasmid was 
co-transfected with cDNA clones encoding the viral replication proteins (NP, P and L) 
resulting in the isolation of infectious recombinant virus (He et al, 1997).
The differences in sense between the respective SV5 RNA analogues (positive sense 
full-length genome analogue versus negative sense le-CAT-tr m ini-genome), may have 
contributed to their ability to be rescued, but it remains unclear why a positive sense 
anti-genome analogue would be intrinsically easier to encapsidate that its negative 
sense counterpart. Recent reports on tlie recovery of recombinant viruses such as rabies 
vims (Schnell et at, 1994), VSV(Lawson et al, 1995), MeV (Radecke et al, 1995) and 
SeV (Garcin et at, 1996) do suggest that the use of anti-genomic transcripts may tip the* 
balance in favour of successful rescue.
However, a series of experiments published in a recent report demonstrated that 
intracellular expression of a full-length transcript generated infectious SeV regardless 
of whether the input transcript was positive or negative sense (Kato et at, 1996). 
Success appears to have come by fine tuning the amounts of NP, P and L proteins used 
in the system, constructing plasmids which gave rise to transcripts with 3' and 5’ ends
160
identical to those of wild-type RNA, and by using vaccinia virus inhibitors (rifampicin 
and cytosine arabinoside) to reduce the cytotoxicity of the vaccinia virus.
Once the system had been optimized, these authors found that infectious SeV could be 
recovered by transfecting naked RNA. This supports earlier reports where naked mini­
genome RNAs were amplified and expressed in cells infected with RSV (Collins et al, 
1991), hPIV3 (De and Banerjee, 1993; Dimock and Collins, 1993) and SeV (Park et at, 
1991).
It is interesting to note that the successful SV5 rescue system mentioned above, has yet 
to support amplification and expression from a le-CAT-tr mini-genome construct, 
suggesting that rescue of the CAT mRNA may be more difficult than rescue of a full- 
length infectious clone. Perhaps this can be explained by considering the efficiency of 
rescue of a recombinant virus versus CAT mRNA. In a similar rescue system to that 
used for SV5, it was calculated that one per 10*^  cells contained recombinant rabies 
virus (Schnell et al, 1994) and a similar success rate might be predicted for SV5. Mini- 
replicons (e.g. le-CAT-tr) do not encode the viral proteins necessary for autonomous 
replication and therefore need a constant supply of viral proteins for their propagation. 
Therefore, the mini-genome system would be expected to be much less efficient due to 
the lack of autonomous transcription / replication and consequently would be more 
difficult to detect.
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2 Protein:Protein Interactions within the 
Replication Complex
2.1 P rotein  : P rotein  in teraction s seen  by IF
Immunofluorescence data demonstrated that when NP was expressed alone in an 
inducible cell line, it formed cytoplasmic aggregates, visualised as punctate and 
granular foci (Chapter 3, Section 2.2), This is consistent with a number of other studies 
on paramyxoviruses which have reported that NP forms homopolymers when expressed 
alone (Buchholz eta l, 1993; Horikami et at, 1996; Spehner eta l, 1997). During this 
self-assembly process, cellular RNA can be non-specifically encapsidated (B. Precious, 
unpublished observation) into an RNase resistant form (Buchholz eta l, 1993; Horikami 
eta l, 1996; Spehner eta l, 1997). Moreover when co-expressed with P, NP formed large 
cytoplasmic aggregates similar to the inclusion bodies seen at late times in SV5 
infection (Chapter 3, Section 2.2). In a recent report with MeV, NP and P co-expression 
led to the formation of similar large cytoplasmic aggregates (Spehner et al, 1997), 
supporting our results obtained with SV5.
These findings seemed to contradict a report in the SeV system where P had been 
proposed to act as a chaperone in keeping NP soluble prior to encapsidation (Cunan et 
al, 1995). The recent study with MeV (Spehner eta l, 1997), showed that although co­
expression of NP and P proteins ultimately led to the formation of large cytoplasmic 
aggregates, P did form soluble complexes with NP. These soluble NP-P complexes 
retained the ability to self-assemble into nucleocapsid-like structures, but to a lesser 
extent than when NP was expressed alone. Therefore by analogy to MeV, during 
ongoing viral replication in both SV5 and SeV, soluble NP-P complexes may be formed 
which deliver soluble NP to the elongating RNA chain during encapsidation. However, 
in the absence of viral replication, the NP-P complexes may self-assemble into the large 
cytoplasmic aggregates which, for SV5, were visualised by immunofluorescence as 
inclusion bodies.
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When co-expressed with V, NP expression was found to give diffuse cytoplasmic and 
nuclear fluorescence, suggesting that V prevented the formation of NP aggregates by 
forming soluble NP-V complexes (Chapter 3, Section 2.2). As yet, there is no evidence 
to suggest that NP-V complexes can self assemble in a similar manner to that seen with 
NP-P and possible reasons for this are discussed below.
2 .2  P rotein  : P rotein  in teraction s b y  capture a ssa y
Data from the capture assays demonstrated direct viral protein : protein interactions 
within the rephcation complex and the results are summarised in Fig. 52. Firstly, 
centrifugation of an extract from NP expressing cells demonstrated that NP was found 
in both soluble and polymeric forms (Fig. 52, Panel A). For MeV NP, a 
phosphorylation event seems to trigger a conformational change in NP, thus allowing 
assembly into nucleocapsid structures (Gombart et al, 1993). Perhaps a similar 
phosphorylation event and conformational change is required by SV5 NP prior to 
assembly, which has yet to be demonstrated experimentally.
Both P (Fig 52 Panel Cii, Panel Dii and Panel Dili) and V (Fig.52 Panel Bii) proteins 
were shown to bind the soluble form of NP by capture assay, suggesting each protein 
could act as a chaperone (similar to MeV or SeV P proteins) in keeping NP soluble 
prior to encapsidation. The P and V proteins are amino co-terminal and therefore the 
site of interaction between P/V and soluble NP was predicted to be in this shared N- 
terminal domain. It is possible that binding of V to soluble NP blocks the proposed 
phosphorylation event (which may be necessary for NP assembly), resulting in a 
soluble NP: V complex which cannot self-assemble. Alternatively, the binding of V to 
NP may prevent NP self-assembly by blocking the NP:NP binding site. However, NP:P 
complexes seem to retain their ability to self-assemble, suggesting a difference in 
character between the NP:P and NP:V complexes.
Capture assays also demonstrated that V could not bind polymeric NP, therefore 
suggesting that V cannot bind nucleocapsids (Fig.52 Panel B iii). This contradicts a 
report by Paterson et al, (1995) which suggested that V formed part of the SV5 RNP 
structure. The study relied on immunogold labelling of purified viral nucleocapsids for
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Fig. 52 NP:P and NP:V interactions
A schematic diagram summarising the results obtained by capture assay. 
Monomeric NP is depicted in Panel A(i) where the P/V common binding site 
and the second P binding site are clearly labelled. Polymeric NP is depicted 
in A(ii), where the P/V common binding site has been blocked by a 
conformational change in NP induced upon polymerisation or following a 
phosphoiylation event.
V is shown alone in Panel B(i). The N-terminus of V interacts with soluble 
(monomeric) NP to form a soluble NP:V complex (B ii). However, V is 
unable to interact with polymeric NP (B iii).
Monomeric P is depicted in Panel C(i). Monomeric P may interact with 
soluble NP via the P/V shared N-terminus forming a soluble NP:P complex 
(Panel C ii). Monomeric P may also interact with polymeric NP via its 
extreme C-terminus (Panel C iii).
Trimerised P is depicted in Panel D(i).The number of monomeric NP 
molecules bound simultaneously by a P trimer, remains to be determined.
Therefore, a P trimer may interact with a single NP molecule (Panel D ii) or i
perhaps with three NP molecules (Panel D iii). Panel D (iv) depicts the C- j
termini of the P trimer interacting with polymeric NP.
i)
P/V common
P binding site
binding site
Soluble NP molecule
P/Vcommon 
site blocked
B
ii) iii)
SV5 V
N-terminus of V 
interacts with 
monomeric NP but V 
cannot interact with 
polymeric NP (iii).
C-terminus of monomeric P 
interacting with polymeric NP.
Monomeric P N-terminus of monomeric 
P interacting with 
monomeric NP.
D
C-termini of trimerised P interacting 
with polymeric NP.
Trimerised P N-terminus of trimerised P 
interacting with a single 
NP monomer.
iii) N-termini of trimerised P interacting with 
three NP monomers.
Fig.52 NP:P and NP: V interactions
examination by electron microscopy. The data presented, clearly showed V on the 
surface of the nucleocapsid. However, the paper was written with a caveat as the 
authors could not be sure if M (and its associated proteins) had been completely 
removed from the nucleocapsid preparations. Therefore it was not clear if V was 
binding the nucleocapsids or merely associated with the contaminating proteins. 
Alternatively, it is possible that V interacts directly with viral RNA. However, the 
capture assays presented in this thesis were performed many times with reproducible 
results, demonstrating that V cannot bind assembled NP. Therefore the alternate 
explanations offered by Paterson et al are favoured.
Since only P (and not V) could bind polymeric NP (Fig.52 Panels C iii and D iv), the P- 
unique C-terminus of the protein was predicted to contain the site of interaction with 
polymeric NP. Taken together, these data suggest there are two binding sites on P for 
NP; the soluble NP binding site, found in the N-tenuinus (common to both P and V 
proteins), and the polymeric NP binding site, found in the P-unique C-terminus. 
Furthermore, the results also suggest that there are two binding sites on NP for P; one 
on soluble NP which is recognised by both P and V proteins, and the other on polymeric 
NP, which is recognised by P only. When assembled, the P/V common binding site on 
NP must be either hidden or conformationally altered thus preventing recognition by V. 
If merely hidden, one would expect at least one site to be available for binding by V. No 
V interaction with polymeric NP has ever been detected so, although possible, it seems 
more likely that NP undergoes a conformational change upon polymerisation. Equally, 
this conformational change may have occuned prior to polymerisation following the 
proposed phosphorylation event mentioned previously. Either way, it seems likely that a 
conformational change in NP takes place which masks the common P/V binding site on 
polymeric NP (Fig.52 Panel A ii).
2 .3  P  in teraction  w ith  p o lym eric  N P
A mAb specific to the C-terminus of P, SV5 P-e. blocked the interaction of P with 
polymeric NP (Chapter 3, Section 3.2). This suggested that the site of interaction 
between P and polymeric NP contained, at least in part, the SV5 P-e epitope. By 
deletion mutant analysis of the C-terminus of the P protein, the extreme C-temiinal 29
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amino acids were predicted to contain the SV5 P-e epitope and therefore the site of 
interaction between P and polymeric NP.
However, one question remained unanswered. P is known to form a homotrimer and is 
thought to only bind the nucleocapsid as a irimer (Curran, 1996). Therefore, does SV5 
P-e block P binding to polymeric NP by merely preventing P trimérisation? In SeV, the 
trimérisation domain was identified as amino acids 344-411, whereas in the 
Rubukivirus, hPIV2, this domain was recently identified as amino acids 211-248 
(Nashio et al, 1997). The binding of SV5 P-e to P protein should not interfere with the 
analogous SV5 trimérisation domain. All of the P deletion mutants (except P-Scal, 174 
amino acids) would also be anticipated to form homotrimers since the predicted 
trimérisation domain in the mutants would be intact. Therefore, it is anticipated that 
SV5 P-e does not prevent P trimérisation but nonetheless blocks P binding to polymeric 
NP.
Since bacterially expressed P also binds polymeric NP and only trimerised P is thought 
to bind polymeric NP, then it could be suggested that bacterially expressed P must also 
form trimers (Chapter 3, Section 3.3). This suggests tliat P protein trimerises 
independently to its phosphorylation state, since bacterially expressed P trimers would 
have no post-translational modifications associated with the mammalian system.
It is not clear whether one molecule of P can bind both soluble and polymeric NP at the 
same time. Perhaps the binding of soluble NP prevents P from binding polymeric NP. If 
this was the case, then it is easier to visualise P acting as a chaperone for soluble NP.
2 .4  T h e  n u clear lo ca lisa tio n  sign a l
A nuclear localisation site has been identified in the V protein of hPIV2 and mapped to 
the extreme N-terminal amino acids 1-46 (Wantanabe eta l, 1996). This study reported 
that when co-expressed with V, NP was transported to the nucleus in the absence of 
virus replication, supporting IF data presented in this tliesis (Chapter 3, Section 2.2). 
What is curious, however, is that the domain in V identified as responsible for the 
nuclear targeting in hPIV2, (nuclear localisation signal), and so by analogy in SV5, is 
found in the P/V common domain, yet P is never found in the nucleus whether 
expressed alone or co-expressed with NP. This suggests that the nuclear localisation
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signal in P is blocked, possibly due to a difference in conformation between the P and 
V proteins.
Trimérisation of P is thought to take place almost immediately after translation (Nashio 
et al, 1997; Curran et al, 1996). Therefore it is possible that a conformational change in 
the trimer structure compared to the monomer prevents the nuclear localisation signal 
from being recognised.
167
3 A model for RNA Replication
During viral transcription, the polymerase complex responds to signals telling it to 
generate discrete leader and mRNAs. In contrast, during replication, the polymerase 
must ignore these signals and generate genome-length positive strand RNA. This RNA 
is then replicated to form the genomic minus-strand RNA. An accepted model to 
explain the switch between transcription and replication states that newly synthesized 
NP binds the nascent RNA thus preventing recognition of the termination signals. This 
model is supported by work on VSV where leader sequence was shown to be 
selectively encapsidated by NP (Blumberg et al, 1983).
The model is attractive because immediately after virus entry, transcription would be 
favoured over replication. However, at later times in infection, when the NP 
concentration has increased, replication would be favoured.
A recent study on SeV P protein suggested that only trimeric P could interact with L 
thus forming the active polymerase complex which could interact with the RNP 
template via the C-terminal tails of the P trimer (Curran et al, 1997). Transcription or 
replication of the genome (or anti-genome) template would rely on the polymerase 
complex being able to traverse the length of the template (Fig.53, Panel A). These 
authors detennined that only 2 C-terminal tails of the trimer were necessary for stable 
interaction with the RNP but all 3 were necessary for viral RNA synthesis. Therefore, 
the third C-terminal leg of the trimer was proposed to be involved in P migration along 
the length of the RNP template. Simultaneous breaking and reforming of contacts 
between the third C-tenninal leg and the RNP, such that two legs are always in contact 
with the RNP, would lead to polymerase movement along the template by a rotation 
mechanism.
The overall replication process can be broadly split into 3 mechanistically linked 
processes: initiation of RNA synthesis, initiation of RNA encapsidation and elongation 
of encapsidation. Both P and V may have active roles in both the encapsidation and 
elongation steps of genome replication. Alternatively, V may play a role in replication
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A Ongoing viral 
replication
IvCader or anti­
leader 
sequence
Polymerase complex 
(P-L)
Encapsidated replication template 
(Genome or anti-genome)
Jascent encapsidated 
RNA
(Genome or anti-genome)
B  Initiation of RNA 
encapsidation
Leader or anti­
leader 
sequence
Polymerase complex 
(P-L)
Encapsidated replication template 
(Genome or anti-genome)
Point of initiation for encapsidation of 
nascent RNA (Genome or anti-genome).
A B C D E 
Molecules with the potential to initiate encapsidation of 
nascent RNA. A soluble NP molecule (A), soluble NP;V 
complex (B), monomeric P in a soluble NP;P complex 
(C), trimeric P in a soluble NP;P complex with a single 
NP molecule (D) and trimeric P in a soluble NP;P 
complex with 3 NP molecules (E).
Fig. 53 Initiation of RNA encapsidation during replication
inhibition and/or viral pathogenesis. The possible role(s) of these proteins in the steps 
of genome replication are discussed below.
3.1  In itia tion  o f  R N A  sy n th esis
Little is known about the mechanism which initiates paramyxovirus RNA synthesis. 
The polymerase complex (P/L) is thought to bind at the 3' terminus of the RNA 
template, which acts as the sole polymerase entry site, or promoter, for the initiation of 
RNA synthesis during both transcription and replication. The leader (and anti-leader) 
sequences have therefore been assumed to contain specific recognition sequences for 
the polymerase, but the mechanism of polymerase targeting to the precise 3' terminus 
has yet to be defined.
3 .2  In itia tion  o f  R N A  en cap sid ation
In the absence of encapsidation, the leader sequence is lost, resulting in polymerase 
reinitiation at the junction between the leader and the first protein-encoding gene. At 
this point the polymerase is committed to transcriptase mode, leading to the generation 
of discrete viral mRNAs. Therefore one of the most important events during viral 
replication, is tlie initiation of nascent RNA encapsidation.
A model for the initiation of RNA encapsidation is given in Fig.53 (Panel B), and 
suggests a number of candidates which could theoretically deliver the initial NP 
molecule to the 5’ terminus of the nascent genomic RNA. A soluble NP molecule has 
the potential to bind at the 5’ end of the nascent RNA genome thus initiating 
encapsidation. However, it is unclear how this molecule could direct its own binding to 
the precise 5' end of the nascent RNA and therefore although possible, this does not 
seem the most feasible candidate.
A soluble NP:V complex could potentially be targeted to the 5' end of the nascent 
genome by V binding directly to the nascent RNA, thus anchoring the first NP 
molecule at the end of the genome. Once the first NP molecule is bound to the RNA, 
the elongation process can begin. It is possible that V would be released from the
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complex by ihe conformational change in NP proposed above, thus allowing V to bind a 
further NP molecule.
NP:P complexes could play a similar role in the initiation of nascent RNA 
encapsidation but may not dissociate from the template after delivery of the NP 
molecule. If the P trimer remained bound to the 5' end of the nascent genomic RNA, a 
further L protein could be recruited to the promoter site for further rounds of 
transcription/replication of the nascent RNP.
3.3 Elongation of RNA encapsidation
Once initiated, a constant supply of encapsidation substrate must be available for the 
elongation process which ensures the entire genome/anti-genome is encapsidated. A 
schematic diagram depicting the delivery of soluble NP during the elongation step of 
RNA encapsidation, is shown in Fig. 54. The mechanism described for the initiation of 
RNA encapsidation can also be used during the elongation phase. The NP:P and NP:V 
complexes described above could then play chaperoning roles for delivery of soluble 
NP to the nascent nucleocapsid, allowing P or V proteins to dissociate once delivery is 
complete. Fig.54 Panel A, shows the NP:V complex delivering a soluble NP molecule 
to the elongating nucleocapsid. Once delivered, V would dissociate from the 
polymerised chain due to the proposed conformational change in NP and would be free 
to re-associate with further soluble NP molecules, thus continuing the elongation 
process.
NP:P complexes may use the same mechanism to deliver NP to the growing 
nucleocapsid as outlined for NP:V. Once the NP molecule(s) have been delivered, P 
may dissociate from the nascent nucleocapsid to bind further soluble NP molecules 
(Fig.54, Panels B and C). P may, however, remain in association with the nucleocapsid 
to target L protein to the nascent RNP in preparation for virion assembly and release 
(Fig.54, Panel D). Alternatively, P may target L onto the nucleocapsid for further 
rounds of transcription / replication as mentioned above. However, since the only 
polymerase entry site (promoter) is at the 3' end of the genome, any new P-L coiuplexes
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Fig. 54 Delivery of soluble NP to nascent RNA for encapsidation.
Schematic diagram depicting potential mechanisms for the delivery of soluble NP to the 
nascent RNA during the elongation step of RNA encapsidation. Panel A shows soluble 
NP:V complexes as the substrate for encapsidation. NP is held in a soluble NP:V complex 
until it is delivered to the growing nucleocapsid chain. Once bound to the nascent 
nucleocapsid, V dissociates, allowing it to complex with a free NP molecule thus foiming 
anotlier soluble NP:V complex.
Panel B shows monomeric P in soluble NP:P complexes as the substrate for 
encapsidation. By the same mechanism as Panel A, soluble NP:P complexes can be used 
to deliver NP to the nascent nucleocapsid, leading to dissociation of P. The P molecule is 
now free to bind more soluble NP thus forming a another soluble NP:P complex.
Panel C shows trimeric P in soluble NP:P complexes as the substrate for encapsidation. 
The NP:P complex is depicted as trimeric P binding one NP molecule, but trimeric P 
could have equally been depicted as binding three NP molecules. Again the delivery 
mechanism shown, leads to dissociation of the trimeric P after delivery of the NP 
molecule(s) to the growing nucleocapsid chain, allowing trimeric P to bind further NP 
molecules.
In Panel D, P trimers are depicted as binding 3 NP molecules in a soluble NP:P complex 
which acts as the encapsidation substrate. Once the NP molecules are delivered, P is 
depicted as staying bound to the nascent nucleocapsid. By remaining bound, P can recruit 
the polymerase protein (L) to form an active polymerase complex (P-L) in preparation for 
virion assemble and release.
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formed along the length of the RNP would have to dissociate from the nucleocapsid and 
re-associate at the promoter region (Fig.54, Panel D).
3.4 Possible roles for V in replication
The V and W proteins of SeV have been shown to both inhibit genome replication and 
also form complexes with soluble NP (Horikami et al, 1996) and is in agreement witli 
the results presented in this thesis (Randall and Bermingham, 1996). A recent study on 
SeV suggested that monomeric P, as well as V and W proteins, could bind soluble NP 
but these soluble complexes were subsequently unable to form active assembly 
complexes for encapsidation (Curran et al, 1997). This suggests that SV5 NP:V 
complexes may not be active in RNP assembly as outlined thus far. Even if the NP: V 
complex plays no direct role in encapsidation, a role in the inhibition of genome 
replication can be postulated.
V may compete with P for the common binding site on NP thus delaying encapsidation 
by depleting the pool of soluble NP available for encapsidation and would result in 
inhibition of genome replication. NP: V complex formation would also prevent both 
NP:NP homopolymer and NP:P heteropolymer formation in the absence of RNA 
replication.
However, the possible roles ascribed to V for inhibition of genome replication or 
initiation of encapsidation may be auxiliary functions to the fundamental mechanism of 
paramyxovirus replication. He et al (1997) successfully rescued a full-length SV5 anti­
genome clone by supplying only NP, P and L protein (and not V protein) suggesting 
that the synthetic RNA had undergone at least one round of replication in the absence of 
V. (After the initial round of replication, the resultant negaiive-sense RNA could be 
used as a transcription template, thus generating V mRNA and therefore V protein.)
This suggests that V is non-essential for SV5 replication and supports similar findings 
from both SeV (Kato et al, 1997a; Delenda etal, 1997)and MeV (Schneider et al,
1997).
In the two recent reports on SeV, full-length recombinant viruses were rescued from 
cDNA clones which did not encode a V protein, thus demonstrating that V was not an 
essential factor for SeV replication (Delenda etal, 1997; Kato et al, 1997a). The latter
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report found that the recombinant virus displayed augmented gene expression and 
cytopathogenicity in vitro, but was strongly attenuated in mice.
A further study by Kato et al (1997b) generated a recombinant SeV expressing a C- 
terminally deleted V protein ( V a c )  for comparison to the V-minus and wild-type SeV. 
Vac virus was able to grow in both tissue culture and in eggs, strengthening further the 
notion that V is a non-essential gene product. However, expression of the N-terminal 
domain of V protein alone was sufficient to convert the augmented phenotype, due to 
total deletion of V protein, to the phenotype characteristic of the wild-type SeV. The 
mechanism for maintaining the normal phenotype, probably involving the N-terminus 
of NP, remains to be elucidated, but may involve the NP chaperoning function 
associated with this region of V.
The V a c  virus, like the V-minus virus, was found to be much less pathogenic in vivo 
than wild-type SeV, supporting the notion that V protein encodes a luxury function for 
in vivo pathogenesis (Kato et a1,1997). A similar basis for attenuation was suggested 
for both the V-minus and V a c  viruses by postulating that the C-terminal half of the V 
protein contained the element important for SeV pathogenesis.
Perhaps V is necessary to evade host defence mechanisms such as natural killer (NK) 
cells and induction of interferons (Anderson, 1982; Muller et al, 1994) but these 
evasion pathways have yet to be elucidated. Recent work in this laboroatory has shown 
that SV5 V protein specifically interact with a cellular protein of 150 kDa, which has, 
as yet, not been identified (Precious et al, 1995). It would be interesting to see if this 
unidentified protein played any role in triggering the anti-viral response in the infected 
cell and if so, was this role in any way impaired by the binding of V.
In the Rubulaviruses , the V gene is encoded by the genome, while in the 
Parainfluenzaviruses and Morbilliviruses encode the P gene and generate V protein by 
mRNA editing. Also, during an SV5 infection, more V mRNA than P mRNA is 
transcribed (B. Precious and R.E. Randall, unpublished observations) suggesting an 
important role for V in the virus life-cycle.
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4 The future for negative-sense RNA viruses
The ability to genetically alter negative-strand RNA viruses has enhanced this field of 
virology and may have a major influence on future developments of structure-function 
analysis, vaccine development and the use of virus vectors. Firstly, structure-function 
studies of individual genes are now possible, in the context of an infectious virus, for a 
number of negative-strand RNA virus families, including a number of medically 
important viruses (e.g. MeV, RSV, hPIV3 and influenza viruses). In the recent past, 
viral genes were studied in isolation by cloning and expressing them in different 
systems. Current approaches favour questioning the roles played by viral genes and 
gene products when interacting with host cell components and the host in general. This 
can be best done by studying genetically defined viruses and subjecting them to direct 
mutational analysis of individual genes, promoter elements or other non-coding 
sequences. These recombinant viruses can then be subjected to biochemical analysis 
and studies on replication, both in vitro and in vivo.
Secondly, genetically engineered negative-strand RNA viruses could become live virus 
vaccine candidates. The tools are now available to design a new generation of vaccines 
for the medically important negative-strand RNA viruses, such as RSV and 
parainfluenza viruses, where previous approaches have failed to result in acceptable 
vaccine candidates.
Finally, negative-strand RNA viruses may become useful vectors for the expression of 
foreign genes. Recombinant rabies vims (Mebatsion et. al, 1996), VSV (Schnell et al,
1996) and SeV (Hasan et al, 1997) have already been used to express additional protein 
sequences or foreign genes. The major advantage in using negative-strand RNA viruses 
as vectors (or vaccines) is that these viruses do not go tlirough a DNA phase and thus 
cannot transform cells by integrating their genetic information into the host genome. 
Furthermore, homologous recombination has never been observed in any of these 
negative-strand RNA viruses. Therefore, contaminating virus should not be generated 
when replication-incompetent viral constructs are grown in complementing cell lines.
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The negative-strand RNA virus vectors are therefore safer, and thus more attractive, 
than their DNA counterparts.
The solution to may of the issues discussed in this thesis will depend on the continued 
development of novel strategies to study viruses and their interaction with the host cell, 
leading us to a better understanding of the natural world.
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Appendix 2
i) Primers used in the construction of pUCSVSCAT as 
shown in Fig. 17
1) SV5 Leader region forward primer
Sacl
5' ATC TTC GAG CTCTTC CAC CAG GOG AAA ATG TGG TGA CTC AAA TCA 
TCG AAG ACC CTC GAG ATT ACA TAG GTC CGG 3'
Forward primer in PCR reaction to generate pUCSVSCAT from pUCSVSTKCAT.
2) Beginning of CAT ORF reverse primer
BstllOVl
5' CAA CGG TGG TAT ACC CAG TGA TTT TTT TCT CCA TTT TTG TGT CGG 
GGA CGA AAA ATT GC 3'
Reverse primer in PCR reaction to generate pUCSVSCAT from pUCSVSTKCAT.
ii) Primers used in the construction of pGEM-BLNP as 
shown in Fig. 20
1) NP forward primer
BamHl l> Beginning of NP ORF 
5' TAG CCT GGA TCC ATG TCA TCC GTC CTTAAA GCA 3'
Forward primer in PCR reaction for pGEM-BLNP from pBR322NP and vRNA
2) NP reverse primer
Hindlll k  End of NP ORF 
5' TAG CCT AAG CTT CTA GAT GCTAAG ATC ACC CAG TGC 3'
Reverse primer in PCR reaction for pGEM-BLNP from pBR322NP and vRNA
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iii) Primers used in the construction of pGEMpGlobinNP 
as shown in Fig. 25.
1) pGlobin forwar d primer
EcoRl
5' TAG ATA GAA TTC ACA CTT GCT TTT GAC ACA ACT GTG TTT ACT TGC 
AAT CCC CCA AAA CAG ACA GAA TG 3'
Forward PCR primer used to generate pGEMpGlobinNP from pGEMBLNP where NP 
ORF initiation ATG is shown in Italics.
2) pGlobin reverse primer
Ndel
5’ ACT ATC GCT CAT ATG CTT TAA GCA CGG ATG ACA TTC TGT CTG TTT 
TGG 3'
Reverse PCR primer used to generate pGEM(3GlobinNP from pGEMBLNP where NP 
ORF sequences are shown in Italics.
iv) Primers used in the constraction of pPANHAN as 
shown in Fig. 30.
1) pPANHAN forward primer
Hindlll
5' GAA TCA GAA TAG GTA TAA GCT TAA AGA AGA GGA T 3 ’
Foiwai'd primer in PCR reaction to generate pPANHAN from pT7.1.
2) pPANHAN reverse primer
Sail
5' GCG GTC GAC GCT GAG TAG CAA GGG GAA 3’
Reverse primer in PCR reaction to generate pPANHAN from pT7.1.
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